The Manitowoc Company, Inc. (MTW) 10-K 23 Feb 24 2023 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Jan. 31, 2024	Jun. 30, 2023
Cover [Abstract]
Entity Registrant Name	The Manitowoc Company, Inc.
Entity Central Index Key	0000061986
Trading Symbol	MTW
Document Type	10-K
Document Period End Date	Dec. 31, 2023
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
ICFR Auditor Attestation Flag	true
Document Financial Statement Error Correction [Flag]	false
Entity Public Float			$ 640.5
Entity Shares Outstanding		35,096,908
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	FY
Entity File Number	1-11978
Entity Tax Identification Number	39-0448110
Entity Address, Address Line One	11270 West Park Place
Entity Address, Address Line Two	Suite 1000
Entity Address, City or Town	Milwaukee
Entity Address, State or Province	WI
Entity Address, Postal Zip Code	53224
City Area Code	414
Local Phone Number	760-4600
Entity Incorporation, State or Country Code	WI
Title of 12(b) Security	Common Stock, $.01 Par Value
Security Exchange Name	NYSE
Entity Interactive Data Current	Yes
Document Annual Report	true
Document Transition Report	false
Documents Incorporated by Reference	Portions of the registrant’s Proxy Statement for the 2024 Annual Meeting of Shareholders, are incorporated by reference in Part III of this Annual Report on Form 10-K
Auditor Name	DELOITTE & TOUCHE LLP
Auditor Location	Milwaukee, Wisconsin
Auditor Firm ID	34

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Net sales	$ 2,227.8	$ 2,032.5	$ 1,720.2
Cost of sales	1,802.6	1,668	1,413
Gross profit	425.2	364.5	307.2
Operating costs and expenses:
Engineering, selling and administrative expenses	328.3	281	258.5
Asset impairment expense	0	171.9	1.9
Amortization of intangible assets	3.2	3.1	1.4
Restructuring (income) expense	1.3	1.5	(1.1)
Total operating costs and expenses	332.8	457.5	260.7
Operating income (loss)	92.4	(93)	46.5
Other income (expense):
Interest expense	(33.9)	(31.6)	(28.9)
Amortization of deferred financing fees	(1.3)	(1.4)	(1.5)
Other income (expense) — net	(13)	5.8	1
Total other expense - net	(48.2)	(27.2)	(29.4)
Income (loss) before income taxes	44.2	(120.2)	17.1
Provision for income taxes	5	3.4	6.1
Net income (loss)	$ 39.2	$ (123.6)	$ 11
Per Share Data
Basic income (loss) per common share	$ 1.12	$ (3.51)	$ 0.32
Diluted income (loss) per share	$ 1.09	$ (3.51)	$ 0.31

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Statement of Comprehensive Income [Abstract]
Net Income (Loss)	$ 39.2	$ (123.6)	$ 11
Other comprehensive income (loss), net of income tax:
Unrealized gains (losses) on derivatives,net of income tax provision of $0.0, $0.0 and $0.0, respectively	(4.1)	5.4	0
Employee pension and postretirement benefit income (expense), net of income tax (provision) benefitof $0.7, $(1.1) and $(0.4), respectively	5	17	15.6
Foreign currency translation adjustments, net of income tax (provision) benefit of $0.1, $(0.4) and $5.1, respectively	20.6	(27.9)	(20.5)
Total other comprehensive income (loss), net of income tax	21.5	(5.5)	(4.9)
Comprehensive income (loss)	$ 60.7	$ (129.1)	$ 6.1

Consolidated Statements of Co_2

Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Statement of Comprehensive Income [Abstract]
Unrealized gain (loss) on derivatives, net of income tax provision	$ 0	$ 0	$ 0
Employee pension and post retirement benefits costs, net of income tax benefit (provision)	0.7	(1.1)	(0.4)
Foreign currency translation adjustments, net of income tax provision (benefit)	$ 0.1	$ (0.4)	$ 5.1

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Current Assets:
Cash and cash equivalents	$ 34.4	$ 64.4
Accounts receivable, less allowances of $6.1 and $5.3, respectively	278.8	266.3
Inventories	666.5	611.9
Notes receivable — net	6.7	10.6
Other current assets	46.6	45.3
Total current assets	1,033	998.5
Property, plant and equipment - net	366.1	335.3
Operating lease right-of-use assets	59.7	45.2
Goodwill	79.6	80.1
Intangible assets - net	125.6	126.7
Other non-current assets	42.7	29.7
Total assets	1,706.7	1,615.5
Current Liabilities:
Accounts payable and accrued expenses	457.4	446.4
Customer advances	19.2	21.9
Short-term borrowings and current portion of long-term debt	13.4	6.1
Product warranties	47.1	48.8
Other liabilities	26.2	24.6
Total current liabilities	563.3	547.8
Non-Current Liabilities:
Long-term debt	358.7	379.5
Operating lease liabilities	47.2	34.3
Deferred income taxes	7.5	4.9
Pension obligations	55.8	51.7
Postretirement health and other benefit obligations	5.6	8.2
Long-term deferred revenue	24.1	15.6
Other non-current liabilities	41.2	35.7
Total non-current liabilities	540.1	529.9
Commitments and contingencies (Note 19)
Total stockholders' equity:
Preferred stock (3,500,000 shares authorized of $.01 par value; none outstanding)	0	0
Common stock (75,000,000 shares authorized, 40,793,983 shares issued, 35,094,993 and 35,085,008 shares outstanding, respectively)	0.4	0.4
Additional paid-in capital	613.1	606.7
Accumulated other comprehensive loss	(86.4)	(107.9)
Retained earnings	143.5	104.3
Treasury stock, at cost (5,698,990 and 5,708,975 shares, respectively)	(67.3)	(65.7)
Total stockholders’ equity	603.3	537.8
Total liabilities and stockholders' equity	$ 1,706.7	$ 1,615.5

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Accounts Receivable, allowances (in dollars)	$ 6.1	$ 5.3
Preferred stock authorized (in shares)	3,500,000	3,500,000
Par value of preferred stock per share (in dollars per share)	$ 0.01	$ 0.01
Preferred stock outstanding (in shares)	0	0
Common stock, shares authorized (in shares)	75,000,000	75,000,000
Common stock, shares issued (in shares)	40,793,983	40,793,983
Common stock, shares outstanding (in shares)	35,094,993	35,085,008
Treasury Stock, Common, Shares	5,698,990	5,708,975

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Cash Flows From Operating Activities
Net income (loss)	$ 39.2	$ (123.6)	$ 11
Adjustments to reconcile net income (loss) to cash provided by operating activities:
Asset impairment expense	0	171.9	1.9
Depreciation	56.6	60.6	45.5
Amortization of intangible assets	3.2	3.1	1.4
Stock-based compensation expense	11.5	8.5	7.1
Amortization of deferred financing fees	1.3	1.4	1.5
Loss (gain) on sale of property, plant and equipment	0	(0.9)	0.2
Net unrealized foreign currency transaction losses (gains)	(4.5)	(3.2)	0.7
Income tax benefit from change in reserve of uncertain tax positions	0	(11)	0
Deferred income tax expense (benefit) - net	(6)	4.4	0.6
Loss on foreign currency adjustments	9.3	0	0
Other	0	0.9	3.2
Changes in operating assets and liabilities
Accounts receivable	(9.3)	(36.4)	(5.2)
Inventories	(46.7)	(42)	(68.3)
Notes receivable	5.7	8.3	1
Other assets	(5.2)	5.8	(7.6)
Accounts payable	(28.5)	40.4	62.9
Accrued expenses and other liabilities	36.4	(11.3)	20.3
Net cash provided by operating activities	63	76.9	76.2
Cash Flows From Investing Activities
Capital expenditures	(77.4)	(61.8)	(40.4)
Proceeds from sale of fixed assets	5.6	1.5	0.3
Acquisition of business (Note 3)	0	2.3	(186.2)
Net cash used for investing activities	(71.8)	(58)	(226.3)
Cash Flows From Financing Activities
Proceeds from (payments on) revolving credit facility - net	0	(20)	(100)
Payments on revolving credit facility	(20)	0	0
Proceeds from (payments on) other debt - net	3.8	(5.1)	(4.9)
Debt issuance and other debt related costs	0	(1.9)	0
Exercises of stock options	0.3	0.1	5.8
Common stock repurchases	(5.5)	(3)	0
Net cash provided by (used for) financing activities	(21.4)	(29.9)	100.9
Effect of exchange rate changes on cash and cash equivalents	0.2	0	(4.1)
Net decrease in cash and cash equivalents	(30)	(11)	(53.3)
Cash and cash equivalents at beginning of period	64.4	75.4	128.7
Cash and cash equivalents at end of period	34.4	64.4	75.4
Supplemental Cash Flow Information
Interest paid	34	30.8	28.9
Income taxes (paid) refunded	$ (10.1)	$ (7.3)	$ 3.7

Consolidated Statements of Equi

Consolidated Statements of Equity - USD ($) $ in Millions	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Retained Earnings	Treasury stock common member
Balance at beginning of period at Dec. 31, 2020		$ 0.4	$ 595.1	$ (97.5)	$ 216.9	$ (71.4)
Increase (Decrease) in Stockholders' Equity
Stock options exercised and issuance of other stock awards			0.2			5.5
Common stock repurchases						0
Stock-based compensation expense			7.1
Other comprehensive income (loss)				(4.9)
Net income (loss)	$ 11				11
Balance at end of period at Dec. 31, 2021	662.4	0.4	602.4	(102.4)	227.9	(65.9)
Increase (Decrease) in Stockholders' Equity
Stock options exercised and issuance of other stock awards			(4.2)			3.2
Common stock repurchases						(3)
Stock-based compensation expense			8.5
Other comprehensive income (loss)				(5.5)
Net income (loss)	(123.6)				(123.6)
Balance at end of period at Dec. 31, 2022	537.8	0.4	606.7	(107.9)	104.3	(65.7)
Increase (Decrease) in Stockholders' Equity
Stock options exercised and issuance of other stock awards			(5.1)			3.9
Common stock repurchases						(5.5)
Stock-based compensation expense			11.5
Other comprehensive income (loss)				21.5
Net income (loss)	39.2				39.2
Balance at end of period at Dec. 31, 2023	$ 603.3	$ 0.4	$ 613.1	$ (86.4)	$ 143.5	$ (67.3)

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Pay vs Performance Disclosure
Net Income (Loss)	$ 39.2	$ (123.6)	$ 11

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Dec. 31, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false

Company and Basis of Presentati

Company and Basis of Presentation	12 Months Ended
	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Company and Basis of Presentation	1. Company and Basis of Presentation The Manitowoc Company, Inc. (“Manitowoc” or the “Company”) was founded in 1902 and has over a 120-year tradition of providing high-quality, customer-focused products and aftermarket support services to its markets. Manitowoc is one of the world's leading providers of engineered lifting solutions. Manitowoc, through its wholly owned subsidiaries, designs, manufactures, markets, distributes, and supports comprehensive product lines of mobile hydraulic cranes, lattice-boom crawler cranes, boom trucks, and tower cranes under the Aspen Equipment, Grove, Manitowoc, MGX Equipment Services, National Crane, Potain, and Shuttlelift brand names. The Company serves a wide variety of customers, including dealers, rental companies, contractors, and government entities, across the petrochemical, industrial, commercial construction, power and utilities, infrastructure and residential construction end markets. Due to the ongoing and predictable maintenance needed by cranes, as well as the high cost of crane downtime, Manitowoc’s aftermarket support operations provide the Company with a consistent stream of recurring revenue. Manitowoc's principal executive offices are located at 11270 West Park Place Suite 1000, Milwaukee, Wisconsin 53224. Basis of Presentation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. All amounts, except per share data and share amounts, are in millions throughout the tables in these notes unless otherwise indicated.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies Cash and Cash Equivalents The Company considers all cash, bankers acceptance and short-term investments purchased with an original maturity of three months or less as cash and cash equivalents. Allowance for Credit Losses Accounts receivable are reduced by an allowance for amounts that may become uncollectible in the future. The Company's allowance for credit losses is based on an estimate of the losses inherent in amounts billed, pools of receivables with similar risk characteristics, existing and future economic conditions, reasonable and supportable forecasts that affect the collectability of the related receivable and any specific customer collection issues the Company has identified. The following table is a rollforward of the allowance for credit losses for the years ended December 31, 2023, 2022 and 2021. 2023 2022 2021 Balance at beginning of period $ 5.3 $ 7.3 $ 8.5 Bad debt expenses 2.3 0.1 — Use of reserve ( 1.4 ) ( 1.8 ) ( 1.3 ) Currency translation ( 0.1 ) ( 0.3 ) 0.1 Balance at end of period $ 6.1 $ 5.3 $ 7.3 Inventories Inventories are valued at the lower of cost or net realizable value. Finished goods and work-in-process inventories include material, labor and manufacturing overhead costs. The Company determines inventory value using the first-in, first-out and average cost methodologies. Business Combinations The Company accounts for business combinations under the acquisition method in accordance with Accounting Standards Codification (“ASC”) Topic 805, Business Combinations (“Topic 805”). The acquisition method requires identifiable assets acquired and liabilities assumed and any non-controlling interest in the business acquired be recognized and measured at fair value on the acquisition date, which is the date that the Company obtains control of the acquired business. The amount by which the fair value of consideration transferred as the purchase price exceeds the net fair value of assets acquired and liabilities assumed is recorded as goodwill. The Company expenses transaction costs in a business combination. Goodwill and Intangible Asset s The Company accounts for goodwill and intangible assets under the guidance of ASC Topic 350-10, “Intangibles — Goodwill and Other” (“Topic 350”). Under ASC Topic 350, goodwill is not amortized; instead, the Company performs an annual impairment test. The date for the annual impairment test is October 31 or more frequently if events or changes in circumstances indicate that the assets might be impaired. To perform its goodwill impairment test, the Company uses a combination of the income approach and market approach with a weighting of 70/30, respectively, to determine the fair value of the Middle East and Asia Pacific (“MEAP”) reporting unit. The Company uses only the income approach to determine the fair value of the Americas - Distribution reporting unit due to a lack of comparable peer companies to determine fair value under the market approach. Impairment is determined based on the amount in which a reporting unit's carrying value exceeds its fair value, not to exceed the carrying amount of goodwill at the reporting unit. In addition, goodwill of a reporting unit is tested for impairment between annual tests if an event occurs or circumstances change that would more-likely-than-not reduce the fair value of a reporting unit below its carrying value. The Company’s indefinite-lived intangible assets are not amortized but are subject to an annual impairment test. To perform its indefinite-lived intangible assets impairment test, the Company uses a fair-value method based on a relief of royalty valuation approach to determine the fair value of its indefinite-lived intangible assets. Management’s judgments and assumptions about the amounts of those cash flows and the discount rates are inputs to the annual impairment test. Impairment is determined based on the amount in which the carrying value of the indefinite-lived intangible asset exceeds its fair value, not to exceed the carrying amount of the indefinite-lived intangible asset. Refer to Note 10, “Goodwill and Intangible Assets,” for further details on the Company's impairment assessments. The Company’s definite-lived intangible assets subject to amortization are subject to impairment testing whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. If an indicator of impairment is identified, the Company would use the undiscounted cash flow model. The Company’s intangible assets subject to amortization are amortized straight-line over the following minimum and maximum estimated useful lives according to the Company's policy: Years Patents 20 Customer relationships 12 - 18 Trademarks and tradenames 5 Noncompetition agreements 5 Property, Plant and Equipment Property, plant and equipment are stated at cost. Expenditures for maintenance and repairs are charged against earnings as incurred. Expenditures for major renewals and improvements that substantially extend the capacity or useful life of an asset are capitalized and depreciated over the remaining estimated useful life. The cost and accumulated depreciation for property, plant and equipment sold, retired or otherwise disposed of are relieved from the accounts, and resulting gains or losses are reflected in earnings. Property, plant and equipment are depreciated over the asset’s estimated useful life using the straight-line depreciation method for financial reporting and accelerated methods for income tax purposes. The Company also has certain leasehold improvements which are depreciated over the lesser of the asset's useful life or lease term using the straight-line depreciation method. Property, plant and equipment are generally depreciated over the following estimated useful lives according to the Company's policy: Years Building and improvements 10 - 50 Machinery, equipment and tooling 5 - 20 Furniture and fixtures 5 - 10 Computer hardware and software 3 - 5 Rental cranes 5 - 10 Property, plant and equipment also includes cranes accounted for as operating leases which are included in rental cranes. Equipment accounted for as operating leases includes rental cranes leased directly to the customer and cranes for which the Company has assisted in the financing arrangement, whereby the Company has made a buyback commitment in which the customer at the time of the order had a significant economic incentive to exercise. Equipment that is leased directly to the customer is accounted for as an operating lease with the related assets capitalized and depreciated over their estimated economic life. Equipment involved in a financing arrangement is depreciated over the life of the underlying arrangement to the buyback amount at the end of the lease period. The amount of rental cranes included in property, plant and equipment - net amounted to $ 153.3 million and $ 119.9 million, net of accumulated depreciation, as of December 31, 2023 and 2022, respectively. The Company reviews property, plant and equipment for impairment whenever events or changes in circumstances indicate that the assets’ carrying amount may not be recoverable. The Company conducts its impairment analyses in accordance with ASC Topic 360-10-5 “Property, Plant and Equipment” (“Topic 360”). Topic 360 requires the Company to group assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities and to evaluate the asset group against the sum of the undiscounted future cash flows. If the undiscounted cash flows are less than the net book value of the assets, any related impairment loss is calculated based upon comparison of the fair value to the net book value of the assets. Warranties Estimated manufacturing warranty costs are recorded in cost of sales at the time of sale of the warranted products based on historical warranty experience for the related product or estimates of projected costs due to specific warranty issues on new products. These estimates are reviewed periodically and are adjusted based on changes in facts, circumstances or actual experience. When a customer purchases an extended warranty, revenue associated with the extended warranty is deferred and recognized over the life of the extended warranty period. Costs during the extended warranty period are expensed as incurred. Costs associated with other warranty activity not related to a manufacturer's standard or extended warranty are recorded in the period a loss is probable and can be reasonably estimated in accordance with ASC Topic 450-20 “Loss Contingencies.” Product Liabilities The Company records product liability reserves for its self-insured portion of any outstanding product liability cases when losses are probable and reasonably estimable. The reserve is based upon two estimates. First, the Company tracks the population of all outstanding product liability cases to determine an appropriate case reserve for each based upon the Company’s best judgment with the advice of legal counsel. These estimates are continually evaluated and adjusted based upon changes to facts and circumstances surrounding the case. Second, the Company determines the amount of additional reserve required to cover incurred, but not reported, product liability obligations and to account for possible adverse development of the established case reserves utilizing actuarially developed estimates. Insurance recoveries related to a product liability case are recorded as an asset in the period it is determined that the gain has been realized or realizable. Refer to Note 19, “Commitments and Contingencies,” for further information. Derivative Financial Instruments and Hedging Activities The Company has policies and procedures that place all financial instruments under the direction of corporate treasury and restrict all derivative transactions to those intended for hedging purposes. The use of financial instruments for trading purposes is strictly prohibited. The Company uses financial instruments to manage the market risk from changes in foreign exchange rates, commodities and interest rates. The Company follows the guidance in accordance with ASC Topic 815 “Derivatives and Hedging” (“Topic 815”). The fair values of all outstanding derivatives are recorded in the Consolidated Balance Sheets. The change in a derivative’s fair value is recorded each period in current earnings or accumulated other comprehensive income (loss) (“AOCI”) depending on whether the derivative is designated and qualifies as a cash flow hedge. The Company selectively hedges anticipated transactions that are subject to foreign exchange exposure, commodity price exposure or variable interest rate exposure, primarily using foreign currency exchange contracts (“FX Forward Contracts”), commodity contracts and interest rate contracts, respectively. These instruments are designated as cash flow hedges in accordance with Topic 815 and are recorded in the Consolidated Balance Sheets at fair value. The effective portion of the contracts’ gains or losses due to changes in fair value are initially recorded as a component of AOCI and are subsequently reclassified into earnings when the hedged transactions, typically sales and costs related to sales and interest expense, occur and affect earnings. These contracts are highly effective in hedging the variability in future cash attributable to changes in currency exchange rates, commodity prices or interest rates. The amount reported as derivative instrument fair market value adjustment in the AOCI account within the Consolidated Statements of Comprehensive Income (Loss) represents the net gain (loss) on foreign currency exchange contracts designated as cash flow hedges, net of income taxes. Stock-Based Compensation The Company recognizes expense net of estimated future forfeitures for non-performance stock-based awards on a straight-line basis over the vesting period of the entire award. The Company recognizes expense net of estimated future forfeitures for stock-based awards with performance goals based on actual or estimated achievement of those goals on a straight-line basis over the vesting period of the entire award. Estimated future forfeiture rates are based on the Company's historical experience. Refer to Note 17, “Stock-Based Compensation,” for more information on stock-based compensation plans. Research and Development Research and development costs are charged to expense as incurred and amounte d to $ 35.3 million, $ 33.5 million and $ 29.1 million for the years ended December 31, 2023, 2022 and 2021 , respectively. Research and development costs include salaries, materials, contractor fees and other administrative costs. These costs are recorded within engineering, selling and administrative expenses in the Consolidated Statement of Operations. Income Taxes The Company utilizes the liability method to recognize deferred tax assets and liabilities for the expected future income tax consequences of events that have been recognized in the Company’s financial statements. Under this method, deferred tax assets and liabilities are determined based on the temporary difference between financial statement carrying amounts and the tax basis of assets and liabilities using enacted tax rates in effect in the years in which the temporary differences are expected to reverse. Valuation allowances are provided for deferred tax assets where it is considered more likely than not that the Company will not realize the benefit of such assets. The Company evaluates its uncertain tax positions as new information becomes available. Tax benefits are recognized to the extent a position is more likely than not to be sustained upon examination by the taxing authority. Ne t Income (Loss) Per Share Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during each year or period. The calculation of diluted net income (loss) per share reflects the effect of all potential dilutive shares that were outstanding during the respective periods, unless the effect of doing so would be antidilutive. The Company uses the treasury stock method to calculate the effect of outstanding stock-based compensation awards. Comprehensive Income (Loss) Comprehensive income (loss) includes, in addition to net income (loss) , other items that are reported as direct adjustments to Manitowoc stockholders’ equity. These items are foreign currency translation adjustments, employee postretirement benefit adjustments and the change in fair value of certain derivative instruments. Net Sales Sales are recognized when obligations under the terms of a contract with the Company’s customer are satisfied; generally this occurs with the transfer of control of the Company’s cranes or attachments or aftermarket parts or completion of performance of services. Sales are measured as the amount of consideration the Company expects to be entitled to receive in exchange for transferring goods or providing services. The Company recognizes sales for extended warranties over the life of the extended warranty period. Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction, and are collected by the Company from a customer, are excluded from sales. Performance Obligations The following is a description of principle activities from which the Company generates sales. Disaggregation of the Company’s revenue sources are disclosed in Note 18, “Segments.” Crane Sales Crane sales are primarily generated through the sale of new and used cranes. Contracts with customers are generally in the form of a purchase order. Based on the nature of the Company’s contracts, the Company does not have any significant financing terms. Contracts may have variable consideration in the form of early pay discounts or rebates, however variable consideration is not material to the overall contract with the customer. Sales are recognized under these contracts when control of the product is transferred to the customer. Control transfers to the customer generally upon delivery to the carrier or acceptance through an independent inspection company that acts as an agent of the customer. From time to time, the Company enters into agreements where the customer has the right to exercise a put option requiring the Company to buyback a crane at an agreed upon price. The Company evaluates each agreement at inception to determine if the customer has a significant economic incentive to exercise that right. If it is determined that the customer has a significant economic incentive to exercise that right, the agreement is accounted for as a lease in accordance with ASC Topic 842 “Leases” (“Topic 842”). If it is determined that the customer does not have a significant economic incentive to exercise that right, then revenue is recognized when control of the asset is transferred to the customer. Refer to Note 20, “Guarantees,” for additional information. Given the nature of the Company’s products, the customer may request that the product be held until a delivery location is identified. Under these “bill and hold” arrangements, sales are recognized when all of the following criteria are met: 1) the reason for the bill-and-hold arrangement is substantive, 2) the product is separately identified as belonging to the customer, 3) the product is ready for transfer to the customer, and 4) the Company does not have the ability to use the product or direct it to another customer. Crane Attachment Sales Crane attachment sales are generated through the sale of new or used crane attachments such as luffing jibs, ecomats and counterweights. Crane attachment sales are recognized when control of the product is transferred to the customer. Control transfers to the customer generally upon delivery to the carrier. Aftermarket Part Sales Aftermarket part sales are generated through the sale of new and used parts to end customers and distributors. Aftermarket part sales are recognized when control of the product is transferred to the customer. Control transfers to the customer generally upon delivery to the carrier. Customers generally have a right of return which the Company estimates using historical information. The amount of estimated returns is deducted from net sales. Other Sales The Company’s other sales consist primarily of sales from: • Repair and field service work; • Remanufacturing; and • Rental of cranes. The Company’s performance obligations for other sales generally relates to performing specific agreed upon services. Depending on the nature of the contract, sales are recognized upon the completion of those services or over the service period based on a measure of progress. Practical Expedients and Exemptions The Company expenses sales commissions when incurred because the amortization period would be one year or less. These costs are recorded within engineering, selling and administrative expenses in the Consolidated Statement of Operations. The Company accounts for shipping and handling activities performed after control of a product has been transferred to the customer as a fulfillment cost. As such, we have applied the practical expedient and we accrue for the costs of shipping and handling activities if revenue is recognized before contractually agreed shipping and handling activities occur. The Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which it recognizes revenue at the amount to which it has the right to invoice for services performed. Rece nt Accounting Changes and Pronouncements In September 2022, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2022-04, "Disclosure of Supplier Financing Program Obligations”. The amendments in this ASU require that a buyer in a supplier finance program disclose sufficient information about the program to allow a user of financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The Company adopted this ASU as of January 1, 2023. The adoption of this ASU did not have a material impact on the Company's consolidated financial statements. In November 2023, the FASB issued ASU No. 2023-07, "Segment Reporting - Improvements to Reportable Segments Disclosures”. The amendments in this ASU improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The standard is effective for annual periods beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company is evaluating the impact the adoption of this ASU will have on its consolidated financial statements. In December 2023, the FASB issued ASU No. 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures”. The amendments in this ASU enhance the transparency and decision usefulness of income tax disclosures. The standard is effective for annual periods beginning after December 15, 2024. Early adoption is permitted. The Company is evaluating the impact the adoption of this ASU will have on its consolidated financial statements.

Business Combinations

Business Combinations	12 Months Ended
	Dec. 31, 2023
Business Combinations [Abstract]
Business Combinations	3. Business Combinations Acquisition of the H&E Crane Business On October 1, 2021, the Company completed the acquisition of substantially all of the assets and certain liabilities of the crane business of H&E Equipment Services, Inc. (“H&E”) for a transaction price of approximately $ 136.8 million which is inclusive of the purchase price of $ 130.0 million, working capital and other adjustments of $ 3.7 million and settlement of outstanding balances between the Company and the acquired company of $ 3.1 million. The acquisition was funded from existing cash resources, including the use of the Company's asset-based revolving credit facility. At the time of acquisition, the acquired crane business of H&E operated with ten full-service branch locations under the Company's wholly owned subsidiary, MGX Equipment Services, LLC ( “MGX” ). The acquired crane business expands Manitowoc’s ability to provide new sales, used sales, aftermarket parts, service and crane financing options to a variety of end market customers. The transaction price was allocated to underlying assets acquired and liabilities assumed based upon their estimated fair values at the date of the combination as follows: Net working capital $ 48.8 Property, plant and equipment 13.1 Rental fleet 48.2 Goodwill 7.8 Noncompetition agreement intangible 3.8 Customer relationships intangible 15.1 Total fair value consideration $ 136.8 The amount of net sales generated by MGX during the years ended December 31, 2023, 2022 and 2021 was $ 277.2 million, $ 218.4 million and $ 50.6 million, respectively. Acquisition of Aspen Equipment Company On September 1, 2021, the Company completed the acquisition of substantially all of the assets of Aspen Equipment Company (“Aspen”), a diversified crane dealer and a leading final stage purpose built work truck upfitter, for a purchase price of approximately $ 50.2 million. The acquisition of Aspen was funded from existing cash resources and expands Manitowoc's direct-to-customer footprint in Iowa, Nebraska and Minnesota with new sales, used sales, parts, service and rentals to a variety of end markets. Included in the purchase price was $ 12.9 million of net working capital, $ 5.6 million of property, plant and equipment, $ 19.3 million of rental fleet, $ 0.4 million of other assets, $ 6.6 million of goodwill and $ 5.4 million of intangible assets. Net sales generated by Aspen during the years ended December 31, 2023, 2022 and 2021 was $ 109.4 million, $ 79.8 million and $ 23.6 million, respectively.

Net Sales

Net Sales	12 Months Ended
	Dec. 31, 2023
Revenue from Contract with Customer [Abstract]
Net Sales	4. Net Sales The Company defers revenue when cash payments are received in advance of satisfying the related performance obligation. These amounts are recorded as customer advances in the Consolidated Balance Sheets. The table below shows the change in the customer advances balance for the year ended December 31, 2023 and 2022. 2023 2022 Balance at beginning of period $ 21.9 $ 28.7 Cash received in advance of satisfying 147.7 130.6 Revenue recognized ( 150.8 ) ( 139.2 ) Currency translation 0.4 1.8 Balance at end of period $ 19.2 $ 21.9 The Company recognizes a contract asset for certain remanufacturing, repair and field service work when the service is completed but unbilled as of the end of the period. Contract assets are recorded in other current assets in the Consolidated Balance Sheets. Contract assets are immaterial as of December 31, 2023 and 2022.

Fair Value of Financial Instrum

Fair Value of Financial Instruments	12 Months Ended
	Dec. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	5. Fair Value of Financial Instruments ASC Topic 820-10 ("ASC 820") defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 classifies the inputs used to measure fair value into the following hierarchy: Level 1 Unadjusted quoted prices in active markets for identical assets or liabilities Level 2 Unadjusted quoted prices in active markets for similar assets or liabilities, or Unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or Inputs other than quoted prices that are observable for the asset or liability Level 3 Unobservable inputs for the asset or liability The following tables sets forth the Company’s financial assets and liabilities related to FX Forward Contracts and the Manitowoc Company, Inc. Deferred Compensation Plan (the "Deferred Compensation Plan") that were accounted for at fair value as of December 31, 2023 and 2022. Fair Value as of December 31, 2023 Level 1 Level 2 Level 3 Total Recognized Location Current Assets: FX Forward Contracts $ — $ 1.6 $ — $ 1.6 Other current assets Deferred Compensation Plan - Program B 8.1 — — 8.1 Other non-current assets Total current assets at fair value $ 8.1 $ 1.6 $ — $ 9.7 Current Liabilities: FX Forward Contracts $ — $ 0.6 $ — $ 0.6 Accounts payable and accrued expenses Fair Value as of December 31, 2022 Level 1 Level 2 Level 3 Total Recognized Location Current Assets: FX Forward Contracts $ — $ 5.7 $ — $ 5.7 Other current assets Current Liabilities: FX Forward Contracts $ — $ 0.3 $ — $ 0.3 Accounts payable and accrued expenses The fair value of the senior secured second lien notes due on April 1, 2026 , with an annual coupon rate of 9.000 % (the “2026 Notes”), was approximatel y $ 302.7 million as of December 31, 2023. Refer to Note 12, “Debt,” for a description of the 2026 Notes and the related carrying value. The Company endeavors to utilize the best available information in measuring fair value. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company estimates the fair value of its 2026 Notes based on quoted market prices of the instruments; because these markets are typically actively traded, the liabilities are classified as Level 1 within the valuation hierarchy. The carrying values of cash and cash equivalents, accounts receivable, accounts payable and short-term variable debt, including any amounts outstanding under the Company's revolving credit facility, approximate fair value, without being discounted as of December 31, 2023 due to the short-term nature of these instruments. FX Forward Contracts are valued through an independent valuation source which uses an industry standard data provider, with resulting valuations periodically validated through third-party or counterparty quotes. As such, these derivative instruments are classified within Level 2. Refer to Note 6, “Derivative Financial Instruments,” for additional information. T he Deferred Compensation Plan utilizes a rabbi trust to hold assets intended to satisfy the Company's corresponding future benefit obligations. The plan assets and corresponding obligations for Program B under the Deferred Compensation Plan are classified within Level 1. Refer to Note 21, "Employee Benefit Plans," for additional information on the Deferred Compensation Plan.

Derivative Financial Instrument

Derivative Financial Instruments	12 Months Ended
	Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	6. Derivative Financial Instruments The Company’s risk management objective is to ensure that business exposures to risks are minimized using the most effective and efficient methods to eliminate, reduce, or transfer such exposures. Operating decisions consider these associated risks and, whenever possible, transactions are structured to avoid or mitigate these risks. From time to time, the Company enters into FX Forward Contracts to manage the exposure on forecasted transaction denominated in non-functional currencies and to manage the risk of transaction gains and losses associated with assets/liabilities in currencies other than the functional currency of certain subsidiaries. Certain of these FX Forward Contracts are designated as cash flow hedges. To the extent these derivatives are effective in offsetting the variability of the hedged cash flows, changes in the derivatives’ fair value are not included in current earnings but are included in AOCI. These changes in fair value are reclassified into earnings as a component of cost of sales, as applicable, when the forecasted transaction impacts earnings. In addition, if the forecasted transaction is no longer probable, the cumulative change in the derivatives’ fair value is recorded as a component of other income (expense) – net in the period in which the transaction is no longer considered probable of occurring. No amounts were recorded related to forecasted transactions no longer being probable during the years ended December 31, 2023, 2022 or 2021. The Company had FX Forward Contracts with an aggregate notional amount of $ 140.1 million an d $ 87.7 million ou tstanding as of December 31, 2023 and 2022, respectively. The aggregate notional amount outstanding as of December 31, 2023 is scheduled to mature within one year . The FX Forward Contracts purchased are denominated in various foreign currencies. As of December 31, 2023 and 2022, the net fair value of these contracts was a net short-term asset of $ 1.0 million and $ 5.4 million, respectively . Net unrealized gains (losses), net of income tax, recorded in AOCI were $ 1.3 million as of December 31, 2023 and $ 5.4 million as of December 31, 2022. The gains (losses) recorded in the Consolidated Statement of Operations for FX Forward Contracts for the years ended December 31, 2023, 2022 and 2021 are summarized as follows: Recognized Location 2023 2022 2021 Designated Cost of sales $ 2.3 $ ( 5.8 ) $ ( 1.1 ) Non-Designated Other income (expense) - net ( 3.3 ) 7.2 0.4

Inventories

Inventories	12 Months Ended
	Dec. 31, 2023
Inventory Disclosure [Abstract]
Inventories	7. Inventories The components of inventories as of December 31, 2023 and 2022 are summarized as follows: 2023 2022 Raw materials $ 164.7 $ 161.2 Work-in-process 111.3 141.3 Finished goods 390.5 309.4 Total Inventories $ 666.5 $ 611.9

Notes Receivable

Notes Receivable	12 Months Ended
	Dec. 31, 2023
Receivables [Abstract]
Notes Receivable	8. Notes Receivable The Company's notes receivable balances are classified as current or long-term based on the timing of amounts due. Long-term notes receivable are included within other non-current assets in the Consolidated Balance Sheet. As of December 31, 2023, the Company had current and long-term notes receivable in the amounts of $ 6.7 million and $ 1.1 million, respectively. As of December 31, 2022, the Company had current and long-term notes receivable in the amounts of $ 10.6 million and $ 2.0 million, respectively. In 2022, the Company recorded income of $ 4.8 million in engineering, selling and administrative expenses in the Consolidated Statements of Operations to recognize the partial recovery of the previously written off long-term note receivable from the 2014 divestiture of the Company's Chinese joint venture.

Property, Plant and Equipment

Property, Plant and Equipment	12 Months Ended
	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	9. Property, Plant and Equipment The components of property, plant and equipment as of December 31, 2023 and 2022 are summarized as follows: 2023 2022 Land $ 14.9 $ 17.9 Building and improvements 201.5 194.7 Machinery, equipment and tooling 318.4 300.6 Furniture and fixtures 13.8 13.8 Computer hardware and software 135.8 129.4 Rental cranes 201.9 157.8 Construction in progress 7.2 8.4 Total cost 893.5 822.6 Less accumulated depreciation ( 527.4 ) ( 487.3 ) Property, plant and equipment — net $ 366.1 $ 335.3 Additions to property, plant and equipment included in accounts payable and accrued expenses in the Consolidated Balance Sheets as of December 31, 2023 was $ 7.0 million. Assets Held for Sale As of December 31, 2023, the Company had $ 3.0 million of property, plant and equipment classified as assets held for sale recorded in other current assets in the Consolidated Balance Sheets. This amount relates to a manufacturing building and land in Fanzeres, Portugal. As of December 31, 2022, the Company ha d $ 6.7 million of property, plant and equipment classified as assets held for sale recorded in other current assets in the Consolidated Balance Sheets. This amount relates to the assets of one of the Company's Brazilian subsidiaries, Manitowoc Brasil Guindastes Ltda, that the Company committed to sell in 2022 and a manufacturing building and land in Fanzeres, Portugal.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	12 Months Ended
	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	10. Goodwill and Intangible Assets The changes in the carrying amount of goodwill for the years ended December 31, 2023 and 2022 are summarized as follows: Americas - Manufacturing Americas - Distribution MEAP Consolidated Balance as of January 1, 2022 $ 166.5 $ 15.1 $ 68.1 $ 249.7 Goodwill impairment ( 166.5 ) — — ( 166.5 ) Purchase accounting adjustments — ( 0.7 ) — ( 0.7 ) Foreign currency impact — — ( 2.4 ) ( 2.4 ) Net balance as of December 31, 2022 — 14.4 65.7 80.1 Foreign currency impact — — ( 0.5 ) ( 0.5 ) Net balance as of December 31, 2023 $ — $ 14.4 $ 65.2 $ 79.6 The gross carrying amount, accumulated impairment, and net book value of the Company's goodwill balances by reporting unit are summarized as follows: December 31, 2023 December 31, 2022 Gross Carrying Amount Accumulated Impairment Amount Net Book Value Gross Carrying Amount Accumulated Impairment Amount Net Book Value Americas - Manufacturing $ 166.5 $ ( 166.5 ) $ — $ 166.5 $ ( 166.5 ) $ — Americas - Distribution 14.4 — 14.4 14.4 — 14.4 EURAF 82.2 ( 82.2 ) — 82.2 ( 82.2 ) — MEAP 65.2 — 65.2 65.7 — 65.7 Total $ 328.3 $ ( 248.7 ) $ 79.6 $ 328.8 $ ( 248.7 ) $ 80.1 The Company performs its annual goodwill impairment test during the fourth quarter, or more frequently if events or changes in circumstances indicate that the asset might be impaired. The Company will continue to monitor changes in circumstances and test more frequently if those changes indicate that assets might be impaired. As of October 31, 2023, the Company performed its annual goodwill impairment test. The fair values of the Americas - Distribution and MEAP reporting units were substantially in excess of their carrying values as of the date of the annual impairment test and, therefore, were not impaired as of December 31, 2023. During the year ended December 31, 2022, the Company recorded a $ 166.5 million non-cash impairment charge to write down the carrying value of goodwill at the Company's Americas - Manufacturing reporting unit to zero. The goodwill impairment charge resulted from a reduction in the estimated fair value of the reporting unit based on a prolonged low Company equity market capitalization that continued into the fourth quarter of 2022 and a higher discount rate. The fair values of the Americas – Distribution and MEAP reporting units were substantially in excess of their carrying values as of the date of the annual impairment test and, therefore, were not impaired as of December 31, 2022. T he gross carrying amount, accumulated amortization and net book value of the Company’s intangible assets other than goodwill as of December 31, 2023 and 2022 are summarized as follows: December 31, 2023 December 31, 2022 Gross Accumulated Net Gross Accumulated Net Definite lived intangible assets: Customer relationships $ 26.5 $ ( 11.6 ) $ 14.9 $ 26.5 $ ( 10.0 ) $ 16.5 Patents 29.2 ( 28.8 ) 0.4 28.7 ( 28.2 ) 0.5 Noncompetition agreements 4.2 ( 2.0 ) 2.2 4.2 ( 1.2 ) 3.0 Trademarks and tradenames 2.2 ( 1.0 ) 1.2 2.2 ( 0.6 ) 1.6 Other intangibles 0.7 ( 0.7 ) - 0.6 ( 0.5 ) 0.1 Total 62.8 ( 44.1 ) 18.7 62.2 ( 40.5 ) 21.7 Indefinite lived intangible assets: Trademarks and tradenames 92.6 — 92.6 91.0 — 91.0 Distribution network 14.3 — 14.3 14.0 — 14.0 Total 106.9 — 106.9 105.0 — 105.0 Total intangible assets $ 169.7 $ ( 44.1 ) $ 125.6 $ 167.2 $ ( 40.5 ) $ 126.7 Amortization expense of intangible assets for the years ended December 31, 2023, 2022 and 2021 was $ 3.2 million, $ 3.1 million and $ 1.4 million, respectively. Excluding the impact of any future acquisitions, divestitures or impairments, the Company's anticipated future amortization of intangible assets as of December 31 , 2023 is summarized as follows: Year 2024 $ 2.9 2025 2.9 2026 2.5 2027 1.4 2028 1.4 Thereafter 7.6 Total $ 18.7 Definite lived intangible assets and long-lived assets are subject to impairment testing whenever events or circumstances indicate that the carrying value of the assets may not be recoverable. The Company determined there was not a triggering event during the year ended December 31, 2023. The Company performs its annual indefinite-lived intangible assets impairment testing during the fourth quarter, or more frequently if events or changes in circumstances indicate that the asset might be impaired. The Company will continue to monitor changes in circumstances and test more frequently if those changes indicate that assets might be impaired. The Company has two indefinite-lived intangible assets subject to an annual impairment test: the Potain trademark, tradename and distribution network assets (“Potain Tradename”) and the Grove trademark, tradename and distribution network assets (“Grove Tradename”). As of October 31, 2023, the Company performed its annual indefinite-lived intangible assets impairment test. The fair value of the Potain and Grove Tradenames were substantially in excess of their carrying value as of the date of the annual impairment test, and, therefore were not impaired as of December 31, 2023. During the year ended December 31, 2022, the Company recorded a non-cash impairment charge of $ 5.4 million to write down the carrying value of the Grove Tradename to its fair value of $ 39.0 million. The Grove Tradename impairment charge was recorded in the Americas segment and was a result of downward pressure from the use of similar assumptions to those used in the annual goodwill impairment test which included revenue growth rate and discount rate. The fair value of the Potain Tradename was substantially in excess of its carrying value as of the date of the annual impairment test and, therefore, was not impaired as of December 31, 2022. A considerable amount of management judgment and assumptions are required in performing the goodwill and indefinite-lived asset impairment tests as it relates to revenue growth rates, projected margin, the discount rate and relevant market multiples, as applicable. While the Company believes the judgments and assumptions are reasonable, different assumptions could change the estimated fair value and, therefore, additional impairments could be required. Weakening industry or economic trends, disruptions to the Company's business, unexpected significant changes or planned changes in the use of the assets or in entity structure are all factors which may adversely impact the assumptions used in the valuations. The Company continually monitors market conditions and determines if any additional interim reviews of other intangibles or long-lived assets are warranted. In the event the Company determines that assets are impaired in the future, the Company would recognize a non-cash impairment charge, which could have a material adverse effect on the Company’s Consolidated Balance Sheets and Results of Operations.

Accounts Payable and Accrued Ex

Accounts Payable and Accrued Expenses	12 Months Ended
	Dec. 31, 2023
Payables and Accruals [Abstract]
Accounts Payable and Accrued Expenses	11. Accounts Payable and Accrued Expenses Accounts payable and accrued expenses as of December 31, 2023 and 2022 are summarized as follows: 2023 2022 Trade accounts payable $ 254.7 $ 274.6 Employee-related expenses 57.9 51.0 Accrued vacation 23.7 22.4 Miscellaneous accrued expenses 121.1 98.4 Total accounts payable and accrued expenses $ 457.4 $ 446.4

Debt

Debt	12 Months Ended
	Dec. 31, 2023
Debt Disclosure [Abstract]
Debt	12. Debt Outstanding debt as of December 31, 2023 and 2022 is summarized as follows: 2023 2022 Borrowing under senior secured asset based revolving $ 60.0 $ 80.0 2026 Notes 300.0 300.0 Other 13.7 8.0 Deferred financing costs ( 1.6 ) ( 2.4 ) Total debt 372.1 385.6 Short-term borrowings and current portion of ( 13.4 ) ( 6.1 ) Long-term debt $ 358.7 $ 379.5 On March 25, 2019, the Company and certain subsidiaries of the Company (the “Loan Parties”) entered into a credit agreement (the “ABL Credit Agreement”) with JP Morgan Chase Bank, N.A. as administrative and collateral agent, and certain financial institutions party thereto as lenders, providing for a senior secured asset-based revolving credit facility (the “ABL Revolving Credit Facility”) of up to $ 275.0 million. The borrowing capacity under the ABL Revolving Credit Facility is based on the value of inventory, accounts receivable and certain fixed assets of the Loan Parties. The Loan Parties’ obligations under the ABL Revolving Credit Facility are secured on a first-priority basis, subject to certain exceptions and permitted liens, by substantially all of the personal property and fee-owned real property of the Loan Parties. The liens securing the ABL Revolving Credit Facility are senior in priority to the second-priority liens securing the obligations under the 2026 Notes and the related guarantees. The ABL Revolving Credit Facility includes a $ 75.0 million letter of credit sub-facility, $ 10.0 million of which is available to the Company’s German subsidiary that is a borrower under the ABL Revolving Credit Facility. On June 17, 2021, the Company amended the ABL Credit Agreement to adjust certain negative covenants which reduced restrictions on the Company's ability to expand its rental business. On May 19, 2022, the Company further amended the ABL Credit Agreement to (i) extend the maturity date to May 19, 2027 (subject to a springing maturity date of December 30, 2025 if the 2026 Notes have not been repaid in full or refinanced prior to December 30, 2025), (ii) permit the inclusion, subject to certain limitations, of the crane rental assets of certain subsidiaries in the borrowing base used to calculate availability under the ABL Credit Agreement, (iii) permit separate financing of crane rental assets not included in the borrowing base and (iv) replace U.S. dollar London Inter-bank Offered Rate with interest rates based on the secured overnight financing rate plus a credit spread adjustment (“SOFR”). Borrowings under the ABL Revolving Credit Facility bear interest at a variable rate using either the Alternative Base Rate or SOFR plus the spread set forth below. The variable interest rate is based upon the average availability as of the most recent determination date as follows: Average quarterly availability Alternative base rate spread SOFR spread ≥ 50% of Aggregate Commitment 0.25 % 1.25 % < 50% of Aggregate Commitment 0.50 % 1.50 % As of December 31, 2023 and 2022, the Company had $ 60.0 million and $ 80.0 million, respectively, of borrowings outstanding under the ABL Revolving Credit Facility. During the year ended December 31, 2023, the highest daily borrowing under the ABL Revolving Credit Facility was $ 119.6 million and the average borrowing was $ 103.4 million, while the weighted-average annual interest rate was 5.2 % . During the year ended December 31, 2022 , the highest daily borrowing under the ABL Revolving Credit Facility was $ 112.5 million and the average borrowing was $ 90.9 million, while the weighted-average annual interest rate was 3.1 %. The interest rate of the ABL Revolving Credit Facility fluctuates based on excess availability. During the year ended December 31, 2023, the spreads for SOFR, and Alternative Base Rate borrowings were 1.25 % and 0.25 %, respectiv ely. Excess availability as of December 31, 2023 was $ 211.6 million, which represents revolver borrowing capacity of $ 275.0 million less $ 60.0 million in borrowings outstanding and U.S. letters of credit outstanding of $ 3.4 million. As of December 31, 2023, the Company had outstanding $ 13.7 million of other indebtedness that has a weighted-average interest rate of approximately 4.9 % . This debt includes balances on local credit lines, overdraft facilities and other financing arrangements. The overdraft facilities are composed of five Euro facilities totaling € 37.0 million and one Chinese Yuan facility totaling ¥ 30.0 million. Total U.S. dollar availability as of December 31, 2023 for the six overdraft facilities is $ 45.2 million, with $ 11.2 million outstanding. On March 25, 2019, the Company and certain of its subsidiaries entered into an indenture with U.S. Bank National Association as trustee and notes collateral agent, pursuant to which the Company issued $ 300.0 million aggregate principal amount of the 2026 Notes with an annual coupon rate of 9.000 %. Interest on the 2026 Notes is payable in cash semi-annual in arrears on April 1 and October 1 of each year. The 2026 Notes are fully and unconditionally guaranteed on a senior secured second lien basis, jointly and severally, by each of the Company’s existing and future domestic subsidiaries that is either a guarantor or a borrower under the ABL Revolving Credit Facility or that guarantees certain other debt of the Company or a guarantor. The 2026 Notes and the related guarantees are secured on a second-priority basis, subject to certain exceptions and permitted liens, by pledges of capital stock and other equity interests and other security interests in substantially all of the personal property and fee-owned real property of the Company and of the guarantors that secure obligations under the ABL Revolving Credit Facility. Both the ABL Revolving Credit Facility and the 2026 Notes include customary covenants which include, without limitation, restrictions on, the Company’s ability and the ability of the Company’s restricted subsidiaries to incur, assume or guarantee additional debt or issue certain preferred shares, pay dividends on or make other distributions in respect of the Company’s capital stock or make other restricted payments, make certain investments, sell or transfer certain assets, create liens on certain assets to secure debt, consolidate, merge, sell, or otherwise dispose of all or substantially all of the Company’s assets, enter into certain transactions with affiliates and designate the Company’s subsidiaries as unrestricted. Both the ABL Revolving Credit Facility and the 2026 Notes also include customary events of default. The ABL Revolving Credit Facility has customary representations and warranties including, as a condition to borrowing, that all such representations and warranties are true and correct, in all material respects, on the date of the borrowing, including representations as to no material adverse change in the Company’s business or financial condition since December 31, 2018. Additionally, the ABL Revolving Credit Facility contains a covenant requiring the Company to maintain a minimum fixed charge coverage ratio under certain circumstances set forth in the ABL Credit Agreement. The aggregate scheduled future maturitie s of outstanding debt obligations as of December 31, 2023 is summarized as follows: Year 2024 $ 13.4 2025 60.3 2026 300.0 2027 — 2028 — Thereafter — Total $ 373.7 T he table of scheduled maturities above does not agree to the Company’s total debt as of December 31, 2023 as shown on the Consolidated Balance Sheet due to $ 1.6 million of deferred financing costs. As of December 31, 2023 , the Company was in compliance with financial covenants pertaining to the ABL Revolving Credit Facility and 2026 Notes. Based upon management’s current plans and outlook, the Company believes it will be able to comply with these covenants during the subsequent twelve months

Accounts Receivable Factoring

Accounts Receivable Factoring	12 Months Ended
	Dec. 31, 2023
Transfers and Servicing [Abstract]
Accounts Receivable Factoring	13. Accounts Receivable Factoring The Company has two non-U.S. accounts receivable financing programs with no maximum availability and one U.S. accounts receivable financing program with maximum availability of $ 25.0 million. Transactions under the non-U.S. and U.S. programs were accounted for as sales in accordance with ASC 860, “Transfers and Servicing.” Under these financing programs, the Company has the ability to sell eligible receivables up to the maximum limit. For the years ended December 31, 2023 and 2022, cash proceeds from the factoring of accounts receivable qualifying as sales were $ 163.5 million and $ 234.5 million, respectively. Financing charges incurred from the factoring of accounts receivable qualifying as sales for the year ended December 31, 2023 , 2022 and 2021 were immaterial.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	14. Income Taxes Income (loss) before income taxes for the years ended December 31, 2023, 2022 and 2021 is summarized as follows: 2023 2022 2021 Income (loss) before income taxes: United States $ ( 32.7 ) $ ( 203.8 ) $ ( 39.0 ) Foreign 76.9 83.6 56.1 Total $ 44.2 $ ( 120.2 ) $ 17.1 Provision for income taxes for the years ended December 31, 2023, 2022 and 2021 is summarized as follows: 2023 2022 2021 Current: United States federal and state $ 0.3 $ ( 11.7 ) $ ( 1.2 ) Foreign 10.7 10.9 7.9 Total current 11.0 ( 0.8 ) 6.7 Deferred: United States federal and state — ( 2.4 ) 0.6 Foreign ( 6.0 ) 6.6 ( 1.2 ) Total deferred ( 6.0 ) 4.2 $ ( 0.6 ) Provision for income taxes $ 5.0 $ 3.4 $ 6.1 The items accounting for the difference between income taxes computed at the United States federal statutory rate and the Company's effective rate for the years ended December 31, 2023, 2022 and 2021 is summarized as follows: 2023 2022 2021 Federal income tax at statutory rate $ 9.3 $ ( 25.2 ) $ 3.6 State income tax provision 2.0 0.9 0.3 Manufacturing and research incentives ( 1.3 ) ( 0.5 ) ( 0.2 ) Taxes on foreign income which differ from the federal 9.1 ( 1.9 ) 1.5 Adjustments for unrecognized tax benefits 0.2 ( 11.0 ) ( 2.3 ) Adjustments to valuation allowances ( 28.6 ) 5.2 4.5 United States tax reform 10.1 4.8 ( 1.6 ) Goodwill and indefinite-lived intangible asset impairment — 31.7 — Audit settlements ( 3.0 ) — ( 1.9 ) Non-deductible expenses 8.2 1.6 1.3 Other items ( 1.0 ) ( 2.2 ) 0.9 Provision for income taxes $ 5.0 $ 3.4 $ 6.1 For the year ended December 31, 2023, the provision for income taxes was favorably impacted by the release of a $ 19.0 million valuation allowance, and a $ 3.2 million tax benefit for the favorable resolution of a previously reserved foreign income tax matter. These benefits were partially offset by the tax effect of $ 8.2 million related to non-deductible expenses. For the year ended December 31, 2022, the benefit for income taxes related to unrecognized tax benefits was primarily driven by a release of a $ 12.1 million uncertain tax position, inclusive of $ 1.2 million of interest, related to U.S. Federal tax planning strategies implemented as a result of the Coronavirus Aid, Relief and Economic Security Act. For the year ended December 31, 2021, the provision for income taxes was favorably impacted by a $ 1.9 million French income tax refund as a result of a Mutually Agreed upon Procedure for 2006 between the Italian and French tax authorities. There were no significant items included in “other items” for the years ended December 31, 2023, 2022 and 2021. For the years ended December 31, 2023, 2022 and 2021 the Company recorded a net income tax inclusion for the global intangible low-taxed income (“GILTI”) in the amount of $ 48.0 million, $ 22.9 million and $ 2.5 million, respectively, which is fully offset by the valuation allowance recorded in the United States. The GILTI inclusion for each respective year is reflective of the final regulations issued in 2020 relating to Internal Revenue Code Section 951A and the treatment of foreign income subject to a high tax rate. While effective beginning in 2021, the regulations allowed for retroactive application which the Company elected in the period of issuance for 2020 and 2019. In 2021, the Company filed an amended return to adopt the regulations for the 2019 tax year, resulting in the recognition of a net income tax benefit of $ 1.6 million for the year ended December 31, 2021. As of each reporting date, the Company considers new evidence, both positive and negative, that could impact its assessment related to future realization of deferred tax assets. The provision for income taxes for the year ended December 31, 2023 includes a $ 19.0 million income tax benefit for the release of a valuation allowance. The income tax provision for the year ended December 31, 2022 includes a $ 1.2 million income tax benefit for the release of a valuation allowance. The income tax provision for the year ended December 31, 2021 includes a $ 7.2 million net increase to valuation allowances for other jurisdictions, partially offset by a $ 2.7 million income tax benefit for the partial release of a valuation allowance. As of December 31, 2023, the Company has recorded valuation allowances on deferred tax assets for certain legal entities in Brazil, China, Chile, Russia, the U.K. and the United States as it is more likely than not that the assets will not be realized. Temporary differences and carryforwards that give rise to deferred tax assets and liabilities are summarized as follows: 2023 2022 Deferred income tax assets: Inventories $ 14.7 $ 25.3 Deferred employee benefits 27.8 28.2 Product warranty reserves 7.8 8.7 Product liability reserves 2.6 2.2 Tax credits 7.9 7.2 Loss and other tax attribute carryforwards 114.1 129.6 Deferred revenue 3.9 0.2 Capitalized research costs 10.5 4.8 Other 12.5 13.8 Total deferred income tax assets 201.8 220.0 Less valuation allowance ( 130.8 ) ( 174.1 ) Net deferred income tax assets $ 71.0 $ 45.9 Deferred income tax liabilities Accounts receivable $ — $ 4.0 Property, plant and equipment 25.6 5.1 Intangible assets 28.5 28.0 Total deferred income tax liabilities $ 54.1 $ 37.1 Net deferred income tax assets $ 16.9 $ 8.8 The net deferred tax assets reflected in the Consolidated Balance Sheets for the years ended December 31, 2023 and 2022 are summarized as follows: 2023 2022 Long-term income tax assets, included in $ 24.4 $ 13.7 Long-term deferred income tax liability ( 7.5 ) ( 4.9 ) Net deferred income tax asset $ 16.9 $ 8.8 The Company believes that certain offshore cash can be accessed in a tax efficient manner and therefore, as of December 31, 2023, deferred taxes were not provided on approximately $ 175.7 million of unremitted earnings of foreign subsidiaries that may be remitted to the United States without material tax cost. The Company had approximately $ 397.4 million and $ 478.1 million of cumulative foreign earnings as of December 31, 2023 and December 31, 2022, respectively, which are asserted to be permanently reinvested. Determination of the amount of unrecognized deferred tax liability related to these earnings is not practicable. As of December 31, 2023, the Company had approximately $ 96.4 million of federal net operating loss carryforwards, which are available to reduce future federal tax liabilities. $ 14.1 million of the federal net operating loss carryforwards expire in 2036 and the remaining $ 82.3 million is not subject to any time restrictions for future use. As of December 31, 2022, the Company had approximately $ 96.8 million of federal loss carryforwards, which are available to reduce future federal tax liabilities. $ 13.5 million of the federal net operating loss carryforward expire in 2036 and the remaining $ 83.3 million is not subject to any time restrictions for future use. However, utilization of the 2023 and 2022 indefinite lived loss carryforwards is limited annually to 80 % of adjusted taxable income. The carryforward is offset by a valuation allowance as of December 31, 2023 and 2022. As of December 31, 2023 and 2022, the Company had approximately $ 43.2 million and $ 26.8 million, respectively, of federal interest expense carryforward that is not subject to any time restrictions for future use. The utilization of the interest expense carryforward is limited annually to 30 % of adjusted taxable income. The carryforward is offset by a full valuation allowance as of December 31, 2023 and 2022. As of December 31, 2023 and 2022, the Company had approximately $ 616.1 million and $ 651.9 million, respectively, of state net operating loss carryforwards, which are available to reduce future state tax liabilities. As of December 31, 2023, these state net operating loss carryforwards expire at various times through 2043 , respectively. The carryforward is offset by a full valuation allowance as of December 31, 2023 and 2022. As of December 31, 2023 and 2022, the Company had approximately $ 212.4 million and $ 263.5 million, respectively, of foreign loss carryforwards, which are available to reduce future foreign tax liabilities. Substantially all the foreign loss carryforwards have an indefinite carryforward period of which $ 48.8 million is offset by a valuation allowance as of December 31, 2023 and $ 163.7 million as of December 31, 2022. The Company or one of its subsidiaries files income tax returns in the United States and certain foreign jurisdictions. The following table provides the open tax years for which the Company could be subject to income tax examination by the tax authorities in its major jurisdictions: Jurisdiction Open Years U.S. federal 2016 — 2023 China 2014 — 2023 France 2021 — 2023 Germany 2018 — 2023 The Company regularly assesses the likelihood of an adverse outcome resulting from examinations to determine the adequacy of its tax reserves. As of December 31, 2023, the Company believes that it is more likely than not that the tax positions taken will be sustained upon the resolution of audits resulting in no material impact on its consolidated financial position and the results of operations and cashflows. However, the final determination with respect to any tax audits, including any related litigation costs, settlements, penalties and/or interest assessments, could be materially different from the Company’s accruals and could have a material effect on its financial position, results of operations and/or cashflows in the periods for which that determination is made. During the years ended December 31, 2023, 2022 and 2021, the Company recorded an increase (decrease) to the gross unrecognized tax benefits including interest and penalties of $ 0.2 million, $( 11.0 ) million and $( 2.1 ) million, respectively, of which $ 0.2 million, $( 1.7 ) million and $( 0.4 ) million, respectively, are a result of the net reductions to interest and penalties. Interest and penalties are recognized as a component of income tax expense. A reconciliation of the beginning and ending amount of unrecognized tax benefits excluding interest and penalties as of December 31, 2023, 2022 and 2021 are summarized as follows: 2023 2022 2021 Balance at beginning of year $ 9.1 $ 18.4 $ 20.1 Additions for tax positions of current year 0.1 0.1 0.1 Additions for tax positions of prior years 0.1 3.6 — Reductions for tax positions of prior years — ( 11.0 ) ( 0.2 ) Reductions based on settlements with tax — — ( 0.2 ) Reductions for lapse of statute of limitations ( 0.2 ) ( 2.0 ) ( 1.4 ) Balance at end of year $ 9.1 $ 9.1 $ 18.4 As of December 31, 2023, 2022 and 2021, the Company recorded interest and penalties of $ 1.4 million, $ 1.2 million and $ 2.9 million, respectively. Approximately $ 4.5 million, $ 4.7 million and $ 14.0 million of the Company’s unrecognized tax benefits as of December 31, 2023, 2022 and 2021, respectively, would impact the effective tax rate. During the next twelve months, the unrecognized tax benefits are not expected to significantly increase or decrease due to audit settlements or lapsing statutes of limitations.

Net Income (Loss) Per Share

Net Income (Loss) Per Share	12 Months Ended
	Dec. 31, 2023
Earnings Per Share [Abstract]
Net Income (Loss) Per Common Share	15. Net Income (Loss) Per Common Share The following is a reconciliation of the weighted average common shares outstanding used to compute basic and diluted net income (loss) per common share: 2023 2022 2021 Basic weighted average common shares outstanding 35,093,963 35,184,336 34,903,189 Effect of dilutive securities - equity 868,815 — 549,366 Diluted weighted average common shares outstanding 35,962,778 35,184,336 35,452,555 Equity compensation awards for which total employee proceeds from exercise exceed the average fair value of the same equity incentive instrument over the period have an anti-dilutive effect on earnings per share during periods with net income, and accordingly, are excluded from diluted weighted average common shares outstanding. Anti-dilutive equity instruments of 431,392 and 358,706 common shares were excluded from the computation of diluted net income per share for the years ended December 31, 2023 and 2021, respectively. Due to the net loss during the year ended December 31, 2022, the assumed exercise of all equity instruments was anti-dilutive and, therefore, not included in the diluted loss per share calculation for the period. No cash dividends were declared or paid as of December 31, 2023, 2022 and 2021.

Equity

Equity	12 Months Ended
	Dec. 31, 2023
Equity [Abstract]
Equity	16. Equity Authorized capitalization consists of 75.0 million shares of $ 0.01 par value common stock and 3.5 million shares of $ 0.01 par value preferred stock. None of the preferred shares have been issued. During 2023, the Board of Directors approved a new authorization to purchase up to $ 35.0 million of the Company's common stock at management's discretion, replacing the previously authorized but unused amount from the prior share repurchase authorization. The Company's share repurchases program purchases shares in the open market to offset stock-based awards issued in conjunction with the Company's 2013 Omnibus Incentive Plan. The total remaining under the new authorization is $ 35.0 million. Under the prior share repurchase authorization, the Company repurchased 320,984 shares of the Company's common stock for $ 5.5 million during 2023. As of December 31, 2023, the Company’s operations in Russia have been substantially curtailed. As a result, the Company released $ 9.3 million of non-cash foreign currency translation adjustments recorded in accumulated other comprehensive loss on the Consolidated Balance Sheets to other income (expense) – net in the Consolidated Statement of Operations. The results of the Company’s Russian operations continue to be included in its consolidated results in accordance with ASC 810, “Consolidation.” The components of accumulated other comprehensive loss as of December 31, 2023 and 2022 are summarized as follows: 2023 2022 Foreign currency translation, net of income tax 0.2 and $ 0.1 $ ( 77.4 ) $ ( 98.0 ) Derivative instrument fair market value, net of income 0.0 and $ 0.0 1.3 5.4 Employee pension and postretirement benefit adjustments, 13.6 and $ 12.9 ( 10.3 ) ( 15.3 ) Total accumulated other comprehensive loss $ ( 86.4 ) $ ( 107.9 ) A reconciliation of the changes in accumulated other comprehensive loss, net of income tax, by component as of December 31, 2023 and 2022 are summarized as follows: Gains (Losses) on Pension & Foreign Total Balance as of December 31, 2021 $ — $ ( 32.3 ) $ ( 70.1 ) $ ( 102.4 ) Other comprehensive income (loss) before ( 0.4 ) 15.5 ( 27.9 ) ( 12.8 ) Amounts reclassified from accumulated other 5.8 1.5 — 7.3 Net other comprehensive income (loss) 5.4 17.0 ( 27.9 ) ( 5.5 ) Balance as of December 31, 2022 5.4 ( 15.3 ) ( 98.0 ) ( 107.9 ) Other comprehensive income (loss) before ( 1.8 ) 2.4 11.3 11.9 Amounts reclassified from accumulated other ( 2.3 ) 2.6 9.3 9.6 Net other comprehensive income (loss) ( 4.1 ) 5.0 20.6 21.5 Balance as of December 31, 2023 $ 1.3 $ ( 10.3 ) $ ( 77.4 ) $ ( 86.4 ) A reconciliation of the reclassifications out of accumulated other comprehensive loss, net of income taxes, for the years ended December 31, 2023, 2022 and 2021 are summarized as follows: Amount Reclassified from Accumulated Other Comprehensive Loss 2023 2022 2021 Recognized Gain (losses) on cash flow hedges FX Forward Contracts $ 2.3 $ ( 5.8 ) $ ( 1.1 ) Cost of sales Total before income taxes 2.3 ( 5.8 ) ( 1.1 ) Provision for income taxes — — — Total, net of income taxes $ 2.3 $ ( 5.8 ) $ ( 1.1 ) Amortization of pension and Actuarial losses $ ( 2.6 ) $ ( 2.9 ) $ ( 4.7 ) (a) Other income (expense) - net Amortization of prior service cost ( 0.1 ) 1.3 2.6 (a) Other income (expense) - net Pension settlement gain 0.1 0.1 0.9 (a) Other income (expense) - net Total before income taxes ( 2.6 ) ( 1.5 ) ( 1.2 ) Provision for income taxes — — 0.1 Total, net of income taxes $ ( 2.6 ) $ ( 1.5 ) $ ( 1.1 ) Foreign currency translation Losses on foreign currency translation $ ( 9.3 ) $ — $ — Total before income taxes ( 9.3 ) — — Provision for income taxes — — — Total, net of income taxes $ ( 9.3 ) $ — $ — Total reclassifications for the period, net $ ( 9.6 ) $ ( 7.3 ) $ ( 2.2 ) (a) These accumulated other comprehensive loss components are components of net periodic pension cost (refer to Note 21, “ Employee Benefit Plans,” for further details).

Stock-Based Compensation

Stock-Based Compensation	12 Months Ended
	Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	17. Stock-Based Compensation The Company’s 2013 Omnibus Incentive Plan (the “2013 Omnibus Plan”) was approved by shareholders on May 7, 2013. The 2013 Omnibus Plan provides for both short-term and long-term incentive awards for employees and non-employee directors. Stock-based awards may take the form of stock options, stock appreciation rights, restricted stock, restricted stock units, and performance share or performance unit awards. The total number of shares of the Company’s common stock available for awards under the 2013 Omnibus P lan is 7,477,395 shares. The total number of shares of the Company’s common stock still available for issuance as of December 31, 2023 is 3,271,119 . The Company recognizes expense net of estimated future forfeitures for all stock-based compensation on a straight-line basis over the vesting period of the entire award. Estimated future forfeitures are based on the Company’s historical experience. During the years ended December 31, 2023, 2022 and 2021, the Company recorded stock-based compensation expense of $ 11.5 million, $ 8.5 million and $ 7.1 million, respectively, in engineering, selling and administrative expense in the Consolidated Statement of Operations. Shares are issued out of treasury stock upon exercise for stock options and vesting of restricted stock units and performance share units. Stock Options Stock option grants to employees are exercisable in three annual increments over a three-year period beginning on the first anniversary of the grant date and expire 10 years subsequent to the grant date. The Company did no t grant employees stock options in 2023, 2022 or 2021. Stock-based compensation expense is calculated by estimating the fair value of non-qualified stock options at the time of grant and is amortized over the stock options’ vesting period. The Company recognized zero , $ 0.1 million and $ 0.6 million of expense before income taxes associated with stock options during the years ended December 31, 2023, 2022 and 2021, respectively. The activity for stock options is summarized as follows: Shares Weighted Aggregate Options outstanding as of December 31, 2022 552,923 $ 21.13 Granted — — Exercised ( 17,135 ) 14.81 Forfeited — — Cancelled ( 41,418 ) 19.63 Options outstanding as of December 31, 2023 494,370 $ 21.47 $ 324,847 Options exercisable as of December 31, 2023 494,370 $ 21.47 $ 324,847 Restricted Stock Units The Company granted 520,132 , 413,543 and 417,535 restricted stock units inclusive of director awards in 2023, 2022 and 2021 , respectively. A total of 77,576 , 56,640 , and 59,280 equity compensation awards were granted to directors in 2023, 2022 and 2021, respectively, which vested immediately upon the grant date. The Company recognized $ 6.3 million, $ 5.2 million and $ 4.7 million of compensation expense associated with restricted stock units during the years ended December 31, 2023, 2022 and 2021, respectively. With the exception of director grants, the restricted stock units are earned based on service over the vesting period. Restricted stock units granted to employees vest in three annual increments over a three-year period beginning on the first anniversary of the grant date. The expense is based on the fair value of the Company's shares as of the grant date which is the grant date closing stock price. The activity for restricted stock units is summarized as follows: Shares Weighted Unvested as of December 31, 2022 647,212 $ 16.45 Granted 520,132 14.28 Vested ( 359,655 ) 15.74 Forfeited ( 2,227 ) 17.27 Unvested as of December 31, 2023 805,462 - $ 15.37 As of December 31, 2023, the Company h as $ 6.2 million of unrecognized compensation expense before income tax related to restricted stock units which will be recognized over a weighted average period of 1.8 years. Performance Share Units The Company granted 316,022 , 122,280 and 159,247 of performance share units in 2023, 2022 and 2021 , respectively. The performance share units are earned based on service over the vesting period and only to the extent to which performance goals are met over the applicable three-year performance period. The performance goals vary for performance share units each grant year. The Company recognized $ 5.2 million , $ 3.2 million and $ 1.9 million of compensation expense associated with performance share units during the years ended December 31, 2023, 2022 and 2021, respectively. The performance goals for the performance share units granted in 2023 are weighted 60 % on the 3-year average of the Company’s adjusted EBITDA percentage from 2023 to 2025 and 40 % on cumulative non-new machine sales from January 1, 2023 through December 31, 2025. The Company defines non-new machine sales as parts sales, used crane sales, rental revenue, service revenue and other revenue. The 2023 performance share units include a +/- 20 % modifier weighted on total shareholder return relative to a defined peer group of companies during the three-year performance period, not to exceed 200 % of target shares granted. The performance goals for the performance share units granted in 2022 are weighted 60 % on the 3-year average of the Company’s adjusted EBITDA percentage from 2022 to 2024 and 40 % on non-new machine sales for the year ending December 31, 2024. The 2022 performance share units include a +/- 20 % modifier weighted on total shareholder return relative to a defined peer group of companies during the three-year performance period, not to exceed 200 % of target shares granted. The performance goals for the performance share units granted in 2021 are weighted 60 % on the 3-year average of the Company’s adjusted EBITDA percentage from 2021 to 2023 and 40 % on non-new machines sales as of the year ended December 31, 2023. The 2021 performance share units include a +/- 20 % modifier weighted on total shareholder return relative to a defined peer group of companies during the three-year performance period, not to exceed 200 % of target shares granted. The activity for performance share units is summarized as follows: Shares Weighted Unvested as of December 31, 2022 459,774 $ 17.30 Granted (1) 316,022 16.05 Adjustment for performance results achieved (2) ( 84,576 ) 12.67 Vested ( 46,145 ) 12.67 Forfeited ( 14,680 ) 18.28 Unvested as of December 31, 2023 630,395 $ 17.39 (1) Performance shares granted assuming achievement of performance goals at target. (2) Adjustment due to performance share units granted in 2020 and vested in 2023 where the number of shares achieved based on the three-year performance period ended December 31, 2022 were lower than target. As of December 31, 2023, the Company has $ 5.5 million of unrecognized compensation expense before income tax related to performance share units expected to be recognized over a weighted average period of 1.7 years. The Company uses the Monte Carlo valuation model to determine fair value of the performance share unit grants. The Company used an average of historical stock prices of selected peers for its volatility assumption. The assumed risk-free rates were based on three-year U.S. Treasury rates in effect at the time of grant. The fair value of each performance share unit was estimated at the date of grant using the following assumptions: 2023 2022 2021 Correlation 28.2 % 25.9 % 27.9 % Risk-free interest rate 4.1 % 1.7 % 0.2 % Expected volatility 60.3 % 59.5 % 59.0 % Expected dividend yield — % — % — %

Segments

Segments	12 Months Ended
	Dec. 31, 2023
Segment Reporting [Abstract]
Segments	18. Segments The Company reports segment information based on the “management” approach. The management approach designates the internal reporting used by the CEO, who is also the Company’s Chief Operating Decision Maker (“CODM”), for making decisions about the allocation of resources and assessing performance as the source of the Company’s reportable operating segments. The results of the acquired businesses are included in the Americas segment. The Company has three reportable segments: Americas, Europe and Africa ( “ EURAF ” ) and MEAP. The Americas reporting segment includes the North America and South America continents. The EURAF reporting segment includes the Europe and Africa continents, excluding the Middle East region. The MEAP reporting segment includes the Asia and Australia continents and the Middle East region. The CODM evaluates the performance of its reportable segments based on net sales and operating income. Segment net sales are recognized in the geographic region the product is sold. Each reportable segment has new and non-new machine sales. Operating income for each segment includes net sales to third parties, cost of sales directly attributable to the segment, and operating expenses directly attributable to the segment. Manufacturing variances generated by the manufacturing locations within each operating segment are maintained in each segment’s operating income. Operating income for each segment excludes other income and expense and certain expenses managed outside the operating segments. Costs excluded from segment operating income include various corporate expenses such as stock-based compensation expenses, income taxes and other separately managed general and administrative costs. The Company does not include intercompany sales between segments for management reporting purposes. The CODM does not evaluate performance of the reportable segments based on total assets. The following table shows information by reportable segment for the years ended December 31, 2023, 2022 and 2021: 2023 2022 2021 Net Sales Americas $ 1,211.2 $ 1,013.0 $ 757.6 EURAF 669.6 761.5 677.0 MEAP 347.0 258.0 285.6 Total $ 2,227.8 $ 2,032.5 $ 1,720.2 Segment Operating Income (Loss) Americas $ 111.7 $ ( 88.8 ) $ 57.3 EURAF ( 7.9 ) ( 3.2 ) 8.9 MEAP 52.3 40.2 30.9 Total $ 156.1 $ ( 51.8 ) $ 97.1 Depreciation Americas $ 29.2 $ 35.4 $ 20.7 EURAF 22.1 20.1 19.8 MEAP 2.4 2.2 2.1 Corporate 2.9 2.9 2.9 Total $ 56.6 $ 60.6 $ 45.5 Capital Expenditures Americas $ 46.5 $ 32.0 $ 11.3 EURAF 28.5 27.7 27.5 MEAP 2.4 2.1 1.5 Corporate — — 0.1 Total $ 77.4 $ 61.8 $ 40.4 A reconciliation of the Company’s segment operating income (loss) to operating income (loss) in the Consolidated Statement of Operations for the years ended December 31, 2023, 2022 and 2021 are summarized as follows: 2023 2022 2021 Segment operating income (loss) $ 156.1 $ ( 51.8 ) $ 97.1 Unallocated corporate expenses ( 63.6 ) ( 41.3 ) ( 51.1 ) Unallocated restructuring income (expense) ( 0.1 ) 0.1 0.5 Total operating income (loss) $ 92.4 $ ( 93.0 ) $ 46.5 Net sales by geographic area for the years ended December 31, 2023, 2022 and 2021 and property, plant and equipment as of December 31, 2023 and 2022 are summarized as follows: Net Sales Property, Plant and Equipment 2023 2022 2021 2023 2022 United States $ 1,039.9 $ 906.4 $ 664.5 $ 158.1 $ 146.7 Europe 641.9 740.1 653.7 183.8 166.6 Other 546.0 386.0 402.0 24.2 22.0 Total $ 2,227.8 $ 2,032.5 $ 1,720.2 $ 366.1 $ 335.3 New machine and non-new machine sales for the years ended December 31, 2023, 2022 and 2021 are summarized as follows: 2023 2022 2021 New machine sales $ 1,615.1 $ 1,487.2 $ 1,271.6 Non-new machine sales 612.7 545.3 448.6 Total net sales $ 2,227.8 $ 2,032.5 $ 1,720.2

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	19. Commitments and Contingencies The Company is subject to various legal proceedings and claims that have arisen in the ordinary course of business which have not been fully resolved. The outcome of any litigation is inherently uncertain. When a loss related to a legal proceeding or claim is probable and reasonably estimable, the Company accrues its best estimate for the ultimate resolution of the matter. As of December 31, 2023 , various product-related lawsuits were pending. To the extent permitted under applicable law, all of these are insured with self-insurance retention levels. The Company’s self-insurance retention levels have varied over the last 10 years . As of December 31, 2023, the largest self-insured retention level for new occurrences currently maintained by the Company is $ 3.0 mill ion per occurrence and applies to product liability claims arising in North America. As of December 31, 2023, current and long-term product liability reserves were $ 11.4 million and $ 5.1 million, respectively. As of December 31, 2022, current and long-term product liabilities reserves were $ 9.4 million and zero , respectively. Current product liability reserves are included within other liabilities and long-term product liability reserves are included within other non-current liabilities in the Consolidated Balance Sheets. These amounts are not reduced for insurance recoveries for claims above the Company's self-insured retention level. As of December 31, 2023 and December 31, 2022, the Company had $ 3.9 mi llion and zero , respectively, of estimated insurance recoveries included in the other current assets in the Consolidated Balance Sheets. Reserves for product-related lawsuits were estimated using a combination of actual case reserves and actuarial methods. Based on the Company’s experience in defending product liability claims, management believes the current reserves are adequate for estimated case resolutions on aggregate self-insured claims and insured claims. Any recoveries from insurance carriers are dependent upon the legal sufficiency of claims and solvency of insurance carriers. As of December 31, 2023 and 2022, the Company had reserved $ 56.8 million and $ 58.0 million, respectively, for warranty and other related claims and are included in product warranties and other non-current liabilities in the Consolidated Balance Sheets. Certain of these warranty and other related claims involve matters in dispute that ultimately are resolved by negotiation, arbitration, or litigation. Refer to Not e 20, “Guarantees,” for further information. It is reasonably possible that the estimates for warranty costs, product liability, asbestos-related claims and other various legal matters may change based upon new information that may arise or matters that are beyond the scope of the Company’s historical experience. Presently, there are no reliable methods to estimate the amount of any such potential changes. The ultimate resolution of these matters, individually and in the aggregate, is not expected to have a material adverse effect on the Company’s financial condition, results of operations or cash flows. In July 2017, the Company received an Information Request from the United States Environmental Protection Agency (“U.S. EPA”) relating to the sales of cranes manufactured between January 1, 2014 and July 31, 2017 and the Company’s related participation in the Transition Program for Equipment Manufacturers (the “TPEM” program). The TPEM program allowed equipment manufacturers to delay installing engines meeting Tier 4 final emission standards in their products, subject to certain percentage allowance restrictions. The Company has provided, and continues to provide, information to the U.S. EPA and the U.S. Department of Justice (“U.S. DOJ”) on the approximately 1,420 engines included in the Company’s cranes relating to the TPEM program and other certification matters. The Company is engaged in confidential discussions with the U.S. EPA and U.S. DOJ with respect to these matters. Based on management's current assessment of the facts underlying these matters, the Company recorded an additional charge of $ 21.2 million as of December 31, 2023. The total recorded estimated liability in accounts payable and accrued expenses in the Company’s Consolidated Balance Sheets was $ 36.1 million and $ 14.9 million as of December 31, 2023 and December 31, 2022, respectively. Other than the foregoing, the Company is unab le to provide further meaningful quantification as to the final resolution of these matters. However, the Company calculated the statutory maximum penalties under the Clean Air Act to be approximately $ 174.0 million. The Company believes it has strong legal and factual defenses and will vigorously defend any allegations of noncompliance and the factors that could apply in the assessment of any civil penalty. Final resolution of these matters may have a material impact on the Company’s financial condition, results of operations or cash flows.

Guarantees

Guarantees	12 Months Ended
	Dec. 31, 2023
Guarantees [Abstract]
Guarantees	20. Guarantees The Company periodically enters into transactions with customers that provide for buyback commitments. The Company evaluates each agreement at inception to determine if the customer has a significant economic incentive to exercise the buyback option. If it is determined that the customer has a significant economic incentive to exercise that right, the revenue is deferred and the agreement is accounted for as a lease in accordance with Topic 842. If it is determined that the customer does not have a significant economic incentive to exercise that right, then revenue is recognized when control of the product is transferred to the customer. The revenue deferred related to buyback obligations accounted for under Topic 842 included in other current and non-current liabilities as of December 31, 2023 and 2022 was $ 32.2 million and $ 27.3 million, respectively. The total amount of buyback commitments given by the Company and outstanding as of December 31, 2023 and 2022 was $ 43.4 million and $ 42.5 million, respectively. These amounts are not reduced for amounts the Company would recover from repossession and subsequent resale of the units. The buyback commitments expi re at various times through 2032. The Company also has various loss guarantees with maximum liabilities of $ 13.0 million and $ 15.0 million as of December 31, 2023 and 2022, respectively. These amounts are not reduced for amounts the Company would recover from repossession and subsequent resale of the cranes securing the related guarantees. In the normal course of business, the Company provides its customers a warranty covering workmanship, and in some cases materials, on products manufactured by the Company. Such warranties generally provide that products will be free from defects for periods ranging from 12 months to 60 months . In addition, the Company may incur other warranty related costs outside of its standard warranty period. Costs for other warranty related work are recorded in the period a loss is probable and can be reasonably estimated. Below is a table summarizing the warranty and other warranty related work for the years ended December 31, 2023, 2022 and 2021: 2023 2022 2021 Balance at beginning of period $ 58.0 $ 60.2 $ 63.2 Adjustments to accruals for warranties 28.9 27.3 30.4 Settlements made (in cash or in kind) during ( 31.0 ) ( 27.8 ) ( 31.3 ) Currency translation 0.9 ( 1.7 ) ( 2.1 ) Balance at end of period $ 56.8 $ 58.0 $ 60.2 Included in the warranty balance as of December 31, 2023 and 2022 is $ 9.7 million and $ 9.2 million , respectively, of long-term warranty which is recorded in other non-current liabilities in the Consolidated Balance Sheets. The revenue deferred related to extended warranty periods included in other current and non-current liabilities as of December 31, 2023 and 2022 was $ 6.1 million and $ 6.6 million, respectively.

Employee Benefit Plans

Employee Benefit Plans	12 Months Ended
	Dec. 31, 2023
Retirement Benefits [Abstract]
Employee Benefit Plans	21. Employee Benefit Plans The Company provides defined benefit pension plans, defined contribution plans and/or other postretirement benefit plans to employees in many of the Company’s locations throughout the world. The Company’s defined benefit plans provide a benefit based on years of service and/or the employee’s average earnings near retirement. The Company’s defined contribution plans allow employees to contribute a portion of their salary to help save for retirement, and in most cases, the Company provides a matching contribution. The benefit obligation related to the Company’s non-U.S. defined benefit pension plans are for employees located primarily in Europe. For postretirement medical and other benefit plans, all of the Company’s benefit obligation is for employees located in the United States. Defined contribution plans The Company maintains two defined contribution retirement plans for its employees in the United States: (1) The Manitowoc Company, Inc. 401(k) Retirement Plan (the “Manitowoc 401(k) Plan”) and (2) The Manitowoc. Deferred Compensation Plan. Each plan results in individual participant balances that reflect a combination of amounts contributed by the Company or deferred by the participant, amounts invested at the direction of either the Company or the participant, and the continuing reinvestment of returns until the accounts are distributed. The Company also has various other non-U.S. defined contribution plans that allow eligible employees to contribute a portion of their salary to the plans. In most cases, the Company provides a matching contribution to the funds contributed by the employees. Company contributions to the plans are generally based upon formulas contained in the plans. Total costs incurred under the Non-U.S. defined contribution plans, and reported within the Consolidated Statement of Operations, wer e $ 1.7 million, $ 1.7 million and $ 1.6 million for the years ended December 31, 2023, 2022 and 2021, respectively. Manitowoc 401(k) Plan The Manitowoc 401(k) Plan is a tax-qualified retirement plan that is available to substantially all U.S. employees of Manitowoc, its subsidiaries and related entities. The Manitowoc 401(k) Plan allows employees to make both pre and after-tax elective deferrals, subject to certain limitations under the Internal Revenue Code of 1986, as amended (the “Tax Code”). The Company also has the right to make the following additional contributions: (1) a safe harbor matching contribution and (2) an additional contribution, which may or may not be made, at the full discretion of the Company and for which the value will be fully determined by the Company based on its performance. Each participant in the Manitowoc 401(k) Plan is allowed to direct the investment of that participant’s account among a diverse mix of investment funds, including a Company stock alternative. To the extent that any funds are invested in the Company’s stock, that portion of the Manitowoc 401(k) Plan is an employee stock ownership plan, as defined under the Tax Code (an “ESOP”). The terms governing the retirement benefits under the Manitowoc 401(k) Plan are the same for the Company’s executive officers as they are for other eligible employees in the U.S. Total costs incurred under this plan, and reported within the Consolidated Statement of Operations, w ere $ 8.7 million, $ 11.9 million and $ 5.8 million for the years ended December 31, 2023, 2022 and 2021, respectively. Manitowoc Deferred Compensation Plan The Manitowoc Deferred Compensation Plan is a non-qualified supplemental deferred compensation plan for highly compensated and key management employees and for non-employee directors of the Company. The Company maintains the Manitowoc Deferred Compensation Plan to allow eligible individuals to save for retirement in a tax-efficient manner despite Tax Code restrictions that would otherwise impair their ability to do so under the Manitowoc 401(k) Plan. The Manitowoc Deferred Compensation Plan also assists the Company in retaining those key employees and directors. The Manitowoc Deferred Compensation Plan accounts are credited with: (1) elective deferrals made at the request of the individual participant; (2) a matching contribution for eligible wages above IRS employee compensation limits for 401(k) retirement plans and/or (3) an additional contribution from the Company for each individual participant, which may or may not be made, at the full discretion of the Company based on its performance. Although unfunded within the meaning of the Tax Code, the Manitowoc Deferred Compensation Plan utilizes a rabbi trust to hold assets intended to satisfy the Company’s corresponding future benefit obligations. Each participant in the Manitowoc Deferred Compensation Plan is credited with earnings based upon individual elections from a diverse mix of investment funds that are intended to reflect investment funds similar to those offered under the Manitowoc 401(k) Plan, including the Company’s stock. Participants do not receive preferential or above-market rates of return under the Manitowoc Deferred Compensation Plan. The Company has two separate investment programs: Program A and B, which allows participants to direct deferrals and Company contributions and restricts the Company’s use and access to the funds but are subject to the claims of the Company’s general creditors in rabbi trusts. Program A invests solely in the Company’s stock; dividends paid, if any, on the Company’s stock are automatically reinvested; and all distributions must be made in Company stock. Program B offers a variety of investment options but does not include Company stock as an investment option. All distributions from Program B must be made in cash. Participants cannot transfer assets between programs. Program A is accounted for as a plan that does not permit diversification. As a result, the Company stock held by Program A is classified in equity in a manner similar to accounting for treasury stock. The deferred compensation obligation is classified as an equity instrument. Changes in the fair value of the Company’s stock and the compensation obligation are not recognized. The asset and obligation for Program A were $ 1.2 million and $ 0.6 million as of December 31, 2023 and 2022, respectively. Program B is accounted for as a plan that permits diversification. As a result, the assets held by Program B are classified as an asset in the Consolidated Balance Sheets and changes in the fair value of the assets are recognized in earnings. The deferred compensation obligation is classified as a liability in the Consolidated Balance Sheets and adjusted, with a charge or credit to compensation cost, to reflect changes in the fair value of the obligation. The assets, which are included in other non-current assets, and obligations, which are included in other non-current liabilities, were $ 8.1 m illion and $ 7.1 million as of December 31, 2023 and 2022, respectively. Total costs incurred under this plan, and reported within the Consolidated Statement of Operations, for the years ended December 31, 2023, 2022 and 2021 w ere $ 0.2 million, $ 0.4 million and $ 0.1 million, respectively. Pension, Postretirement Medical and Other Benefit Plans The Company provides certain pension, postretirement medical and other benefits (death benefits) for eligible retirees and their dependents in the U.S. under various frozen plans. Pension benefits are provided under the Manitowoc U.S. Pension Plan (“U.S. Pension Plan”). Certain pension benefits are funded, the postretirement medical benefits are not funded but are paid as incurred, and the death benefits are fully insured. Eligibility for coverage is based on meeting certain years of service and retirement qualifications. The healthcare benefits may be subject to deductibles, co-payment provisions, and other limitations. The Company has reserved the right to modify these benefits which have been frozen. In addition to the U.S. Pension Plan, the Company also maintains defined benefit pension plans for various Non-US subsidiaries which are sponsored directly by the Company or its subsidiaries and offered only to employees or retirees of those subsidiaries (“Non-U.S. Pension Plans”). Certain Non-U.S. Pension Plans have frozen benefit accruals. During 2021, the unvested portion of Portugal's pension plan was transferred to a defined contribution plan. As a result, the Company recognized a settlement gain of $ 0.9 million. The components of periodic benefit costs for the years ended December 31, 2023, 2022 and 2021 are summarized as follows: U.S. Pension Plan Non-U.S. Pension Plans Postretirement Medical 2023 2022 2021 2023 2022 2021 2023 2022 2021 Service cost - benefits earned $ — $ — $ — $ 1.2 $ 1.6 $ 2.3 $ 0.1 $ 0.1 $ 0.1 Interest cost of projected 5.5 3.2 2.8 3.0 1.7 1.5 0.4 0.2 0.2 Expected return on assets ( 3.9 ) ( 5.2 ) ( 4.9 ) ( 1.6 ) ( 1.2 ) ( 1.0 ) — — — Amortization of prior service — — — 0.1 0.1 0.1 — ( 1.4 ) ( 2.7 ) Amortization of actuarial net 2.2 1.9 3.2 1.6 1.5 1.8 ( 1.2 ) ( 0.5 ) ( 0.3 ) Pension settlement gain — — — ( 0.1 ) ( 0.1 ) ( 0.9 ) — — — Net periodic benefit cost $ 3.8 $ ( 0.1 ) $ 1.1 $ 4.2 $ 3.6 $ 3.8 $ ( 0.7 ) $ ( 1.6 ) $ ( 2.7 ) Weighted average Effective discount rate for 5.4 % 2.8 % 2.4 % 4.7 % 1.4 % 1.2 % 5.4 % 2.5 % 2.0 % Expected return on 5.0 % 4.7 % 4.3 % 5.4 % 2.9 % 1.6 % N/A N/A N/A Rate of compensation N/A N/A N/A 3.7 % 4.1 % 4.1 % N/A N/A N/A The prior service costs are amortized on a straight-line basis over the average remaining service period of active participants. Gains and losses in excess of 10 % of the greater of the benefit obligation and the market-related value of assets are amortized over the average remaining service period of active participants. To develop the expected long-term rate of return on assets assumptions, the Company considered the historical returns and future expectations for returns in each asset class net of fees, as well as targeted asset allocation percentages within the pension portfolio. The following is a reconciliation of the changes in benefit obligation, plan assets, and funded status as of December 31, 2023 and 2022: U.S. Pension Plan Non-U.S. Pension Plans Postretirement 2023 2022 2023 2022 2023 2022 Change in Benefit Obligation Benefit obligation, beginning of year $ 106.4 $ 141.2 $ 59.0 $ 94.5 $ 9.5 $ 13.7 Service cost — — 1.2 1.6 0.1 0.1 Interest cost 5.5 3.2 3.0 1.7 0.4 0.2 Participant contributions — — — — 0.1 0.1 Actuarial (gain) loss 2.5 ( 30.1 ) ( 0.3 ) ( 27.1 ) ( 2.4 ) ( 3.4 ) Currency translation adjustment — — 2.6 ( 8.0 ) — — Pension settlement — — ( 0.1 ) ( 0.3 ) — — Benefits paid ( 8.0 ) ( 7.9 ) ( 3.5 ) ( 3.4 ) ( 1.1 ) ( 1.2 ) Benefit obligation, end of year $ 106.4 $ 106.4 $ 61.9 $ 59.0 $ 6.6 $ 9.5 Change in Plan Assets Fair value of plan assets, beginning of year $ 82.3 $ 114.6 $ 29.7 $ 50.2 $ — $ — Actual return on plan assets 7.4 ( 24.9 ) — ( 15.0 ) — — Employer contributions 0.5 0.5 3.6 3.4 1.0 1.1 Participant contributions — — — — 0.1 0.1 Currency translation adjustment — — 1.6 ( 5.2 ) — — Pension settlement — — ( 0.1 ) ( 0.3 ) — — Benefits paid ( 8.0 ) ( 7.9 ) ( 3.5 ) ( 3.4 ) ( 1.1 ) ( 1.2 ) Fair value of plan assets, end of year 82.2 82.3 31.3 29.7 — — Funded status $ ( 24.2 ) $ ( 24.1 ) $ ( 30.6 ) $ ( 29.3 ) $ ( 6.6 ) $ ( 9.5 ) Amounts recognized in the Consolidated Pension asset $ — $ — $ 2.7 $ — $ — $ — Short-term pension obligation ( 0.5 ) ( 0.5 ) ( 1.2 ) ( 1.2 ) — — Long-term pension obligation ( 23.7 ) ( 23.6 ) ( 32.1 ) ( 28.1 ) — — Short-term postretirement medical and other — — — — ( 1.0 ) ( 1.3 ) Long-term postretirement medical and other — — — — ( 5.6 ) ( 8.2 ) Net amount recognized $ ( 24.2 ) $ ( 24.1 ) $ ( 30.6 ) $ ( 29.3 ) $ ( 6.6 ) $ ( 9.5 ) Weighted-Average Assumptions Discount rate 5.1 % 2.8 % 4.2 % 4.2 % 5.0 % 5.4 % Rate of compensation increase N/A N/A 3.8 % 2.7 % N/A N/A The Company determines its discount rates with advice from an independent third party. The Company uses different discount rates for each plan depending on the plan jurisdiction, the demographics of participants and the expected timing of benefit payments. For the qualified U.S. pension plan and postretirement medical plans, the Company uses a discount rate calculated based on an appropriate mix of high-quality corporate bonds. For the non-U.S. pension and postretirement plans, the Company consistently uses the relevant country specific benchmark indices for determining the various discount rates. Amounts recognized in accumulated other comprehensive loss as of December 31, 2023 and 2022, are summarized as follows: Pensions Postretirement 2023 2022 2023 2022 Net actuarial gain (loss) $ ( 32.0 ) $ ( 35.0 ) $ 8.3 $ 7.0 Prior service cost ( 0.2 ) ( 0.3 ) — — Total amount recognized $ ( 32.2 ) $ ( 35.3 ) $ 8.3 $ 7.0 For measurement purposes, a 6.50 % a nnual rate of increase in the per capita cost of covered health care benefits was assumed for the postretirement medical and other plan for 2023. The rate was assume d to decrease gradually to 4.00 % in 2047 and remain at that level thereafter. The weighted-average asset allocation of the U.S. Pension Plan as of December 31, 2023 and 2022, by asset category are summarized as follows: 2023 2022 Equity 53.3 % 52.8 % Fixed income 39.7 % 36.9 % Other 7.0 % 10.3 % Total 100.0 % 100.0 % The weighted-average asset allocation of the Non-U.S. Pension Plans as of December 31, 2023 and 2022, by asset category are summarized as follows: 2023 2022 Equity — % — % Fixed income 39.4 % 45.2 % Other (1) 60.6 % 54.8 % Total 100.0 % 100.0 % (1) Includes diversified investments that have equity and fixed income holdings. The Board of Directors has established the Retirement Plan Committee (the “Committee”) to manage the operations and administration of all benefit plans and related trusts. On a quarterly basis, the Committee reviews progress toward achieving the pension plans’ and individual investment managers’ performance objectives. Investment Strategy The overall objective of the Company's pension assets is to earn a rate of return over time to satisfy the benefit obligations of the pension plans and to maintain sufficient liquidity to pay benefits and address other cash requirements of the pension funds. Specific investment objectives for the Company’s long-term investment strategy include reducing the volatility of pension assets relative to pension liabilities, achieving a competitive, total investment return, achieving diversification between and within asset classes and managing other risks. Investment objectives for each asset class are determined based on specific risks and investment opportunities identified. The Company reviews its long-term, strategic asset allocations annually. The Company uses various analytics to determine the optimal asset mix and considers plan liability characteristics, liquidity characteristics, funding requirements, expected rates of return and the distribution of returns. The Company identifies investment benchmarks for the asset classes in the strategic asset allocation that are market-based. Actual allocations to each asset class vary from target allocations due to periodic investment strategy changes, market value fluctuations, the length of time it takes to fully implement investment allocation positions and the timing of benefit payments and contributions. The asset allocation is monitored and rebalanced monthly. The actual and target allocations for the pension assets as of December 31, 2023, by asset class, are summarized as follows: Target Allocations Weighted Average Asset U.S. Plan Non-U.S. Plans U.S. Plans Non-U.S. Plans Equity Securities 50.0 % 0.0 % 53.3 % — % Debt Securities 40.0 % 48.0 % 39.7 % 39.4 % Other 10.0 % 52.0 % 7.0 % 60.6 % Risk Management In managing the plan assets, the Company reviews and manages risk associated with funded status risk, interest rate risk, market risk, counterparty risk, liquidity risk and operational risk. Liability management and asset class diversification are central to the Company’s risk management approach and are integral to the overall investment strategy. Further, asset classes are constructed to achieve diversification by investment strategy, by industry or sector and by holding. Asset performance is monitored against benchmarked indices. Fair Value Measurements The following tables present the Company’s plan assets using the fair value hierarchy as of December 31, 2023 and 2022. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value. Refer to Note 5, “Fair Value of Financial Instruments,” for definitions of each fair value level. December 31, 2023 Assets Quoted Significant Unobservable Net Asset Value ("NAV")* Total Equity: U.S. equity $ — $ — $ — $ 21.7 $ 21.7 International equity — — — 22.1 22.1 Fixed income: Corporate bonds and notes — — — 16.6 16.6 Government and agency bonds — — — 25.5 25.5 Commingled funds — — — 11.1 11.1 International fixed income — — — 4.7 4.7 Other: Cash and cash equivalents 1.0 — — — 1.0 Money market funds 0.7 — — — 0.7 Annuity contracts — — 7.4 — 7.4 Other — — — 2.7 2.7 Total $ 1.7 $ — $ 7.4 $ 104.4 $ 113.5 * Certain assets that are measured at fair value using the NAV per share practical expedient have not been classified in the fair value hierarchy. December 31, 2022 Assets Quoted Significant Unobservable Net Asset Value ("NAV")* Total Equity: U.S. equity $ — $ — $ — $ 16.9 $ 16.9 International equity — — — 27.8 27.8 Fixed income: Corporate bonds and notes — — — 18.5 18.5 Government and agency bonds — — — 25.4 25.4 Commingled funds — — — 8.6 8.6 International fixed income — — — 1.9 1.9 Other: Cash and cash equivalents 0.9 — — — 0.9 Money market funds — 0.7 — — 0.7 Annuity contracts — — 8.5 — 8.5 Other — — — 2.8 2.8 Total $ 0.9 $ 0.7 $ 8.5 $ 101.9 $ 112.0 *Certain assets that are measured at fair value using the NAV per share practical expedient have not been classified in the fair value hierarchy. Cash and cash equivalents, which are used to pay benefits, are primarily held in registered money market funds which are valued using a market approach based on the quoted market prices of identical instruments. Other cash and cash equivalents are valued daily by the fund using a market approach with inputs that include quoted market prices for similar instruments. Insurance group annuity contracts are valued at the present value of the future benefit payments owed by the insurance Company to the Non-U.S. Pension Plan's participants. The valuation methodologies described above may generate a fair value calculation that may not be indicative of net realizable value or future fair values. While the Company believes the valuation methodologies used are appropriate, the use of different methodologies or assumptions in calculating fair value could result in different amounts. A reconciliation of the fair value measurements of plan assets using significant unobservable inputs (Level 3) from the beginning of the year to the end of the year is as follows: Annuity Contracts 2023 2022 Beginning Balance $ 8.5 $ 12.6 Additions 0.5 — Actual return on assets ( 1.2 ) ( 1.9 ) Benefit payments ( 0.9 ) ( 0.8 ) Foreign currency impact 0.5 ( 1.4 ) Ending Balance $ 7.4 $ 8.5 The expected 2024 minimum contributions for the U.S. pension pla n are $ 5.5 million and there are no planned discretionary or non-cash contributions. The expected 2024 minimum contributions for the non-U.S. pension plans are $ 3.3 million and there are no planned discretionary or non-cash contributions. E xpected Company paid claims for the postretirement medical and other plans a re $ 1.0 million fo r 2024 . Projected future benefit payments from the plans as of December 31, 2023 are estimated as follows: U.S. Pension Non-U.S. Postretirement 2024 $ 8.7 $ 3.0 $ 1.0 2025 8.8 3.0 0.9 2026 8.7 3.4 0.8 2027 8.7 3.6 0.8 2028 8.7 4.2 0.7 Thereafter 41.2 20.7 2.6 Total $ 84.8 $ 37.9 $ 6.8 The fair value of plan assets for which the accumulated benefit obligation is in excess of the plan assets as of December 31, 2023 and 2022 is summarized as follows: U.S. Pension Plan Non U.S. Pension Plans 2023 2022 2023 2022 Projected benefit obligation $ 106.4 $ 106.4 $ 33.8 $ 59.0 Accumulated benefit obligation 106.4 106.4 30.6 56.1 Fair value of plan assets 82.2 82.3 0.5 29.7 The measurement date for all plans is December 31, 2023 .

Leases

Leases	12 Months Ended
	Dec. 31, 2023
Leases [Abstract]
Leases	22. Leases The Company has operating leases for offices, warehouses, land for storage of cranes, vehicles, information technology equipment and manufacturing equipment. The remaining lease terms are up t o 20 years, s ome of which include options to extend the lease term for up to 9 years, and some which include options to terminate the lease within one year . Certain leases include one or more options to renew; the exercise of lease renewal options is at the Company’s discretion. The Company includes renewal option periods in the lease term when it is determined that the options are reasonably certain to be exercised. The Company’s financing leases have an immaterial impact on the consolidated financial statements. The components of lease expense for the years ended December 31, 2023, 2022 and 2021 are summarized as follows: 2023 2022 2021 Operating lease cost $ 15.5 $ 14.0 $ 13.2 Variable lease cost* 1.2 1.4 1.5 Total lease cost $ 16.7 $ 15.4 $ 14.7 *Includes short-term leases, which are immaterial. Supplemental Consolidated Balance Sheet information related to leases as of December 31, 2023 and 2022 are summarized as follows: 2023 2022 Operating lease right-of-use assets $ 59.7 $ 45.2 Other liabilities $ 13.0 $ 11.6 Operating lease liabilities 47.2 34.3 Total operating lease liabilities $ 60.2 $ 45.9 Cash paid for operating leases included in operating cash flows was $ 29.5 milli on, $ 26.8 million and $ 25.1 million for the years ended December 31, 2023, 2022 and 2021, respectively. Operating lease right-of-use asset obtained in exchange for lease obligations were $ 26.0 million for the year ended December 31, 2023. As of December 31, 2023, the Company’s operating leases have a weighted-average remaining le ase term of 6.4 years and a weighted average discount rate of 5.9 %. A s of December 31, 2022 , the Company's leases had a weighted-average remaining lease term of 6.3 years and a weighted average discount rate of 4.9 %. Topic 842 requires a lessee to discount its unpaid lease obligations using the interest rate implicit in the lease, or if not readily determinable, the incremental borrowing rate at the time of lease commencement. Generally, the Company uses its incremental borrowing rate as the implicit rate cannot be determined. The Company’s incremental borrowing rate for a lease is the rate of interest the Company would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms in a similar region. Maturities of operating lease liabilities as of December 31, 2023 are summarized as follows: Year 2024 $ 15.4 2025 13.4 2026 10.7 2027 9.8 2028 7.6 Thereafter 15.7 Total lease payments 72.6 Less: imputed interest ( 12.4 ) Present value of lease liabilities $ 60.2 As of December 31, 2023, we have additional operating leases for facilities that have not yet commenced with undiscounted lease obligations of approximately $ 4.0 million. These leases are expected to commence during the year ending December 31, 2024 and have terms of up to 20 years . Lessor Accounting The Company rents cranes to its customers and actively manages the size, quality, age and composition of its rental fleet to meet customer demands and trends. The rental fleet is serviced through the Company’s parts and service team. The rental activities create cross-selling opportunities in crane sales including rent-to-own purchase options whereby customers are given a period of time to exercise an option to purchase the related equipment at an established price with any rental payments paid applied to reduce the purchase price. All of the Company's leasing arrangements are classified as operating leases. Rental revenue is recognized on a straight-line basis over the rental period. In most cases, the Company's rental arrangements include non-lease components, including delivery and pick-up services. The Company accounts for these non-lease components separate from the rental arrangement and recognizes the revenue associated with these components when the service is performed. The Company has elected to exclude from rental revenue all taxes collected from customers related to rental activities. The Company manages the residual value risk of its rented assets by (i) monitoring the quality, aging and anticipated retail market value of the rental fleet assets to determine the optimal period to remove an asset from the rental fleet, (ii) maintaining the quality of assets through parts and service support and (iii) requiring physical damage insurance of customers. The Company primarily disposes of the rental assets through its rent to own program or sale of the asset. Refer to Note 9, “Property, Plant and Equipment,” for the balance of rental cranes included in property, plant and equipment in the Consolidated Balance Sheets.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2023
Accounting Policies [Abstract]
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all cash, bankers acceptance and short-term investments purchased with an original maturity of three months or less as cash and cash equivalents.
Allowance for Credit Losses	Allowance for Credit Losses Accounts receivable are reduced by an allowance for amounts that may become uncollectible in the future. The Company's allowance for credit losses is based on an estimate of the losses inherent in amounts billed, pools of receivables with similar risk characteristics, existing and future economic conditions, reasonable and supportable forecasts that affect the collectability of the related receivable and any specific customer collection issues the Company has identified. The following table is a rollforward of the allowance for credit losses for the years ended December 31, 2023, 2022 and 2021. 2023 2022 2021 Balance at beginning of period $ 5.3 $ 7.3 $ 8.5 Bad debt expenses 2.3 0.1 — Use of reserve ( 1.4 ) ( 1.8 ) ( 1.3 ) Currency translation ( 0.1 ) ( 0.3 ) 0.1 Balance at end of period $ 6.1 $ 5.3 $ 7.3
Inventories	Inventories Inventories are valued at the lower of cost or net realizable value. Finished goods and work-in-process inventories include material, labor and manufacturing overhead costs. The Company determines inventory value using the first-in, first-out and average cost methodologies.
Business Combinations	Business Combinations The Company accounts for business combinations under the acquisition method in accordance with Accounting Standards Codification (“ASC”) Topic 805, Business Combinations (“Topic 805”). The acquisition method requires identifiable assets acquired and liabilities assumed and any non-controlling interest in the business acquired be recognized and measured at fair value on the acquisition date, which is the date that the Company obtains control of the acquired business. The amount by which the fair value of consideration transferred as the purchase price exceeds the net fair value of assets acquired and liabilities assumed is recorded as goodwill. The Company expenses transaction costs in a business combination.
Goodwill and Intangible Assets	Goodwill and Intangible Asset s The Company accounts for goodwill and intangible assets under the guidance of ASC Topic 350-10, “Intangibles — Goodwill and Other” (“Topic 350”). Under ASC Topic 350, goodwill is not amortized; instead, the Company performs an annual impairment test. The date for the annual impairment test is October 31 or more frequently if events or changes in circumstances indicate that the assets might be impaired. To perform its goodwill impairment test, the Company uses a combination of the income approach and market approach with a weighting of 70/30, respectively, to determine the fair value of the Middle East and Asia Pacific (“MEAP”) reporting unit. The Company uses only the income approach to determine the fair value of the Americas - Distribution reporting unit due to a lack of comparable peer companies to determine fair value under the market approach. Impairment is determined based on the amount in which a reporting unit's carrying value exceeds its fair value, not to exceed the carrying amount of goodwill at the reporting unit. In addition, goodwill of a reporting unit is tested for impairment between annual tests if an event occurs or circumstances change that would more-likely-than-not reduce the fair value of a reporting unit below its carrying value. The Company’s indefinite-lived intangible assets are not amortized but are subject to an annual impairment test. To perform its indefinite-lived intangible assets impairment test, the Company uses a fair-value method based on a relief of royalty valuation approach to determine the fair value of its indefinite-lived intangible assets. Management’s judgments and assumptions about the amounts of those cash flows and the discount rates are inputs to the annual impairment test. Impairment is determined based on the amount in which the carrying value of the indefinite-lived intangible asset exceeds its fair value, not to exceed the carrying amount of the indefinite-lived intangible asset. Refer to Note 10, “Goodwill and Intangible Assets,” for further details on the Company's impairment assessments. The Company’s definite-lived intangible assets subject to amortization are subject to impairment testing whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. If an indicator of impairment is identified, the Company would use the undiscounted cash flow model. The Company’s intangible assets subject to amortization are amortized straight-line over the following minimum and maximum estimated useful lives according to the Company's policy: Years Patents 20 Customer relationships 12 - 18 Trademarks and tradenames 5 Noncompetition agreements 5
Property, Plant and Equipment	Property, Plant and Equipment Property, plant and equipment are stated at cost. Expenditures for maintenance and repairs are charged against earnings as incurred. Expenditures for major renewals and improvements that substantially extend the capacity or useful life of an asset are capitalized and depreciated over the remaining estimated useful life. The cost and accumulated depreciation for property, plant and equipment sold, retired or otherwise disposed of are relieved from the accounts, and resulting gains or losses are reflected in earnings. Property, plant and equipment are depreciated over the asset’s estimated useful life using the straight-line depreciation method for financial reporting and accelerated methods for income tax purposes. The Company also has certain leasehold improvements which are depreciated over the lesser of the asset's useful life or lease term using the straight-line depreciation method. Property, plant and equipment are generally depreciated over the following estimated useful lives according to the Company's policy: Years Building and improvements 10 - 50 Machinery, equipment and tooling 5 - 20 Furniture and fixtures 5 - 10 Computer hardware and software 3 - 5 Rental cranes 5 - 10 Property, plant and equipment also includes cranes accounted for as operating leases which are included in rental cranes. Equipment accounted for as operating leases includes rental cranes leased directly to the customer and cranes for which the Company has assisted in the financing arrangement, whereby the Company has made a buyback commitment in which the customer at the time of the order had a significant economic incentive to exercise. Equipment that is leased directly to the customer is accounted for as an operating lease with the related assets capitalized and depreciated over their estimated economic life. Equipment involved in a financing arrangement is depreciated over the life of the underlying arrangement to the buyback amount at the end of the lease period. The amount of rental cranes included in property, plant and equipment - net amounted to $ 153.3 million and $ 119.9 million, net of accumulated depreciation, as of December 31, 2023 and 2022, respectively. The Company reviews property, plant and equipment for impairment whenever events or changes in circumstances indicate that the assets’ carrying amount may not be recoverable. The Company conducts its impairment analyses in accordance with ASC Topic 360-10-5 “Property, Plant and Equipment” (“Topic 360”). Topic 360 requires the Company to group assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities and to evaluate the asset group against the sum of the undiscounted future cash flows. If the undiscounted cash flows are less than the net book value of the assets, any related impairment loss is calculated based upon comparison of the fair value to the net book value of the assets.
Warranties	Warranties Estimated manufacturing warranty costs are recorded in cost of sales at the time of sale of the warranted products based on historical warranty experience for the related product or estimates of projected costs due to specific warranty issues on new products. These estimates are reviewed periodically and are adjusted based on changes in facts, circumstances or actual experience. When a customer purchases an extended warranty, revenue associated with the extended warranty is deferred and recognized over the life of the extended warranty period. Costs during the extended warranty period are expensed as incurred. Costs associated with other warranty activity not related to a manufacturer's standard or extended warranty are recorded in the period a loss is probable and can be reasonably estimated in accordance with ASC Topic 450-20 “Loss Contingencies.”
Product Liabilities	Product Liabilities The Company records product liability reserves for its self-insured portion of any outstanding product liability cases when losses are probable and reasonably estimable. The reserve is based upon two estimates. First, the Company tracks the population of all outstanding product liability cases to determine an appropriate case reserve for each based upon the Company’s best judgment with the advice of legal counsel. These estimates are continually evaluated and adjusted based upon changes to facts and circumstances surrounding the case. Second, the Company determines the amount of additional reserve required to cover incurred, but not reported, product liability obligations and to account for possible adverse development of the established case reserves utilizing actuarially developed estimates. Insurance recoveries related to a product liability case are recorded as an asset in the period it is determined that the gain has been realized or realizable. Refer to Note 19, “Commitments and Contingencies,” for further information.
Derivative Financial Instruments and Hedging Activities	Derivative Financial Instruments and Hedging Activities The Company has policies and procedures that place all financial instruments under the direction of corporate treasury and restrict all derivative transactions to those intended for hedging purposes. The use of financial instruments for trading purposes is strictly prohibited. The Company uses financial instruments to manage the market risk from changes in foreign exchange rates, commodities and interest rates. The Company follows the guidance in accordance with ASC Topic 815 “Derivatives and Hedging” (“Topic 815”). The fair values of all outstanding derivatives are recorded in the Consolidated Balance Sheets. The change in a derivative’s fair value is recorded each period in current earnings or accumulated other comprehensive income (loss) (“AOCI”) depending on whether the derivative is designated and qualifies as a cash flow hedge. The Company selectively hedges anticipated transactions that are subject to foreign exchange exposure, commodity price exposure or variable interest rate exposure, primarily using foreign currency exchange contracts (“FX Forward Contracts”), commodity contracts and interest rate contracts, respectively. These instruments are designated as cash flow hedges in accordance with Topic 815 and are recorded in the Consolidated Balance Sheets at fair value. The effective portion of the contracts’ gains or losses due to changes in fair value are initially recorded as a component of AOCI and are subsequently reclassified into earnings when the hedged transactions, typically sales and costs related to sales and interest expense, occur and affect earnings. These contracts are highly effective in hedging the variability in future cash attributable to changes in currency exchange rates, commodity prices or interest rates. The amount reported as derivative instrument fair market value adjustment in the AOCI account within the Consolidated Statements of Comprehensive Income (Loss) represents the net gain (loss) on foreign currency exchange contracts designated as cash flow hedges, net of income taxes.
Stock-Based Compensation	Stock-Based Compensation The Company recognizes expense net of estimated future forfeitures for non-performance stock-based awards on a straight-line basis over the vesting period of the entire award. The Company recognizes expense net of estimated future forfeitures for stock-based awards with performance goals based on actual or estimated achievement of those goals on a straight-line basis over the vesting period of the entire award. Estimated future forfeiture rates are based on the Company's historical experience. Refer to Note 17, “Stock-Based Compensation,” for more information on stock-based compensation plans.
Research and Development	Research and Development Research and development costs are charged to expense as incurred and amounte d to $ 35.3 million, $ 33.5 million and $ 29.1 million for the years ended December 31, 2023, 2022 and 2021 , respectively. Research and development costs include salaries, materials, contractor fees and other administrative costs. These costs are recorded within engineering, selling and administrative expenses in the Consolidated Statement of Operations.
Income Taxes	Income Taxes The Company utilizes the liability method to recognize deferred tax assets and liabilities for the expected future income tax consequences of events that have been recognized in the Company’s financial statements. Under this method, deferred tax assets and liabilities are determined based on the temporary difference between financial statement carrying amounts and the tax basis of assets and liabilities using enacted tax rates in effect in the years in which the temporary differences are expected to reverse. Valuation allowances are provided for deferred tax assets where it is considered more likely than not that the Company will not realize the benefit of such assets. The Company evaluates its uncertain tax positions as new information becomes available. Tax benefits are recognized to the extent a position is more likely than not to be sustained upon examination by the taxing authority.
Net Income (Loss) Per Share	Ne t Income (Loss) Per Share Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during each year or period. The calculation of diluted net income (loss) per share reflects the effect of all potential dilutive shares that were outstanding during the respective periods, unless the effect of doing so would be antidilutive. The Company uses the treasury stock method to calculate the effect of outstanding stock-based compensation awards.
Comprehensive Income (Loss)	Comprehensive Income (Loss) Comprehensive income (loss) includes, in addition to net income (loss) , other items that are reported as direct adjustments to Manitowoc stockholders’ equity. These items are foreign currency translation adjustments, employee postretirement benefit adjustments and the change in fair value of certain derivative instruments.
Net Sales	Net Sales Sales are recognized when obligations under the terms of a contract with the Company’s customer are satisfied; generally this occurs with the transfer of control of the Company’s cranes or attachments or aftermarket parts or completion of performance of services. Sales are measured as the amount of consideration the Company expects to be entitled to receive in exchange for transferring goods or providing services. The Company recognizes sales for extended warranties over the life of the extended warranty period. Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction, and are collected by the Company from a customer, are excluded from sales. Performance Obligations The following is a description of principle activities from which the Company generates sales. Disaggregation of the Company’s revenue sources are disclosed in Note 18, “Segments.” Crane Sales Crane sales are primarily generated through the sale of new and used cranes. Contracts with customers are generally in the form of a purchase order. Based on the nature of the Company’s contracts, the Company does not have any significant financing terms. Contracts may have variable consideration in the form of early pay discounts or rebates, however variable consideration is not material to the overall contract with the customer. Sales are recognized under these contracts when control of the product is transferred to the customer. Control transfers to the customer generally upon delivery to the carrier or acceptance through an independent inspection company that acts as an agent of the customer. From time to time, the Company enters into agreements where the customer has the right to exercise a put option requiring the Company to buyback a crane at an agreed upon price. The Company evaluates each agreement at inception to determine if the customer has a significant economic incentive to exercise that right. If it is determined that the customer has a significant economic incentive to exercise that right, the agreement is accounted for as a lease in accordance with ASC Topic 842 “Leases” (“Topic 842”). If it is determined that the customer does not have a significant economic incentive to exercise that right, then revenue is recognized when control of the asset is transferred to the customer. Refer to Note 20, “Guarantees,” for additional information. Given the nature of the Company’s products, the customer may request that the product be held until a delivery location is identified. Under these “bill and hold” arrangements, sales are recognized when all of the following criteria are met: 1) the reason for the bill-and-hold arrangement is substantive, 2) the product is separately identified as belonging to the customer, 3) the product is ready for transfer to the customer, and 4) the Company does not have the ability to use the product or direct it to another customer. Crane Attachment Sales Crane attachment sales are generated through the sale of new or used crane attachments such as luffing jibs, ecomats and counterweights. Crane attachment sales are recognized when control of the product is transferred to the customer. Control transfers to the customer generally upon delivery to the carrier. Aftermarket Part Sales Aftermarket part sales are generated through the sale of new and used parts to end customers and distributors. Aftermarket part sales are recognized when control of the product is transferred to the customer. Control transfers to the customer generally upon delivery to the carrier. Customers generally have a right of return which the Company estimates using historical information. The amount of estimated returns is deducted from net sales. Other Sales The Company’s other sales consist primarily of sales from: • Repair and field service work; • Remanufacturing; and • Rental of cranes. The Company’s performance obligations for other sales generally relates to performing specific agreed upon services. Depending on the nature of the contract, sales are recognized upon the completion of those services or over the service period based on a measure of progress. Practical Expedients and Exemptions The Company expenses sales commissions when incurred because the amortization period would be one year or less. These costs are recorded within engineering, selling and administrative expenses in the Consolidated Statement of Operations. The Company accounts for shipping and handling activities performed after control of a product has been transferred to the customer as a fulfillment cost. As such, we have applied the practical expedient and we accrue for the costs of shipping and handling activities if revenue is recognized before contractually agreed shipping and handling activities occur. The Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which it recognizes revenue at the amount to which it has the right to invoice for services performed.
Recent Accounting Changes and Pronouncements	Rece nt Accounting Changes and Pronouncements In September 2022, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2022-04, "Disclosure of Supplier Financing Program Obligations”. The amendments in this ASU require that a buyer in a supplier finance program disclose sufficient information about the program to allow a user of financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The Company adopted this ASU as of January 1, 2023. The adoption of this ASU did not have a material impact on the Company's consolidated financial statements. In November 2023, the FASB issued ASU No. 2023-07, "Segment Reporting - Improvements to Reportable Segments Disclosures”. The amendments in this ASU improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The standard is effective for annual periods beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company is evaluating the impact the adoption of this ASU will have on its consolidated financial statements. In December 2023, the FASB issued ASU No. 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures”. The amendments in this ASU enhance the transparency and decision usefulness of income tax disclosures. The standard is effective for annual periods beginning after December 15, 2024. Early adoption is permitted. The Company is evaluating the impact the adoption of this ASU will have on its consolidated financial statements.
Fair Value Measurement	ASC Topic 820-10 ("ASC 820") defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 classifies the inputs used to measure fair value into the following hierarchy: Level 1 Unadjusted quoted prices in active markets for identical assets or liabilities Level 2 Unadjusted quoted prices in active markets for similar assets or liabilities, or Unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or Inputs other than quoted prices that are observable for the asset or liability Level 3 Unobservable inputs for the asset or liability

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2023
Accounting Policies [Abstract]
Schedule of Rollforward of the Allowance for Credit Losses	The following table is a rollforward of the allowance for credit losses for the years ended December 31, 2023, 2022 and 2021. 2023 2022 2021 Balance at beginning of period $ 5.3 $ 7.3 $ 8.5 Bad debt expenses 2.3 0.1 — Use of reserve ( 1.4 ) ( 1.8 ) ( 1.3 ) Currency translation ( 0.1 ) ( 0.3 ) 0.1 Balance at end of period $ 6.1 $ 5.3 $ 7.3
Schedule of Estimated Useful Lives of Intangible Assets Subject to Amortization	The Company’s intangible assets subject to amortization are amortized straight-line over the following minimum and maximum estimated useful lives according to the Company's policy: Years Patents 20 Customer relationships 12 - 18 Trademarks and tradenames 5 Noncompetition agreements 5
Schedule of Estimated Useful Lives of Property, Plant and Equipment	Property, plant and equipment are generally depreciated over the following estimated useful lives according to the Company's policy: Years Building and improvements 10 - 50 Machinery, equipment and tooling 5 - 20 Furniture and fixtures 5 - 10 Computer hardware and software 3 - 5 Rental cranes 5 - 10

Business Combinations (Tables)

Business Combinations (Tables)	12 Months Ended
	Dec. 31, 2023
Business Combinations [Abstract]
Schedule of assets acquired and liabilities based upon their estimated fair value	The transaction price was allocated to underlying assets acquired and liabilities assumed based upon their estimated fair values at the date of the combination as follows: Net working capital $ 48.8 Property, plant and equipment 13.1 Rental fleet 48.2 Goodwill 7.8 Noncompetition agreement intangible 3.8 Customer relationships intangible 15.1 Total fair value consideration $ 136.8

Net Sales (Tables)

Net Sales (Tables)	12 Months Ended
	Dec. 31, 2023
Revenue from Contract with Customer [Abstract]
Schedule of Change In Customer Advances Balance	The table below shows the change in the customer advances balance for the year ended December 31, 2023 and 2022. 2023 2022 Balance at beginning of period $ 21.9 $ 28.7 Cash received in advance of satisfying 147.7 130.6 Revenue recognized ( 150.8 ) ( 139.2 ) Currency translation 0.4 1.8 Balance at end of period $ 19.2 $ 21.9

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2023
Fair Value Disclosures [Abstract]
Financial Assets and Liabilities Related to Foreign Currency Exchange Contracts Accounted for at Fair Value	The following tables sets forth the Company’s financial assets and liabilities related to FX Forward Contracts and the Manitowoc Company, Inc. Deferred Compensation Plan (the "Deferred Compensation Plan") that were accounted for at fair value as of December 31, 2023 and 2022. Fair Value as of December 31, 2023 Level 1 Level 2 Level 3 Total Recognized Location Current Assets: FX Forward Contracts $ — $ 1.6 $ — $ 1.6 Other current assets Deferred Compensation Plan - Program B 8.1 — — 8.1 Other non-current assets Total current assets at fair value $ 8.1 $ 1.6 $ — $ 9.7 Current Liabilities: FX Forward Contracts $ — $ 0.6 $ — $ 0.6 Accounts payable and accrued expenses Fair Value as of December 31, 2022 Level 1 Level 2 Level 3 Total Recognized Location Current Assets: FX Forward Contracts $ — $ 5.7 $ — $ 5.7 Other current assets Current Liabilities: FX Forward Contracts $ — $ 0.3 $ — $ 0.3 Accounts payable and accrued expenses

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2023
Foreign Currency Exchange Contracts
Derivative Instruments Gain Loss [Line Items]
Summary of Gains or Losses Recorded in Consolidated Statement of Operations for FX Forward Contracts	The gains (losses) recorded in the Consolidated Statement of Operations for FX Forward Contracts for the years ended December 31, 2023, 2022 and 2021 are summarized as follows: Recognized Location 2023 2022 2021 Designated Cost of sales $ 2.3 $ ( 5.8 ) $ ( 1.1 ) Non-Designated Other income (expense) - net ( 3.3 ) 7.2 0.4

Inventories (Tables)

Inventories (Tables)	12 Months Ended
	Dec. 31, 2023
Inventory Disclosure [Abstract]
Schedule of the components of inventories	The components of inventories as of December 31, 2023 and 2022 are summarized as follows: 2023 2022 Raw materials $ 164.7 $ 161.2 Work-in-process 111.3 141.3 Finished goods 390.5 309.4 Total Inventories $ 666.5 $ 611.9

Property, Plant and Equipment (

Property, Plant and Equipment (Tables)	12 Months Ended
	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
Components of Property, Plant and Equipment	The components of property, plant and equipment as of December 31, 2023 and 2022 are summarized as follows: 2023 2022 Land $ 14.9 $ 17.9 Building and improvements 201.5 194.7 Machinery, equipment and tooling 318.4 300.6 Furniture and fixtures 13.8 13.8 Computer hardware and software 135.8 129.4 Rental cranes 201.9 157.8 Construction in progress 7.2 8.4 Total cost 893.5 822.6 Less accumulated depreciation ( 527.4 ) ( 487.3 ) Property, plant and equipment — net $ 366.1 $ 335.3

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Changes in goodwill by reportable segment	The changes in the carrying amount of goodwill for the years ended December 31, 2023 and 2022 are summarized as follows: Americas - Manufacturing Americas - Distribution MEAP Consolidated Balance as of January 1, 2022 $ 166.5 $ 15.1 $ 68.1 $ 249.7 Goodwill impairment ( 166.5 ) — — ( 166.5 ) Purchase accounting adjustments — ( 0.7 ) — ( 0.7 ) Foreign currency impact — — ( 2.4 ) ( 2.4 ) Net balance as of December 31, 2022 — 14.4 65.7 80.1 Foreign currency impact — — ( 0.5 ) ( 0.5 ) Net balance as of December 31, 2023 $ — $ 14.4 $ 65.2 $ 79.6
Schedule of Goodwill Balances by Reporting Unit	The gross carrying amount, accumulated impairment, and net book value of the Company's goodwill balances by reporting unit are summarized as follows: December 31, 2023 December 31, 2022 Gross Carrying Amount Accumulated Impairment Amount Net Book Value Gross Carrying Amount Accumulated Impairment Amount Net Book Value Americas - Manufacturing $ 166.5 $ ( 166.5 ) $ — $ 166.5 $ ( 166.5 ) $ — Americas - Distribution 14.4 — 14.4 14.4 — 14.4 EURAF 82.2 ( 82.2 ) — 82.2 ( 82.2 ) — MEAP 65.2 — 65.2 65.7 — 65.7 Total $ 328.3 $ ( 248.7 ) $ 79.6 $ 328.8 $ ( 248.7 ) $ 80.1
Gross carrying amount, accumulated amortization and net book value of intangible assets other than goodwill	T he gross carrying amount, accumulated amortization and net book value of the Company’s intangible assets other than goodwill as of December 31, 2023 and 2022 are summarized as follows: December 31, 2023 December 31, 2022 Gross Accumulated Net Gross Accumulated Net Definite lived intangible assets: Customer relationships $ 26.5 $ ( 11.6 ) $ 14.9 $ 26.5 $ ( 10.0 ) $ 16.5 Patents 29.2 ( 28.8 ) 0.4 28.7 ( 28.2 ) 0.5 Noncompetition agreements 4.2 ( 2.0 ) 2.2 4.2 ( 1.2 ) 3.0 Trademarks and tradenames 2.2 ( 1.0 ) 1.2 2.2 ( 0.6 ) 1.6 Other intangibles 0.7 ( 0.7 ) - 0.6 ( 0.5 ) 0.1 Total 62.8 ( 44.1 ) 18.7 62.2 ( 40.5 ) 21.7 Indefinite lived intangible assets: Trademarks and tradenames 92.6 — 92.6 91.0 — 91.0 Distribution network 14.3 — 14.3 14.0 — 14.0 Total 106.9 — 106.9 105.0 — 105.0 Total intangible assets $ 169.7 $ ( 44.1 ) $ 125.6 $ 167.2 $ ( 40.5 ) $ 126.7
Estimated Amortization Expense	Excluding the impact of any future acquisitions, divestitures or impairments, the Company's anticipated future amortization of intangible assets as of December 31 , 2023 is summarized as follows: Year 2024 $ 2.9 2025 2.9 2026 2.5 2027 1.4 2028 1.4 Thereafter 7.6 Total $ 18.7

Accounts Payable and Accrued _2

Accounts Payable and Accrued Expenses (Tables)	12 Months Ended
	Dec. 31, 2023
Payables and Accruals [Abstract]
Schedule of accounts payable and accrued expenses	Accounts payable and accrued expenses as of December 31, 2023 and 2022 are summarized as follows: 2023 2022 Trade accounts payable $ 254.7 $ 274.6 Employee-related expenses 57.9 51.0 Accrued vacation 23.7 22.4 Miscellaneous accrued expenses 121.1 98.4 Total accounts payable and accrued expenses $ 457.4 $ 446.4

Debt (Tables)

Debt (Tables)	12 Months Ended
	Dec. 31, 2023
Debt Disclosure [Abstract]
Schedule of outstanding debt	Outstanding debt as of December 31, 2023 and 2022 is summarized as follows: 2023 2022 Borrowing under senior secured asset based revolving $ 60.0 $ 80.0 2026 Notes 300.0 300.0 Other 13.7 8.0 Deferred financing costs ( 1.6 ) ( 2.4 ) Total debt 372.1 385.6 Short-term borrowings and current portion of ( 13.4 ) ( 6.1 ) Long-term debt $ 358.7 $ 379.5
Schedule of revolving credit facility bear interest at variable rate based upon average quarterly availability	Average quarterly availability Alternative base rate spread SOFR spread ≥ 50% of Aggregate Commitment 0.25 % 1.25 % < 50% of Aggregate Commitment 0.50 % 1.50 %
Schedule of aggregate future maturities of outstanding debt obligations	The aggregate scheduled future maturitie s of outstanding debt obligations as of December 31, 2023 is summarized as follows: Year 2024 $ 13.4 2025 60.3 2026 300.0 2027 — 2028 — Thereafter — Total $ 373.7 T

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Summary of Income (Loss) from Continuing Operations Before Income Taxes	Income (loss) before income taxes for the years ended December 31, 2023, 2022 and 2021 is summarized as follows: 2023 2022 2021 Income (loss) before income taxes: United States $ ( 32.7 ) $ ( 203.8 ) $ ( 39.0 ) Foreign 76.9 83.6 56.1 Total $ 44.2 $ ( 120.2 ) $ 17.1
Schedule of Provision for Income Taxes	Provision for income taxes for the years ended December 31, 2023, 2022 and 2021 is summarized as follows: 2023 2022 2021 Current: United States federal and state $ 0.3 $ ( 11.7 ) $ ( 1.2 ) Foreign 10.7 10.9 7.9 Total current 11.0 ( 0.8 ) 6.7 Deferred: United States federal and state — ( 2.4 ) 0.6 Foreign ( 6.0 ) 6.6 ( 1.2 ) Total deferred ( 6.0 ) 4.2 $ ( 0.6 ) Provision for income taxes $ 5.0 $ 3.4 $ 6.1
Reconciliation of the U.S. Federal Statutory Income Tax Rate to the Company's Effective Income Tax Rate for Continuing Operations	The items accounting for the difference between income taxes computed at the United States federal statutory rate and the Company's effective rate for the years ended December 31, 2023, 2022 and 2021 is summarized as follows: 2023 2022 2021 Federal income tax at statutory rate $ 9.3 $ ( 25.2 ) $ 3.6 State income tax provision 2.0 0.9 0.3 Manufacturing and research incentives ( 1.3 ) ( 0.5 ) ( 0.2 ) Taxes on foreign income which differ from the federal 9.1 ( 1.9 ) 1.5 Adjustments for unrecognized tax benefits 0.2 ( 11.0 ) ( 2.3 ) Adjustments to valuation allowances ( 28.6 ) 5.2 4.5 United States tax reform 10.1 4.8 ( 1.6 ) Goodwill and indefinite-lived intangible asset impairment — 31.7 — Audit settlements ( 3.0 ) — ( 1.9 ) Non-deductible expenses 8.2 1.6 1.3 Other items ( 1.0 ) ( 2.2 ) 0.9 Provision for income taxes $ 5.0 $ 3.4 $ 6.1
Schedules of Deferred Tax Assets (Liabilities)	Temporary differences and carryforwards that give rise to deferred tax assets and liabilities are summarized as follows: 2023 2022 Deferred income tax assets: Inventories $ 14.7 $ 25.3 Deferred employee benefits 27.8 28.2 Product warranty reserves 7.8 8.7 Product liability reserves 2.6 2.2 Tax credits 7.9 7.2 Loss and other tax attribute carryforwards 114.1 129.6 Deferred revenue 3.9 0.2 Capitalized research costs 10.5 4.8 Other 12.5 13.8 Total deferred income tax assets 201.8 220.0 Less valuation allowance ( 130.8 ) ( 174.1 ) Net deferred income tax assets $ 71.0 $ 45.9 Deferred income tax liabilities Accounts receivable $ — $ 4.0 Property, plant and equipment 25.6 5.1 Intangible assets 28.5 28.0 Total deferred income tax liabilities $ 54.1 $ 37.1 Net deferred income tax assets $ 16.9 $ 8.8 The net deferred tax assets reflected in the Consolidated Balance Sheets for the years ended December 31, 2023 and 2022 are summarized as follows: 2023 2022 Long-term income tax assets, included in $ 24.4 $ 13.7 Long-term deferred income tax liability ( 7.5 ) ( 4.9 ) Net deferred income tax asset $ 16.9 $ 8.8
Schedule of Open Tax Years for Which the Company could be Subject to Income Tax Examination	The following table provides the open tax years for which the Company could be subject to income tax examination by the tax authorities in its major jurisdictions: Jurisdiction Open Years U.S. federal 2016 — 2023 China 2014 — 2023 France 2021 — 2023 Germany 2018 — 2023
Reconciliation of the Beginning and Ending Amount of Unrecognized Tax Benefits	A reconciliation of the beginning and ending amount of unrecognized tax benefits excluding interest and penalties as of December 31, 2023, 2022 and 2021 are summarized as follows: 2023 2022 2021 Balance at beginning of year $ 9.1 $ 18.4 $ 20.1 Additions for tax positions of current year 0.1 0.1 0.1 Additions for tax positions of prior years 0.1 3.6 — Reductions for tax positions of prior years — ( 11.0 ) ( 0.2 ) Reductions based on settlements with tax — — ( 0.2 ) Reductions for lapse of statute of limitations ( 0.2 ) ( 2.0 ) ( 1.4 ) Balance at end of year $ 9.1 $ 9.1 $ 18.4

Net Income (Loss) Per Common Sh

Net Income (Loss) Per Common Share (Tables)	12 Months Ended
	Dec. 31, 2023
Earnings Per Share [Abstract]
Reconciliation of the weighted average shares outstanding used to compute basic and diluted net income (loss) per common share	The following is a reconciliation of the weighted average common shares outstanding used to compute basic and diluted net income (loss) per common share: 2023 2022 2021 Basic weighted average common shares outstanding 35,093,963 35,184,336 34,903,189 Effect of dilutive securities - equity 868,815 — 549,366 Diluted weighted average common shares outstanding 35,962,778 35,184,336 35,452,555

Equity (Tables)

Equity (Tables)	12 Months Ended
	Dec. 31, 2023
Equity [Abstract]
Schedule of Components of Accumulated Other Comprehensive Loss	The components of accumulated other comprehensive loss as of December 31, 2023 and 2022 are summarized as follows: 2023 2022 Foreign currency translation, net of income tax 0.2 and $ 0.1 $ ( 77.4 ) $ ( 98.0 ) Derivative instrument fair market value, net of income 0.0 and $ 0.0 1.3 5.4 Employee pension and postretirement benefit adjustments, 13.6 and $ 12.9 ( 10.3 ) ( 15.3 ) Total accumulated other comprehensive loss $ ( 86.4 ) $ ( 107.9 ) A reconciliation of the changes in accumulated other comprehensive loss, net of income tax, by component as of December 31, 2023 and 2022 are summarized as follows: Gains (Losses) on Pension & Foreign Total Balance as of December 31, 2021 $ — $ ( 32.3 ) $ ( 70.1 ) $ ( 102.4 ) Other comprehensive income (loss) before ( 0.4 ) 15.5 ( 27.9 ) ( 12.8 ) Amounts reclassified from accumulated other 5.8 1.5 — 7.3 Net other comprehensive income (loss) 5.4 17.0 ( 27.9 ) ( 5.5 ) Balance as of December 31, 2022 5.4 ( 15.3 ) ( 98.0 ) ( 107.9 ) Other comprehensive income (loss) before ( 1.8 ) 2.4 11.3 11.9 Amounts reclassified from accumulated other ( 2.3 ) 2.6 9.3 9.6 Net other comprehensive income (loss) ( 4.1 ) 5.0 20.6 21.5 Balance as of December 31, 2023 $ 1.3 $ ( 10.3 ) $ ( 77.4 ) $ ( 86.4 )
Reconciliation of Reclassifications Out of Accumulated Other Comprehensive Income (Loss), Net of Income Taxes	A reconciliation of the reclassifications out of accumulated other comprehensive loss, net of income taxes, for the years ended December 31, 2023, 2022 and 2021 are summarized as follows: Amount Reclassified from Accumulated Other Comprehensive Loss 2023 2022 2021 Recognized Gain (losses) on cash flow hedges FX Forward Contracts $ 2.3 $ ( 5.8 ) $ ( 1.1 ) Cost of sales Total before income taxes 2.3 ( 5.8 ) ( 1.1 ) Provision for income taxes — — — Total, net of income taxes $ 2.3 $ ( 5.8 ) $ ( 1.1 ) Amortization of pension and Actuarial losses $ ( 2.6 ) $ ( 2.9 ) $ ( 4.7 ) (a) Other income (expense) - net Amortization of prior service cost ( 0.1 ) 1.3 2.6 (a) Other income (expense) - net Pension settlement gain 0.1 0.1 0.9 (a) Other income (expense) - net Total before income taxes ( 2.6 ) ( 1.5 ) ( 1.2 ) Provision for income taxes — — 0.1 Total, net of income taxes $ ( 2.6 ) $ ( 1.5 ) $ ( 1.1 ) Foreign currency translation Losses on foreign currency translation $ ( 9.3 ) $ — $ — Total before income taxes ( 9.3 ) — — Provision for income taxes — — — Total, net of income taxes $ ( 9.3 ) $ — $ — Total reclassifications for the period, net $ ( 9.6 ) $ ( 7.3 ) $ ( 2.2 ) (a) These accumulated other comprehensive loss components are components of net periodic pension cost (refer to Note 21, “ Employee Benefit Plans,” for further details).

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	12 Months Ended
	Dec. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Summary of the Company's Stock Option Activity	The activity for stock options is summarized as follows: Shares Weighted Aggregate Options outstanding as of December 31, 2022 552,923 $ 21.13 Granted — — Exercised ( 17,135 ) 14.81 Forfeited — — Cancelled ( 41,418 ) 19.63 Options outstanding as of December 31, 2023 494,370 $ 21.47 $ 324,847 Options exercisable as of December 31, 2023 494,370 $ 21.47 $ 324,847
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of Nonvested Share Activity	The activity for restricted stock units is summarized as follows: Shares Weighted Unvested as of December 31, 2022 647,212 $ 16.45 Granted 520,132 14.28 Vested ( 359,655 ) 15.74 Forfeited ( 2,227 ) 17.27 Unvested as of December 31, 2023 805,462 - $ 15.37
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of Nonvested Share Activity	The activity for performance share units is summarized as follows: Shares Weighted Unvested as of December 31, 2022 459,774 $ 17.30 Granted (1) 316,022 16.05 Adjustment for performance results achieved (2) ( 84,576 ) 12.67 Vested ( 46,145 ) 12.67 Forfeited ( 14,680 ) 18.28 Unvested as of December 31, 2023 630,395 $ 17.39 (1) Performance shares granted assuming achievement of performance goals at target. (2) Adjustment due to performance share units granted in 2020 and vested in 2023 where the number of shares achieved based on the three-year performance period ended December 31, 2022 were lower than target.
Schedule of the Assumptions Used to Estimate the Fair Value of Each Option Grant	The fair value of each performance share unit was estimated at the date of grant using the following assumptions: 2023 2022 2021 Correlation 28.2 % 25.9 % 27.9 % Risk-free interest rate 4.1 % 1.7 % 0.2 % Expected volatility 60.3 % 59.5 % 59.0 % Expected dividend yield — % — % — %

Segments (Tables)

Segments (Tables)	12 Months Ended
	Dec. 31, 2023
Segment Reporting [Abstract]
Schedule of Information by Reportable Segment	The following table shows information by reportable segment for the years ended December 31, 2023, 2022 and 2021: 2023 2022 2021 Net Sales Americas $ 1,211.2 $ 1,013.0 $ 757.6 EURAF 669.6 761.5 677.0 MEAP 347.0 258.0 285.6 Total $ 2,227.8 $ 2,032.5 $ 1,720.2 Segment Operating Income (Loss) Americas $ 111.7 $ ( 88.8 ) $ 57.3 EURAF ( 7.9 ) ( 3.2 ) 8.9 MEAP 52.3 40.2 30.9 Total $ 156.1 $ ( 51.8 ) $ 97.1 Depreciation Americas $ 29.2 $ 35.4 $ 20.7 EURAF 22.1 20.1 19.8 MEAP 2.4 2.2 2.1 Corporate 2.9 2.9 2.9 Total $ 56.6 $ 60.6 $ 45.5 Capital Expenditures Americas $ 46.5 $ 32.0 $ 11.3 EURAF 28.5 27.7 27.5 MEAP 2.4 2.1 1.5 Corporate — — 0.1 Total $ 77.4 $ 61.8 $ 40.4
Schedule of Reconciliation of the Company's Segment Operating Income (Loss)	A reconciliation of the Company’s segment operating income (loss) to operating income (loss) in the Consolidated Statement of Operations for the years ended December 31, 2023, 2022 and 2021 are summarized as follows: 2023 2022 2021 Segment operating income (loss) $ 156.1 $ ( 51.8 ) $ 97.1 Unallocated corporate expenses ( 63.6 ) ( 41.3 ) ( 51.1 ) Unallocated restructuring income (expense) ( 0.1 ) 0.1 0.5 Total operating income (loss) $ 92.4 $ ( 93.0 ) $ 46.5
Schedule of Net Sales and Property, Plant and Equipment by Geographic Area	Net sales by geographic area for the years ended December 31, 2023, 2022 and 2021 and property, plant and equipment as of December 31, 2023 and 2022 are summarized as follows: Net Sales Property, Plant and Equipment 2023 2022 2021 2023 2022 United States $ 1,039.9 $ 906.4 $ 664.5 $ 158.1 $ 146.7 Europe 641.9 740.1 653.7 183.8 166.6 Other 546.0 386.0 402.0 24.2 22.0 Total $ 2,227.8 $ 2,032.5 $ 1,720.2 $ 366.1 $ 335.3
Schedule of Net Sales By Product	New machine and non-new machine sales for the years ended December 31, 2023, 2022 and 2021 are summarized as follows: 2023 2022 2021 New machine sales $ 1,615.1 $ 1,487.2 $ 1,271.6 Non-new machine sales 612.7 545.3 448.6 Total net sales $ 2,227.8 $ 2,032.5 $ 1,720.2

Guarantees (Tables)

Guarantees (Tables)	12 Months Ended
	Dec. 31, 2023
Guarantees [Abstract]
Summary of Warranty Activity	Below is a table summarizing the warranty and other warranty related work for the years ended December 31, 2023, 2022 and 2021: 2023 2022 2021 Balance at beginning of period $ 58.0 $ 60.2 $ 63.2 Adjustments to accruals for warranties 28.9 27.3 30.4 Settlements made (in cash or in kind) during ( 31.0 ) ( 27.8 ) ( 31.3 ) Currency translation 0.9 ( 1.7 ) ( 2.1 ) Balance at end of period $ 56.8 $ 58.0 $ 60.2

Employee Benefit Plans (Tables)

Employee Benefit Plans (Tables)	12 Months Ended
	Dec. 31, 2023
Retirement Benefits [Abstract]
Schedule of Components of Period Benefit Costs	The components of periodic benefit costs for the years ended December 31, 2023, 2022 and 2021 are summarized as follows: U.S. Pension Plan Non-U.S. Pension Plans Postretirement Medical 2023 2022 2021 2023 2022 2021 2023 2022 2021 Service cost - benefits earned $ — $ — $ — $ 1.2 $ 1.6 $ 2.3 $ 0.1 $ 0.1 $ 0.1 Interest cost of projected 5.5 3.2 2.8 3.0 1.7 1.5 0.4 0.2 0.2 Expected return on assets ( 3.9 ) ( 5.2 ) ( 4.9 ) ( 1.6 ) ( 1.2 ) ( 1.0 ) — — — Amortization of prior service — — — 0.1 0.1 0.1 — ( 1.4 ) ( 2.7 ) Amortization of actuarial net 2.2 1.9 3.2 1.6 1.5 1.8 ( 1.2 ) ( 0.5 ) ( 0.3 ) Pension settlement gain — — — ( 0.1 ) ( 0.1 ) ( 0.9 ) — — — Net periodic benefit cost $ 3.8 $ ( 0.1 ) $ 1.1 $ 4.2 $ 3.6 $ 3.8 $ ( 0.7 ) $ ( 1.6 ) $ ( 2.7 ) Weighted average Effective discount rate for 5.4 % 2.8 % 2.4 % 4.7 % 1.4 % 1.2 % 5.4 % 2.5 % 2.0 % Expected return on 5.0 % 4.7 % 4.3 % 5.4 % 2.9 % 1.6 % N/A N/A N/A Rate of compensation N/A N/A N/A 3.7 % 4.1 % 4.1 % N/A N/A N/A
Reconciliation of the Changes in Benefit Obligation, the Changes in Plan Assets, and the Funded Status	The following is a reconciliation of the changes in benefit obligation, plan assets, and funded status as of December 31, 2023 and 2022: U.S. Pension Plan Non-U.S. Pension Plans Postretirement 2023 2022 2023 2022 2023 2022 Change in Benefit Obligation Benefit obligation, beginning of year $ 106.4 $ 141.2 $ 59.0 $ 94.5 $ 9.5 $ 13.7 Service cost — — 1.2 1.6 0.1 0.1 Interest cost 5.5 3.2 3.0 1.7 0.4 0.2 Participant contributions — — — — 0.1 0.1 Actuarial (gain) loss 2.5 ( 30.1 ) ( 0.3 ) ( 27.1 ) ( 2.4 ) ( 3.4 ) Currency translation adjustment — — 2.6 ( 8.0 ) — — Pension settlement — — ( 0.1 ) ( 0.3 ) — — Benefits paid ( 8.0 ) ( 7.9 ) ( 3.5 ) ( 3.4 ) ( 1.1 ) ( 1.2 ) Benefit obligation, end of year $ 106.4 $ 106.4 $ 61.9 $ 59.0 $ 6.6 $ 9.5 Change in Plan Assets Fair value of plan assets, beginning of year $ 82.3 $ 114.6 $ 29.7 $ 50.2 $ — $ — Actual return on plan assets 7.4 ( 24.9 ) — ( 15.0 ) — — Employer contributions 0.5 0.5 3.6 3.4 1.0 1.1 Participant contributions — — — — 0.1 0.1 Currency translation adjustment — — 1.6 ( 5.2 ) — — Pension settlement — — ( 0.1 ) ( 0.3 ) — — Benefits paid ( 8.0 ) ( 7.9 ) ( 3.5 ) ( 3.4 ) ( 1.1 ) ( 1.2 ) Fair value of plan assets, end of year 82.2 82.3 31.3 29.7 — — Funded status $ ( 24.2 ) $ ( 24.1 ) $ ( 30.6 ) $ ( 29.3 ) $ ( 6.6 ) $ ( 9.5 ) Amounts recognized in the Consolidated Pension asset $ — $ — $ 2.7 $ — $ — $ — Short-term pension obligation ( 0.5 ) ( 0.5 ) ( 1.2 ) ( 1.2 ) — — Long-term pension obligation ( 23.7 ) ( 23.6 ) ( 32.1 ) ( 28.1 ) — — Short-term postretirement medical and other — — — — ( 1.0 ) ( 1.3 ) Long-term postretirement medical and other — — — — ( 5.6 ) ( 8.2 ) Net amount recognized $ ( 24.2 ) $ ( 24.1 ) $ ( 30.6 ) $ ( 29.3 ) $ ( 6.6 ) $ ( 9.5 ) Weighted-Average Assumptions Discount rate 5.1 % 2.8 % 4.2 % 4.2 % 5.0 % 5.4 % Rate of compensation increase N/A N/A 3.8 % 2.7 % N/A N/A
Amounts Recognized in Accumulated Other Comprehensive Loss	Amounts recognized in accumulated other comprehensive loss as of December 31, 2023 and 2022, are summarized as follows: Pensions Postretirement 2023 2022 2023 2022 Net actuarial gain (loss) $ ( 32.0 ) $ ( 35.0 ) $ 8.3 $ 7.0 Prior service cost ( 0.2 ) ( 0.3 ) — — Total amount recognized $ ( 32.2 ) $ ( 35.3 ) $ 8.3 $ 7.0
Schedule of the Weighted-Average Asset Allocation of the Pension Plans	The weighted-average asset allocation of the U.S. Pension Plan as of December 31, 2023 and 2022, by asset category are summarized as follows: 2023 2022 Equity 53.3 % 52.8 % Fixed income 39.7 % 36.9 % Other 7.0 % 10.3 % Total 100.0 % 100.0 % The weighted-average asset allocation of the Non-U.S. Pension Plans as of December 31, 2023 and 2022, by asset category are summarized as follows: 2023 2022 Equity — % — % Fixed income 39.4 % 45.2 % Other (1) 60.6 % 54.8 % Total 100.0 % 100.0 % (1) Includes diversified investments that have equity and fixed income holdings.
Schedule of the Actual Allocations for the Pension Assets and Target Allocations by Asset Class	The actual and target allocations for the pension assets as of December 31, 2023, by asset class, are summarized as follows: Target Allocations Weighted Average Asset U.S. Plan Non-U.S. Plans U.S. Plans Non-U.S. Plans Equity Securities 50.0 % 0.0 % 53.3 % — % Debt Securities 40.0 % 48.0 % 39.7 % 39.4 % Other 10.0 % 52.0 % 7.0 % 60.6 %
Schedule of Plan Assets Using the Fair Value Hierarchy	The following tables present the Company’s plan assets using the fair value hierarchy as of December 31, 2023 and 2022. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value. Refer to Note 5, “Fair Value of Financial Instruments,” for definitions of each fair value level. December 31, 2023 Assets Quoted Significant Unobservable Net Asset Value ("NAV")* Total Equity: U.S. equity $ — $ — $ — $ 21.7 $ 21.7 International equity — — — 22.1 22.1 Fixed income: Corporate bonds and notes — — — 16.6 16.6 Government and agency bonds — — — 25.5 25.5 Commingled funds — — — 11.1 11.1 International fixed income — — — 4.7 4.7 Other: Cash and cash equivalents 1.0 — — — 1.0 Money market funds 0.7 — — — 0.7 Annuity contracts — — 7.4 — 7.4 Other — — — 2.7 2.7 Total $ 1.7 $ — $ 7.4 $ 104.4 $ 113.5 * Certain assets that are measured at fair value using the NAV per share practical expedient have not been classified in the fair value hierarchy. December 31, 2022 Assets Quoted Significant Unobservable Net Asset Value ("NAV")* Total Equity: U.S. equity $ — $ — $ — $ 16.9 $ 16.9 International equity — — — 27.8 27.8 Fixed income: Corporate bonds and notes — — — 18.5 18.5 Government and agency bonds — — — 25.4 25.4 Commingled funds — — — 8.6 8.6 International fixed income — — — 1.9 1.9 Other: Cash and cash equivalents 0.9 — — — 0.9 Money market funds — 0.7 — — 0.7 Annuity contracts — — 8.5 — 8.5 Other — — — 2.8 2.8 Total $ 0.9 $ 0.7 $ 8.5 $ 101.9 $ 112.0 *Certain assets that are measured at fair value using the NAV per share practical expedient have not been classified in the fair value hierarchy.
Reconciliation of the Fair Values Measurements of Plan Assets Using Significant Unobservable Inputs (Level 3) from the Beginning of the Year to the End of the Year	A reconciliation of the fair value measurements of plan assets using significant unobservable inputs (Level 3) from the beginning of the year to the end of the year is as follows: Annuity Contracts 2023 2022 Beginning Balance $ 8.5 $ 12.6 Additions 0.5 — Actual return on assets ( 1.2 ) ( 1.9 ) Benefit payments ( 0.9 ) ( 0.8 ) Foreign currency impact 0.5 ( 1.4 ) Ending Balance $ 7.4 $ 8.5
Schedule of Projected Future Benefit Payments from the Plans	Projected future benefit payments from the plans as of December 31, 2023 are estimated as follows: U.S. Pension Non-U.S. Postretirement 2024 $ 8.7 $ 3.0 $ 1.0 2025 8.8 3.0 0.9 2026 8.7 3.4 0.8 2027 8.7 3.6 0.8 2028 8.7 4.2 0.7 Thereafter 41.2 20.7 2.6 Total $ 84.8 $ 37.9 $ 6.8
Schedule of Fair Value of Plan Assets for which the Accumulated Benefit Obligation is in Excess of Plan Assets	The fair value of plan assets for which the accumulated benefit obligation is in excess of the plan assets as of December 31, 2023 and 2022 is summarized as follows: U.S. Pension Plan Non U.S. Pension Plans 2023 2022 2023 2022 Projected benefit obligation $ 106.4 $ 106.4 $ 33.8 $ 59.0 Accumulated benefit obligation 106.4 106.4 30.6 56.1 Fair value of plan assets 82.2 82.3 0.5 29.7

Leases (Tables)

Leases (Tables)	12 Months Ended
	Dec. 31, 2023
Leases [Abstract]
Summary of Components of Lease Expense	The components of lease expense for the years ended December 31, 2023, 2022 and 2021 are summarized as follows: 2023 2022 2021 Operating lease cost $ 15.5 $ 14.0 $ 13.2 Variable lease cost* 1.2 1.4 1.5 Total lease cost $ 16.7 $ 15.4 $ 14.7 *Includes short-term leases, which are immaterial.
Summary of Supplemental Consolidated Balance Sheet Information Related to Leases	Supplemental Consolidated Balance Sheet information related to leases as of December 31, 2023 and 2022 are summarized as follows: 2023 2022 Operating lease right-of-use assets $ 59.7 $ 45.2 Other liabilities $ 13.0 $ 11.6 Operating lease liabilities 47.2 34.3 Total operating lease liabilities $ 60.2 $ 45.9
Summary of Maturities of Operating Lease Liabilities	Maturities of operating lease liabilities as of December 31, 2023 are summarized as follows: Year 2024 $ 15.4 2025 13.4 2026 10.7 2027 9.8 2028 7.6 Thereafter 15.7 Total lease payments 72.6 Less: imputed interest ( 12.4 ) Present value of lease liabilities $ 60.2

Company and Basis of Presenta_2

Company and Basis of Presentation - Narrative (Details)	12 Months Ended
	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Period of providing high-quality, customer-focused products and support services	120 years

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Schedule of Rollforward of the Allowance for Credit Losses (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Accounts Receivable, after Allowance for Credit Loss [Abstract]
Balance at beginning of period	$ 5.3	$ 7.3	$ 8.5
Bad debt expense	2.3	0.1	0
Use of reserve	(1.4)	(1.8)	(1.3)
Currency translation	(0.1)	(0.3)	0.1
Balance at end of period	$ 6.1	$ 5.3	$ 7.3

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Intangible Assets Subject to Amortization (Details)	Dec. 31, 2023
Patents
Estimated useful lives of other intangible assets
Finite-lived intangible asset, useful life	20 years
Customer Relationships | Minimum [Member]
Estimated useful lives of other intangible assets
Finite-lived intangible asset, useful life	12 years
Customer Relationships | Maximum [Member]
Estimated useful lives of other intangible assets
Finite-lived intangible asset, useful life	18 years
Trademarks and Tradenames
Estimated useful lives of other intangible assets
Finite-lived intangible asset, useful life	5 years
Noncompetition agreements
Estimated useful lives of other intangible assets
Finite-lived intangible asset, useful life	5 years

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Property, Plant and Equipment (Details)	Dec. 31, 2023
Building and Improvements | Minimum
Property, Plant and Equipment
Property, plant and equipment, useful lives	10 years
Building and Improvements | Maximum
Property, Plant and Equipment
Property, plant and equipment, useful lives	50 years
Machinery, Equipment and Tooling | Minimum
Property, Plant and Equipment
Property, plant and equipment, useful lives	5 years
Machinery, Equipment and Tooling | Maximum
Property, Plant and Equipment
Property, plant and equipment, useful lives	20 years
Furniture and Fixtures | Minimum
Property, Plant and Equipment
Property, plant and equipment, useful lives	5 years
Furniture and Fixtures | Maximum
Property, Plant and Equipment
Property, plant and equipment, useful lives	10 years
Computer Hardware and Software | Minimum
Property, Plant and Equipment
Property, plant and equipment, useful lives	3 years
Computer Hardware and Software | Maximum
Property, Plant and Equipment
Property, plant and equipment, useful lives	5 years
Rental Cranes | Minimum
Property, Plant and Equipment
Property, plant and equipment, useful lives	5 years
Rental Cranes | Maximum
Property, Plant and Equipment
Property, plant and equipment, useful lives	10 years

Summary of Significant Accoun_7

Summary of Significant Accounting Policies - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Property, plant and equipment - net	$ 366.1	$ 335.3
Research and development costs	35.3	33.5	$ 29.1
Assets Leased to Others
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Property, plant and equipment - net	$ 153.3	$ 119.9

Business Combinations - Narrati

Business Combinations - Narrative (Details) - USD ($) $ in Millions			12 Months Ended
	Oct. 01, 2021	Sep. 01, 2021	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Aspen
Business Acquisition [Line Items]
Business acquisition purchase price		$ 50.2
Acquisition Reason and Description		The acquisition of Aspen was funded from existing cash resources and expands Manitowoc's direct-to-customer footprint in Iowa, Nebraska and Minnesota with new sales, used sales, parts, service and rentals to a variety of end markets.
Revenue			$ 109.4	$ 79.8	$ 23.6
H&E equipment Services Inc
Business Acquisition [Line Items]
Business acquisition purchase price	$ 136.8		136.8
Acquisitions			7.8
Other Adjustments	3.7
Net working capital	$ 130		48.8
Property, Plant and Equipment			13.1
Rental Fleet			48.2
Acquisition Reason and Description	the acquired crane business of H&E operated with ten full-service branch locations under the Company's wholly owned subsidiary, MGX Equipment Services, LLC (“MGX”). The acquired crane business expands Manitowoc’s ability to provide new sales, used sales, aftermarket parts, service and crane financing options to a variety of end market customers.
Outstanding Balances .	$ 3.1
Revenue			$ 277.2	$ 218.4	$ 50.6
ASC 805 | Aspen
Business Acquisition [Line Items]
Acquisitions		$ 6.6
Net working capital		12.9
Property, Plant and Equipment		5.6
Rental Fleet		19.3
Intangible Assets Amount Included In Purchase Price		5.4
Other Assets		$ 0.4

Business Combinations - Schedul

Business Combinations - Schedule of assets acquired and liabilities based upon their estimated fair value (Details) - USD ($) $ in Millions			12 Months Ended
	Oct. 01, 2021	Sep. 01, 2021	Dec. 31, 2023
Aspen [Member]
Business Acquisition [Line Items]
Total fair value consideration		$ 50.2
Aspen [Member] | Accounting Standards Codification Eight Hundred And Five [Member]
Business Acquisition [Line Items]
Net working capital		12.9
Property, Plant and Equipment		5.6
Rental Fleet		19.3
Goodwil		$ 6.6
H&E equipment Services Inc
Business Acquisition [Line Items]
Net working capital	$ 130		$ 48.8
Property, Plant and Equipment			13.1
Rental Fleet			48.2
Goodwil			7.8
Noncompetition agreement intangible			3.8
Customer relationships intangible			15.1
Total fair value consideration	$ 136.8		$ 136.8

Recent Accounting Changes and P

Recent Accounting Changes and Pronouncements - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Reduction in beginning retained earnings	$ 143.5	$ 104.3
Reduction in accounts receivable	$ 9.3	$ 36.4	$ 5.2

Net Sales - Schedule of Change

Net Sales - Schedule of Change In Customer Advances Balance (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Revenue from Contract with Customer [Abstract]
Balance at beginning of period	$ 21.9	$ 28.7
Cash received in advance of satisfying performance obligation	147.7	130.6
Revenue recognized	(150.8)	(139.2)
Currency translation	0.4	1.8
Balance at end of period	$ 19.2	$ 21.9

Fair Value of Financial Instr_3

Fair Value of Financial Instruments - Financial Assets and Liabilities Related to Foreign Currency Exchange Contracts Account for at Fair value (Details) - Estimate of Fair Value Measurement - Fair Value, Measurements, Recurring - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Derivatives assets, current	$ 9.7
Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration]	Other Assets, Current
Level 1
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Derivatives assets, current	$ 8.1
Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Derivatives assets, current	1.6
Level 3
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Derivatives assets, current	0
Foreign Currency Exchange Contracts
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Derivatives assets, current	1.6	$ 5.7
Derivative liabilities, current	0.6	0.3
Foreign Currency Exchange Contracts | Level 1
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Derivatives assets, current	0	0
Derivative liabilities, current	0	0
Foreign Currency Exchange Contracts | Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Derivatives assets, current	1.6	5.7
Derivative liabilities, current	0.6	0.3
Foreign Currency Exchange Contracts | Level 3
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Derivatives assets, current	0	0
Derivative liabilities, current	0	$ 0
Deferred Compensation Plan - Program B
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Derivatives assets, current	8.1
Deferred Compensation Plan - Program B | Level 1
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Derivatives assets, current	8.1
Deferred Compensation Plan - Program B | Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Derivatives assets, current	0
Deferred Compensation Plan - Program B | Level 3
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Derivatives assets, current	$ 0

Fair Value of Financial Instr_4

Fair Value of Financial Instruments - Narrative (Details) - Senior Notes Due 2026 - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Mar. 25, 2019
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Debt instruments at fair value	$ 302.7
Interest rate, stated percentage (as a percent)	9%	9%
Debt instrument maturity date	Apr. 01, 2026

Derivative Financial Instrume_3

Derivative Financial Instruments - Narrative (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Derivatives Fair Value [Line Items]
Net unrealized gain (losses) net of income tax	$ 1.3	$ 5.4
Foreign Exchange Forward
Derivatives Fair Value [Line Items]
Derivative, notional amount	$ 140.1	87.7
Derivative remaining maturity period	1 year
Derivative net current liability	$ (1)	$ (5.4)

Derivative Financial Instrume_4

Derivative Financial Instruments - Summary of Gains or Losses Recorded in Consolidated Statement of Operations for FX Forward Contracts (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Designated | Cost of Sales
Derivative Instruments Gain Loss [Line Items]
Gains (loss) on foreign currency exchange contracts	$ 2.3	$ (5.8)	$ (1.1)
Non-Designated | Other Income (Expense) - Net
Derivative Instruments Gain Loss [Line Items]
Gains (loss) on foreign currency exchange contracts	$ (3.3)	$ 7.2	$ 0.4

Inventories - Components of Inv

Inventories - Components of Inventories (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Inventory Disclosure [Abstract]
Raw materials	$ 164.7	$ 161.2
Work-in-process	111.3	141.3
Finished goods	390.5	309.4
Total Inventories	$ 666.5	$ 611.9

Notes Receivable - Narrative (D

Notes Receivable - Narrative (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Receivables [Abstract]
Notes receivable, current	$ 6.7	$ 10.6
Notes receivable, long term	1.1	$ 2
Reserve for the remaining net value of the note	$ 4.8

Property, Plant and Equipment -

Property, Plant and Equipment - Components of property, plant and equipment (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment
Total cost	$ 893.5	$ 822.6
Less accumulated depreciation	(527.4)	(487.3)
Property, plant and equipment — net	366.1	335.3
Land
Property, Plant and Equipment
Total cost	14.9	17.9
Building and Improvements
Property, Plant and Equipment
Total cost	201.5	194.7
Machinery, Equipment and Tooling
Property, Plant and Equipment
Total cost	318.4	300.6
Furniture and Fixtures
Property, Plant and Equipment
Total cost	13.8	13.8
Computer Hardware and Software
Property, Plant and Equipment
Total cost	135.8	129.4
Rental Cranes
Property, Plant and Equipment
Total cost	201.9	157.8
Property, plant and equipment — net	153.3	119.9
Construction in Progress
Property, Plant and Equipment
Total cost	$ 7.2	$ 8.4

Property, Plant and Equipment_2

Property, Plant and Equipment - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Property, Plant and Equipment
Asset impairment expense	$ 0	$ 171.9	$ 1.9
Additions of property, plant and equipment	7
Other Current Assets
Property, Plant and Equipment
Assets held for sale	$ 3	$ 6.7

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Changes in goodwill by reportable segment (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Goodwill
Balance at the beginning of the period	$ 80.1	$ 249.7
Goodwill impairment		(166.5)
Purchase accounting adjustments		(0.7)
Foreign currency impact	(0.5)	(2.4)
Net balance at the end of the period	79.6	80.1
Americas - Manufacturing
Goodwill
Balance at the beginning of the period	0	166.5
Goodwill impairment		(166.5)
Purchase accounting adjustments		0
Foreign currency impact	0	0
Net balance at the end of the period	0	0
Americas Distribution
Goodwill
Balance at the beginning of the period	14.4	15.1
Goodwill impairment		0
Purchase accounting adjustments		(0.7)
Foreign currency impact	0	0
Net balance at the end of the period	14.4	14.4
Middle East and Asia Pacific ("MEAP")
Goodwill
Balance at the beginning of the period	65.7	68.1
Goodwill impairment		0
Purchase accounting adjustments		0
Foreign currency impact	(0.5)	(2.4)
Net balance at the end of the period	$ 65.2	$ 65.7

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Schedule of Goodwill Balances by Reporting Unit (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Goodwill [Line Items]
Gross Amount	$ 328.3	$ 328.8
Accumulated Impairment Amount	(248.7)	(248.7)
Net Amount	79.6	80.1	$ 249.7
Americas - Manufacturing
Goodwill [Line Items]
Gross Amount	166.5	166.5
Accumulated Impairment Amount	(166.5)	(166.5)
Net Amount	0	0	166.5
Americas Distribution
Goodwill [Line Items]
Gross Amount	14.4	14.4
Accumulated Impairment Amount	0	0
Net Amount	14.4	14.4	15.1
EURAF
Goodwill [Line Items]
Gross Amount	82.2	82.2
Accumulated Impairment Amount	(82.2)	(82.2)
Net Amount	0	0
Middle East and Asia Pacific ("MEAP")
Goodwill [Line Items]
Gross Amount	65.2	65.7
Accumulated Impairment Amount	0	0
Net Amount	$ 65.2	$ 65.7	$ 68.1

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Goodwill [Line Items]
Amortization of intangible assets	$ 3.2	$ 3.1	$ 1.4
Non Cash Impairement Charge To Write Down Of Goodwill		166.5
Americas
Goodwill [Line Items]
Non-cash impairment charge		$ 5.4
Impairment, Intangible Asset, Indefinite-Lived (Excluding Goodwill), Statement of Income or Comprehensive Income [Extensible Enumeration]		Asset Impairment Charges
Grove Tradename to its fair value		$ 39

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets - Gross carrying amount, accumulated amortization and net book value of intangible assets other than goodwill (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Intangible asset balances by major asset class
Intangible assets, gross (excluding goodwill)	$ 169.7	$ 167.2
Finite-lived intangible assets, amortization amount	(44.1)	(40.5)
Finite-lived intangible assets, book value	18.7
Intangible assets, book value	125.6	126.7
Indefinite-lived Intangible Assets
Intangible asset balances by major asset class
Intangible assets, gross (excluding goodwill)	106.9	105
Finite-lived intangible assets, amortization amount	0	0
Intangible assets, book value	106.9	105
Indefinite-lived Intangible Assets | Distribution Network
Intangible asset balances by major asset class
Indefinite-lived intangible assets, book value	14.3	14
Finite-lived intangible assets, amortization amount	0	0
Indefinite-lived Intangible Assets | Trademarks and Tradenames
Intangible asset balances by major asset class
Indefinite-lived intangible assets, book value	92.6	91
Finite-lived intangible assets, amortization amount	0	0
Finite-Lived Intangible Assets
Intangible asset balances by major asset class
Finite-lived intangible assets, carrying amount	62.8	62.2
Finite-lived intangible assets, amortization amount	(44.1)	(40.5)
Finite-lived intangible assets, book value	18.7	21.7
Finite-Lived Intangible Assets | Customer Relationships
Intangible asset balances by major asset class
Finite-lived intangible assets, carrying amount	26.5	26.5
Finite-lived intangible assets, amortization amount	(11.6)	(10)
Finite-lived intangible assets, book value	14.9	16.5
Finite-Lived Intangible Assets | Patents
Intangible asset balances by major asset class
Finite-lived intangible assets, carrying amount	29.2	28.7
Finite-lived intangible assets, amortization amount	(28.8)	(28.2)
Finite-lived intangible assets, book value	0.4	0.5
Finite-Lived Intangible Assets | Noncompetition agreements
Intangible asset balances by major asset class
Finite-lived intangible assets, carrying amount	4.2	4.2
Finite-lived intangible assets, amortization amount	(2)	(1.2)
Finite-lived intangible assets, book value	2.2	3
Finite-Lived Intangible Assets | Other Intangibles
Intangible asset balances by major asset class
Finite-lived intangible assets, carrying amount	0.7	0.6
Finite-lived intangible assets, amortization amount	(0.7)	(0.5)
Finite-lived intangible assets, book value	0	0.1
Finite-Lived Intangible Assets | Trademarks and Tradenames
Intangible asset balances by major asset class
Finite-lived intangible assets, carrying amount	2.2	2.2
Finite-lived intangible assets, amortization amount	(1)	(0.6)
Finite-lived intangible assets, book value	$ 1.2	$ 1.6

Goodwill and Intangible Asset_6

Goodwill and Intangible Assets - Estimated Amortization Expense (Details) $ in Millions	Dec. 31, 2023 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2024	$ 2.9
2025	2.9
2026	2.5
2027	1.4
2028	1.4
Thereafter	7.6
Total	$ 18.7

Accounts Payable and Accrued _3

Accounts Payable and Accrued Expenses - Schedule of Accounts Payable and Accrued Expenses (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Payables and Accruals [Abstract]
Trade accounts payable	$ 254.7	$ 274.6
Employee-related expenses	57.9	51
Accrued vacation	23.7	22.4
Miscellaneous accrued expenses	121.1	98.4
Total accounts payable and accrued expenses	$ 457.4	$ 446.4

Debt - Schedule of outstanding

Debt - Schedule of outstanding debt (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Total debt	$ 372.1	$ 385.6
Deferred financing costs	(1.6)	(2.4)
Short-term borrowings and current portion of long-term debt	(13.4)	(6.1)
Long-term debt	358.7	379.5
ABL Revolving Credit Facility
Debt Instrument [Line Items]
Borrowing under senior secured asset based revolving credit facility	60	80
Senior Notes Due 2026
Debt Instrument [Line Items]
Total debt	300	300
Other
Debt Instrument [Line Items]
Total debt	$ 13.7	$ 8

Debt - Narrative (Details)

Debt - Narrative (Details) € in Millions, ¥ in Millions, $ in Millions		12 Months Ended
	Mar. 25, 2019 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2023 EUR (€)	Dec. 31, 2023 CNY (¥)
Debt Instrument [Line Items]
Unamortized debt issuance costs		$ 1.6	$ 2.4
Carrying amount		372.1	385.6
Overdraft Facilities		45.2		€ 37	¥ 30
Bank Overdraft outsatanding		$ 11.2
Period for which the entity will be able to comply with the financial covenants		12 months
Senior Notes Due 2026
Debt Instrument [Line Items]
Face amount of debt	$ 300
Debt instrument interest rate	9%	9%		9%	9%
Interest on the notes	Interest on the 2026 Notes is payable in cash semi-annual in arrears on April 1 and October 1 of each year.
Carrying amount		$ 300	$ 300
ABL Revolving Credit Facility
Debt Instrument [Line Items]
Maximum borrowing capacity under revolving credit facility	$ 275
Weighted average interest rate (as a percent)		5.20%	3.10%	5.20%	5.20%
Line of credit outstanding		$ 60	$ 80
Highest daily borrowing		119.6	112.5
Average borrowing		103.4	90.9
Excess capacity		211.6
Line of credit borrowing capacity		$ 275
ABL Revolving Credit Facility | SOFR Spread
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)		1.25%
ABL Revolving Credit Facility | Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)		0.25%
ABL Revolving Credit Facility | Letter of Credit
Debt Instrument [Line Items]
Maximum borrowing capacity under revolving credit facility	75
Line of credit outstanding		$ 3.4
ABL Revolving Credit Facility | Letter of Credit | German Borrowers
Debt Instrument [Line Items]
Maximum borrowing capacity under revolving credit facility	$ 10
Other
Debt Instrument [Line Items]
Carrying amount		$ 13.7	$ 8
Weighted average interest rate (as a percent)		4.90%		4.90%	4.90%

Debt - Schedule of Revolving Cr

Debt - Schedule of Revolving Credit Facility Bear Interest at Variable Rate Based Upon Average Quarterly Availability (Details) - ABL Revolving Credit Facility	12 Months Ended
	Dec. 31, 2023
SOFR Spread
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)	1.25%
Greater Than or Equal to 50% of Aggregate Commitment | Alternative Base Rate Spread
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)	0.25%
Greater Than or Equal to 50% of Aggregate Commitment | SOFR Spread
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)	1.25%
Less Than 50% of Aggregate Commitment | Alternative Base Rate Spread
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)	0.50%
Less Than 50% of Aggregate Commitment | SOFR Spread
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)	1.50%

Debt - Schedule of Aggregate Fu

Debt - Schedule of Aggregate Future Maturities of Outstanding Debt Obligations (Details) $ in Millions	Dec. 31, 2023 USD ($)
Aggregate scheduled future maturities of outstanding debt obligations
2024	$ 13.4
2025	60.3
2026	300
2028	0
Thereafter	0
Total	$ 373.7

Debt - Schedule of Aggregate _2

Debt - Schedule of Aggregate Future Maturities of Outstanding Debt Obligations (Parenthetical) (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Debt Disclosure [Abstract]
Deferred financing costs	$ 1.6	$ 2.4

Accounts Receivable Factoring -

Accounts Receivable Factoring - Narrative (Details) € in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2023 EUR (€)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Transfers and Servicing [Abstract]
Proceeds from factoring of accounts receivable		$ 163.5	$ 234.5
Non U S maximum availability under these programs | €	€ 0
Maximum availability under these programs		$ 25

Income Taxes - Summary of Incom

Income Taxes - Summary of Income (Loss) from Continuing Operations Before Income Taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income (loss) from continuing operations before income taxes:
United States	$ (32.7)	$ (203.8)	$ (39)
Foreign	76.9	83.6	56.1
Income (loss) before income taxes	$ 44.2	$ (120.2)	$ 17.1

Income Taxes - Schedule of Prov

Income Taxes - Schedule of Provision for Income Taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Current:
United States federal and state	$ 0.3	$ (11.7)	$ (1.2)
Foreign	10.7	10.9	7.9
Total current	11	(0.8)	6.7
Deferred:
United States federal and state	0	(2.4)	0.6
Foreign	(6)	6.6	(1.2)
Total deferred	(6)	4.2	(0.6)
Provision for income taxes	$ 5	$ 3.4	$ 6.1

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Operating Loss Carryforwards [Line Items]
Discrete tax benefit foreign	$ 3.2
Tax effect of non-deductible legal reserves	8.2
Tax cuts and jobs act of 2017 change in net operating losses and valuation allowance	48	$ 22.9	$ 2.5
Recognized tax benefit			1.6
Deferred tax assets, valuation allowance	130.8	174.1
Tax cuts and jobs act, unremitted earnings of non-United States subsidiaries	175.7
Tax cuts and jobs act, additional unremitted earnings of non-United States subsidiaries	397.4	478.1
Federal income tax at statutory rate	9.3	(25.2)	3.6
Interest expense carryforwards	$ 43.2	26.8
Percentage of tax adjustable	30%
Change to gross unrecognized tax (expense) benefits including interest and penalties	$ 0.2	(11)	(2.1)
Uncertain tax liabilities interest and penalties	0.2	(1.7)	(0.4)
Uncertain tax liabilities interest and penalties	9.1	9.1	18.4	$ 20.1
Uncertain tax liabilities interest and penalties accrued	1.4	1.2	2.9
Unrecognized tax benefits due to the closing of statues of limitations	0.2	2	1.4
Unrecognized tax benefits that would impact effective tax rate	4.5	4.7	14
Coronavirus aid relief and economic security act
Operating Loss Carryforwards [Line Items]
Uncertain tax liabilities interest and penalties		12.1
Interest on uncertain tax position		1.2
Domestic Tax Authority
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	96.4	96.8
Federal income tax at statutory rate			1.9
Operating loss carryforwards with specific expiration period	14.1	13.5
Operating loss carryforwards without time restrictions for future use	$ 82.3	$ 83.3
Operating loss carryforwards expiration period	2036	2036
Maximum annual utilization percentage of indefinite lived loss carryforwards	80%
State and Local Jurisdiction
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	$ 616.1	$ 651.9
Operating loss carryforwards expiration period	2043
Non-U.S. Tax Authority
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	$ 212.4	263.5
Net operating loss carryforwards, valuation allowance	48.8	163.7
Ministry of Foreign Countries
Operating Loss Carryforwards [Line Items]
Change in valuation allowance, deferred tax asset			(7.2)
Deferred tax assets, valuation allowance	$ 19	$ 1.2	2.7
Increase in deferred tax assets, valuation allowance			$ 7.2

Income Taxes - Reconciliation o

Income Taxes - Reconciliation of the U.S. Federal Statutory Income Tax Rate to the Company's Effective Income Tax Rate for Continuing Operations (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]
Federal income tax at statutory rate	$ 9.3	$ (25.2)	$ 3.6
State income tax provision	2	0.9	0.3
Manufacturing and research incentives	(1.3)	(0.5)	(0.2)
Taxes on foreign income which differ from the federal statutory rate	9.1	(1.9)	1.5
Adjustments for unrecognized tax benefits	0.2	(11)	(2.3)
Adjustments to valuation allowances	(28.6)	5.2	4.5
United States tax reform	10.1	4.8	(1.6)
Goodwill and indefinite-lived intangible asset impairment	0	31.7	0
Audit settlements	(3)	0	(1.9)
Non-deductible expenses	8.2	1.6	1.3
Other items	(1)	(2.2)	0.9
Provision for income taxes	$ 5	$ 3.4	$ 6.1

Income Taxes - Schedules of Def

Income Taxes - Schedules of Deferred Tax Assets (Liabilities) (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Non-current deferred income tax assets (liabilities):
Inventories	$ 14.7	$ 25.3
Deferred employee benefits	27.8	28.2
Product warranty reserves	7.8	8.7
Product liability reserves	2.6	2.2
Tax credits	7.9	7.2
Loss and other tax attribute carryforwards	114.1	129.6
Deferred revenue	3.9	0.2
Capitalized research costs	10.5	4.8
Other	12.5	13.8
Total deferred income tax assets	201.8	220
Less valuation allowance	(130.8)	(174.1)
Net deferred income tax assets	71	45.9
Accounts receivable	0	(4)
Property, plant and equipment	25.6	5.1
Intangible assets	28.5	28
Total deferred income tax liabilities	54.1	37.1
Net deferred income tax assets	16.9	8.8
Components of Deferred Tax Assets and Liabilities [Abstract]
Long-term income tax assets, included in other non-current assets	24.4	13.7
Long-term deferred income tax liability	(7.5)	(4.9)
Net deferred income tax asset	$ 16.9	$ 8.8

Income Taxes - Schedule of Open

Income Taxes - Schedule of Open Tax Years for Which the Company could be Subject to Income Tax Examination (Details)	12 Months Ended
	Dec. 31, 2023
United States | Earliest Tax Year
Income Tax Examination [Line Items]
Year under examination	2016
United States | Latest Tax Year
Income Tax Examination [Line Items]
Year under examination	2023
China | Earliest Tax Year
Income Tax Examination [Line Items]
Year under examination	2014
China | Latest Tax Year
Income Tax Examination [Line Items]
Year under examination	2023
France | Earliest Tax Year
Income Tax Examination [Line Items]
Year under examination	2021
France | Latest Tax Year
Income Tax Examination [Line Items]
Year under examination	2023
Germany | Earliest Tax Year
Income Tax Examination [Line Items]
Year under examination	2018
Germany | Latest Tax Year
Income Tax Examination [Line Items]
Year under examination	2023

Income Taxes - Reconciliation_2

Income Taxes - Reconciliation of the Beginning and Ending Amount of Unrecognized Tax Benefits (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Balance at beginning of year	$ 9.1	$ 18.4	$ 20.1
Additions for tax positions of current year	0.1	0.1	0.1
Additions for tax positions of prior years	0.1	3.6	0
Reductions for tax positions of prior years	0	(11)	(0.2)
Reductions based on settlements with tax authorities	0	0	(0.2)
Reductions for lapse of statute of limitations	(0.2)	(2)	(1.4)
Balance at end of year	$ 9.1	$ 9.1	$ 18.4

Net Income (Loss) Per Common _2

Net Income (Loss) Per Common Share - Reconciliation of the weighted average shares outstanding used to compute basic and diluted net income (loss) per common share (Details) - shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Earnings Per Share [Abstract]
Basic weighted average common shares outstanding (in shares)	35,093,963	35,184,336	34,903,189
Effect of dilutive securities - equity compensation awards	868,815		549,366
Diluted weighted average common shares outstanding (in shares)	35,962,778	35,184,336	35,452,555

Net Income (Loss) Per Common _3

Net Income (Loss) Per Common Share - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Earnings Per Share [Abstract]
Number of anti-dilutive shares excluded from the calculation of diluted earnings per share	431,392		358,706
Cash dividends declared or paid	$ 0	$ 0	$ 0

Equity - Narrative (Details)

Equity - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Class Of Stock [Line Items]
Common stock, shares authorized (in shares)	75,000,000	75,000,000
Par value of common stock (in dollars per share)	$ 0.01
Preferred stock, shares authorized (in shares)	3,500,000	3,500,000
Par value of preferred stock per share (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares issued (in shares)	0
Common stock repurchased, shares	320,984
Gain (Loss), Foreign Currency Transaction, after Tax, Total	$ (9.3)	$ 0	$ 0
Common Stock
Class Of Stock [Line Items]
Stock repurchase program, authorized amount	5.5
Stock repurchase program, remaining authorized amount	35
Maximum | Common Stock
Class Of Stock [Line Items]
Stock repurchase program, authorized amount	$ 35

Equity - Schedule of Components

Equity - Schedule of Components of Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Equity [Abstract]
Foreign currency translation, net of income tax benefit of $0.2 and $0.1	$ (77.4)	$ (98)
Derivative instrument fair market value, net of incometax provision of $0.0 and $0.0	1.3	5.4
Employee pension and postretirement benefit adjustments, net of income benefit of $13.6 and $12.9	(10.3)	(15.3)
Total accumulated other comprehensive loss	$ (86.4)	$ (107.9)

Equity - Schedule of Componen_2

Equity - Schedule of Components of Accumulated Other Comprehensive Loss (Parenthetical) (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Equity [Abstract]
Foreign currency translation, tax provision	$ 0.2	$ 0.1
Derivative instrument fair market value, tax provision	0	0
Employee pension and postretirement benefit adjustments, tax benefit	$ 13.6	$ 12.9

Equity - Reconciliation of Accu

Equity - Reconciliation of Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Increase (Decrease) in Equity [Roll Forward]
Beginning balance	$ 537.8
Total other comprehensive income (loss), net of income tax	21.5	$ (5.5)	$ (4.9)
Ending balance	603.3	537.8
Gains (Losses) on Cash Flow Hedges
Increase (Decrease) in Equity [Roll Forward]
Beginning balance	5.4	0
Other comprehensive income (loss) before reclassifications	(1.8)	(0.4)
Amounts reclassified from accumulated other comprehensive loss	(2.3)	5.8
Total other comprehensive income (loss), net of income tax	(4.1)	5.4
Ending balance	1.3	5.4	0
Pension & Postretirement
Increase (Decrease) in Equity [Roll Forward]
Beginning balance	(15.3)	(32.3)
Other comprehensive income (loss) before reclassifications	2.4	15.5
Amounts reclassified from accumulated other comprehensive loss	2.6	1.5
Total other comprehensive income (loss), net of income tax	5	17
Ending balance	(10.3)	(15.3)	(32.3)
Foreign Currency Translation
Increase (Decrease) in Equity [Roll Forward]
Beginning balance	(98)	(70.1)
Other comprehensive income (loss) before reclassifications	11.3	(27.9)
Amounts reclassified from accumulated other comprehensive loss	9.3	0
Total other comprehensive income (loss), net of income tax	20.6	(27.9)
Ending balance	(77.4)	(98)	(70.1)
Accumulated Other Comprehensive Loss
Increase (Decrease) in Equity [Roll Forward]
Beginning balance	(107.9)	(102.4)
Other comprehensive income (loss) before reclassifications	11.9	(12.8)
Amounts reclassified from accumulated other comprehensive loss	9.6	7.3
Total other comprehensive income (loss), net of income tax	21.5	(5.5)
Ending balance	$ (86.4)	$ (107.9)	$ (102.4)

Equity - Reconciliation of Recl

Equity - Reconciliation of Reclassifications Out of Accumulated Other Comprehensive Income (Loss), Net of Income Taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Schedule of Reclassifications out of Accumulated Comprehensive Income (Loss) [Line Items]
Cost of sales	$ 1,802.6	$ 1,668	$ 1,413
Total before income taxes	44.2	(120.2)	17.1
Income tax benefit (provision)	(5)	(3.4)	(6.1)
Net income (loss)	39.2	(123.6)	11
Other expense - net	(13)	5.8	1
Reclassification out of Accumulated Other Comprehensive Income
Schedule of Reclassifications out of Accumulated Comprehensive Income (Loss) [Line Items]
Net income (loss)	(9.6)	(7.3)	(2.2)
Gains and Losses on Cash Flow Hedges | Reclassification out of Accumulated Other Comprehensive Income
Schedule of Reclassifications out of Accumulated Comprehensive Income (Loss) [Line Items]
Total before income taxes	2.3	(5.8)	(1.1)
Income tax benefit (provision)	0	0	0
Net income (loss)	2.3	(5.8)	(1.1)
Gains and Losses on Cash Flow Hedges | Reclassification out of Accumulated Other Comprehensive Income | Foreign Currency Exchange Contracts
Schedule of Reclassifications out of Accumulated Comprehensive Income (Loss) [Line Items]
Cost of sales	2.3	(5.8)	(1.1)
Actuarial Losses | Reclassification out of Accumulated Other Comprehensive Income
Schedule of Reclassifications out of Accumulated Comprehensive Income (Loss) [Line Items]
Other expense - net	(2.6)	(2.9)	(4.7)
Amortization of Prior Service Cost | Reclassification out of Accumulated Other Comprehensive Income
Schedule of Reclassifications out of Accumulated Comprehensive Income (Loss) [Line Items]
Other expense - net	(0.1)	1.3	2.6
Pension Settlement Charge | Reclassification out of Accumulated Other Comprehensive Income
Schedule of Reclassifications out of Accumulated Comprehensive Income (Loss) [Line Items]
Other expense - net	0.1	0.1	0.9
Pension & Postretirement | Reclassification out of Accumulated Other Comprehensive Income
Schedule of Reclassifications out of Accumulated Comprehensive Income (Loss) [Line Items]
Total before income taxes	(2.6)	(1.5)	(1.2)
Income tax benefit (provision)	0	0	0.1
Net income (loss)	(2.6)	(1.5)	(1.1)
Foreign currency translation | Reclassification out of Accumulated Other Comprehensive Income
Schedule of Reclassifications out of Accumulated Comprehensive Income (Loss) [Line Items]
Total before income taxes	(9.3)	0	0
Income tax benefit (provision)	0	0	0
Net income (loss)	(9.3)	0	0
Losses on foreign currency translation	$ (9.3)	$ 0	$ 0

Stock-Based Compensation - Narr

Stock-Based Compensation - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023		Dec. 31, 2022	Dec. 31, 2021
Stock-Based Compensation
Share-based compensation, remaining shares available for issuance (in shares)	3,271,119
Engineering Selling and Administrative Expenses
Stock-Based Compensation
Stock-based compensation expense (in dollars)	$ 11.5		$ 8.5	$ 7.1
Restricted Stock | Director
Stock-Based Compensation
Number of shares of other than options granted during the period (in shares)	77,576		56,640	59,280
Employee Stock Option
Stock-Based Compensation
Stock-based compensation expense (in dollars)	$ 0		$ 0.1	$ 0.6
Number of share options granted during the period (in shares)	0
Employee Stock Option | Employees
Stock-Based Compensation
Vesting period (in years)	3 years
Expiration period (in years)	10 years
Number of share options granted during the period (in shares)	0		0	0
Restricted Stock Units
Stock-Based Compensation
Stock-based compensation expense (in dollars)	$ 6.3		$ 5.2	$ 4.7
Unrecognized compensation expense before income tax (in dollars)	$ 6.2
Recognition period for unrecognized compensation expense (in years)	1 year 9 months 18 days
Number of shares of other than options granted during the period (in shares)	520,132		413,543	417,535
Restricted Stock Units | Employees
Stock-Based Compensation
Vesting period (in years)	3 years
Anniversary period from grant date, for grants made prior to 2019 (in years)				3 years
Performance Shares
Stock-Based Compensation
Stock-based compensation expense (in dollars)	$ 5.2		$ 3.2	$ 1.9
Unrecognized compensation expense before income tax (in dollars)	$ 5.5
Recognition period for unrecognized compensation expense (in years)	1 year 8 months 12 days
Performance period (in years)	3 years
Period of U.S. Treasury rates as a basis for assumed risk-free rates (in years)	3 years
Number of shares of other than options granted during the period (in shares)	316,022	[1]	122,280	159,247
2013 Omnibus Plan
Stock-Based Compensation
Share-based compensation, shares authorized (in shares)	7,477,395
Performance Shares 2023 | Performance Shares
Stock-Based Compensation
Performance period (in years)	3 years
Percentage of shares paid based on total shareholder return relative to peer group (as a percent)	60%
Percentage of shares paid based on adjusted EBITDA (as a percent)	40%
Increase decrease in percentage of shares paid based on total shareholder return relative to defined peer group	20%
Percentage of shares of other than options granted during the period	200%
Performance Shares 2022 | Performance Shares
Stock-Based Compensation
Performance period (in years)			3 years
Percentage of shares paid based on total shareholder return relative to peer group (as a percent)			60%
Percentage of shares paid based on adjusted EBITDA (as a percent)			40%
Increase decrease in percentage of shares paid based on total shareholder return relative to defined peer group			20%
Percentage of shares of other than options granted during the period			200%
Performance Shares 2021 | Performance Shares
Stock-Based Compensation
Performance period (in years)				3 years
Percentage of shares paid based on total shareholder return relative to peer group (as a percent)				60%
Percentage of shares paid based on adjusted EBITDA (as a percent)				40%
Increase decrease in percentage of shares paid based on total shareholder return relative to defined peer group				20%
Percentage of shares of other than options granted during the period				200%
[1] Performance shares granted assuming achievement of performance goals at target.

Stock-Based Compensation - Summ

Stock-Based Compensation - Summary of the Company's Stock Option Activity (Details) - Employee Stock Option $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2023 USD ($) $ / shares shares
Shares
Options outstanding as of December 31, 2022 | shares	552,923
Granted | shares	0
Exercised | shares	(17,135)
Forfeited | shares	0
Canceled | shares	(41,418)
Options outstanding as of December 31, 2023 | shares	494,370
Options exercisable as of December 31, 2023 | shares	494,370
Weighted Average Exercise Price Per Share
Options outstanding as of December 31, 2022 | $ / shares	$ 21.13
Granted | $ / shares	0
Exercised | $ / shares	14.81
Options forfeited weighted average cost | $ / shares	0
Options canceled weighted average cost | $ / shares	19.63
Options outstanding as of December 31, 2023 | $ / shares	21.47
Options exercisable as of December 31, 2023 | $ / shares	$ 21.47
Aggregate Intrinsic Value
Options outstanding | $	$ 324,847
Options exercisable | $	$ 324,847

Stock-Based Compensation - Sche

Stock-Based Compensation - Schedule of Nonvested Share Activity (Details) - $ / shares		12 Months Ended
		Dec. 31, 2023		Dec. 31, 2022	Dec. 31, 2021
Restricted Stock Units
Shares
Unvested as of December 31, 2022 (in shares)		647,212
Granted (in shares)		520,132		413,543	417,535
Vested (in shares)		(359,655)
Forfeited (in shares)		(2,227)
Unvested as of December 31, 2023 (in shares)		805,462		647,212
Weighted Average Grant Date Fair Value Per Share
Weighted average grant date fair value as of December 31, 2022 (in dollars per share)		$ 16.45
Granted (in dollars per share)		14.28
Vested (in dollars per share)		15.74
Cancelled (in dollars per share)		17.27
Weighted average grant date fair value as of December 31, 2023 (in dollars per share)		$ 15.37		$ 16.45
Performance Shares
Shares
Unvested as of December 31, 2022 (in shares)		459,774
Granted (in shares)		316,022	[1]	122,280	159,247
Adjustment for performance results achieved	[2]	(84,576)
Vested (in shares)		(46,145)
Forfeited (in shares)		(14,680)
Unvested as of December 31, 2023 (in shares)		630,395		459,774
Weighted Average Grant Date Fair Value Per Share
Weighted average grant date fair value as of December 31, 2022 (in dollars per share)		$ 17.30
Granted (in dollars per share)	[1]	16.05
Adjustment for performance results achieved	[2]	12.67
Vested (in dollars per share)		12.67
Cancelled (in dollars per share)		18.28
Weighted average grant date fair value as of December 31, 2023 (in dollars per share)		$ 17.39		$ 17.30
[1] Performance shares granted assuming achievement of performance goals at target. Adjustment due to performance share units granted in 2020 and vested in 2023 where the number of shares achieved based on the three-year performance period ended December 31, 2022 were lower than target.

Stock-Based Compensation - Sc_2

Stock-Based Compensation - Schedule of Nonvested Share Activity (Parenthetical) (Details) - Performance Shares	12 Months Ended
	Dec. 31, 2023
Stock-Based Compensation
Performance period (in years)	3 years
Performance Share Granted 2020 and Vested 2023
Stock-Based Compensation
Performance period (in years)	3 years

Stock-Based Compensation - Sc_3

Stock-Based Compensation - Schedule of the Assumptions Used to Estimate the Fair Value of Each Option Grant (Details) - Performance Shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Assumptions used to estimate the fair value of each option grant
Correlation (as a percent)	28.20%	25.90%	27.90%
Risk-free Interest rate (as a percent)	4.10%	1.70%	0.20%
Expected volatility (as a percent)	60.30%	59.50%	59%
Expected dividend yield (as a percent)	0%	0%	0%

Segments - Narrative (Details)

Segments - Narrative (Details)	12 Months Ended
	Dec. 31, 2023 Segment
Segment Reporting [Abstract]
Number of reportable segments	3

Segments - Schedule of Informat

Segments - Schedule of Information by Reportable Segment (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Segment Reporting Information [Line Items]
Net sales	$ 2,227.8	$ 2,032.5	$ 1,720.2
Operating (loss) income	92.4	(93)	46.5
Depreciation	56.6	60.6	45.5
Capital Expenditures	77.4	61.8	40.4
Operating Segments
Segment Reporting Information [Line Items]
Operating (loss) income	156.1	(51.8)	97.1
Operating Segments | Americas
Segment Reporting Information [Line Items]
Net sales	1,211.2	1,013	757.6
Operating (loss) income	111.7	(88.8)	57.3
Depreciation	29.2	35.4	20.7
Capital Expenditures	46.5	32	11.3
Operating Segments | EURAF
Segment Reporting Information [Line Items]
Net sales	669.6	761.5	677
Operating (loss) income	(7.9)	(3.2)	8.9
Depreciation	22.1	20.1	19.8
Capital Expenditures	28.5	27.7	27.5
Operating Segments | Middle East and Asia Pacific ("MEAP")
Segment Reporting Information [Line Items]
Net sales	347	258	285.6
Operating (loss) income	52.3	40.2	30.9
Depreciation	2.4	2.2	2.1
Capital Expenditures	2.4	2.1	1.5
Corporate
Segment Reporting Information [Line Items]
Operating (loss) income	(63.6)	(41.3)	(51.1)
Depreciation	2.9	2.9	2.9
Capital Expenditures	$ 0	$ 0	$ 0.1

Segments - Schedule of Reconcil

Segments - Schedule of Reconciliation of the Company's Segment Operating Income (Loss) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Segment Reporting Reconciling Item For Operating Profit Loss From Segment To Consolidated [Line Items]
Total operating income (loss)	$ 92.4	$ (93)	$ 46.5
Unallocated restructuring expense	1.3	1.5	(1.1)
Operating Segments
Segment Reporting Reconciling Item For Operating Profit Loss From Segment To Consolidated [Line Items]
Total operating income (loss)	156.1	(51.8)	97.1
Corporate
Segment Reporting Reconciling Item For Operating Profit Loss From Segment To Consolidated [Line Items]
Total operating income (loss)	(63.6)	(41.3)	(51.1)
Material Reconciling Items
Segment Reporting Reconciling Item For Operating Profit Loss From Segment To Consolidated [Line Items]
Unallocated restructuring expense	$ (0.1)	$ 0.1	$ 0.5

Segments - Schedule of Net Sale

Segments - Schedule of Net Sales and Property, Plant and Equipment by Geographic Area (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	$ 2,227.8	$ 2,032.5	$ 1,720.2
Property, Plant and Equipment	366.1	335.3
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	1,039.9	906.4	664.5
Property, Plant and Equipment	158.1	146.7
Europe
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	641.9	740.1	653.7
Property, Plant and Equipment	183.8	166.6
Other
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	546	386	$ 402
Property, Plant and Equipment	$ 24.2	$ 22

Segments - Schedule of Net Sa_2

Segments - Schedule of Net Sales By Product (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Product Information [Line Items]
Total net sales	$ 2,227.8	$ 2,032.5	$ 1,720.2
New Machine Sales [Member]
Product Information [Line Items]
Total net sales	1,615.1	1,487.2	1,271.6
Non New Machine Sales [Member]
Product Information [Line Items]
Total net sales	$ 612.7	$ 545.3	$ 448.6

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Commitments And Contingencies [Line Items]
Period over which product liability self-insurance retention levels have varied (in years)	10 years
Product liability reserves - Current	$ 11.4	$ 9.4
Product liability reserves - Non-Current	5.1	0
Estimated insurance recoveries	3.9	0
Warranty claims reserves	56.8	58
Commitment expense	21.2
Statutory maximum penalties	174
Accounts Payable and Accrued Expenses
Commitments And Contingencies [Line Items]
Commitment liability	36.1	$ 14.9
Maximum
Commitments And Contingencies [Line Items]
Product liability self-insurance maximum retention level for new occurrence	$ 3

Guarantees - Narrative (Details

Guarantees - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Product Warranty Liability [Line Items]
Revenue deferred related to buyback obligations included in other current and non-current liabilities	$ 32.2	$ 27.3
Amount of residual value buyback commitments and given by the company	43.4	42.5
Amount of loss guarantees with maximum liabilities	13	15
Revenue deferred related to extended warranties included in other current and non-current liabilities	$ 6.1	6.6
Standard product warranties, low end of range (in months)	12 months
Standard product warranties, high end of range (in months)	60 months
Other Noncurrent Liabilities
Product Warranty Liability [Line Items]
Revenue deferred related to extended warranties included in other current and non-current liabilities	$ 9.7	$ 9.2

Guarantees - Summary of Warrant

Guarantees - Summary of Warranty Activity (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Warranty activity
Balance at beginning of period	$ 58	$ 60.2	$ 63.2
Adjustments to accruals for warranties	28.9	27.3	30.4
Settlements made (in cash or in kind) during the period	(31)	(27.8)	(31.3)
Currency translation	0.9	(1.7)	(2.1)
Balance at end of period	$ 56.8	$ 58	$ 60.2

Restructuring - Narrative (Deta

Restructuring - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Restructuring Cost and Reserve [Line Items]
Restructuring (income) expense	$ 1.3	$ 1.5	$ (1.1)

Employee Benefit Plans - Narrat

Employee Benefit Plans - Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2023 USD ($) Plan	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Manitowoc Deferred Compensation Plan
Total cost incurred under defined contribution plan	$ 8.7	$ 11.9	$ 5.8
Defined contribution plan, Plan name	Manitowoc 401(k) Plan	Manitowoc 401(k) Plan	Manitowoc 401(k) Plan
Amortization of gains and losses in excess of specified percentage (as a percent)	10%
Gain (loss) due to settlements on employee benefit plan			$ 0.9
Postretirement Medical and Other
Manitowoc Deferred Compensation Plan
Annual rate of increase in the per capita cost of covered health care benefits assumed for measurement purposes (as a percent)	6.50%
Ultimate health care cost trend rate (as a percent)	4%
Estimated future employer contributions	$ 1
Gain (loss) due to settlements on employee benefit plan	$ 0	$ 0	0
Deferred Compensation Plan
Manitowoc Deferred Compensation Plan
Number of investment programs | Plan	2
Deferred Compensation Plan | Program A
Manitowoc Deferred Compensation Plan
Program asset	$ 1.2	0.6
Program obligation	1.2	0.6
Deferred Compensation Plan | Program B
Manitowoc Deferred Compensation Plan
Total cost incurred under defined contribution plan	0.2	0.4	0.1
Program asset	8.1	7.1
Program obligation	$ 8.1	7.1
U.S. Pension Plans
Manitowoc Deferred Compensation Plan
Number of defined contribution retirement plans for the employees | Plan	2
Estimated future employer contributions	$ 5.5
Non-U.S. Pension Plans
Manitowoc Deferred Compensation Plan
Total cost incurred under defined contribution plan	1.7	$ 1.7	$ 1.6
Estimated future employer contributions	$ 3.3

Employee Benefit Plans - Schedu

Employee Benefit Plans - Schedule of Components of Period Benefit Costs (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Components of periodic benefit costs
Pension settlement gain			$ (0.9)
United States
Components of periodic benefit costs
Service cost - benefits earned during the year	$ 0	$ 0
Interest cost of projected benefit obligation	5.5	3.2
Non-US Pension Plans
Components of periodic benefit costs
Service cost - benefits earned during the year	1.2	1.6
Interest cost of projected benefit obligation	3	1.7
Pension Plan | United States
Components of periodic benefit costs
Service cost - benefits earned during the year	0	0	0
Interest cost of projected benefit obligation	5.5	3.2	2.8
Expected return on assets	(3.9)	(5.2)	(4.9)
Amortization of prior service cost	0	0	0
Amortization of actuarial net loss (gain)	2.2	1.9	3.2
Pension settlement gain	0	0	0
Net periodic benefit cost	$ 3.8	$ (0.1)	$ 1.1
Weighted average assumptions:
Effective discount rate for benefit obligations (as a percent)	5.40%	2.80%	2.40%
Expected return on plan assets (as a percent)	5%	4.70%	4.30%
Pension Plan | Non-US Pension Plans
Components of periodic benefit costs
Service cost - benefits earned during the year	$ 1.2	$ 1.6	$ 2.3
Interest cost of projected benefit obligation	3	1.7	1.5
Expected return on assets	(1.6)	(1.2)	(1)
Amortization of prior service cost	0.1	0.1	0.1
Amortization of actuarial net loss (gain)	1.6	1.5	1.8
Pension settlement gain	(0.1)	(0.1)	(0.9)
Net periodic benefit cost	$ 4.2	$ 3.6	$ 3.8
Weighted average assumptions:
Effective discount rate for benefit obligations (as a percent)	4.70%	1.40%	1.20%
Expected return on plan assets (as a percent)	5.40%	2.90%	1.60%
Rate of compensation increase (as a percent)	3.70%	4.10%	4.10%
Postretirement Medical and Other
Components of periodic benefit costs
Service cost - benefits earned during the year	$ 0.1	$ 0.1	$ 0.1
Interest cost of projected benefit obligation	0.4	0.2	0.2
Expected return on assets	0	0	0
Amortization of prior service cost	0	(1.4)	(2.7)
Amortization of actuarial net loss (gain)	(1.2)	(0.5)	(0.3)
Pension settlement gain	0	0	0
Net periodic benefit cost	$ (0.7)	$ (1.6)	$ (2.7)
Weighted average assumptions:
Effective discount rate for benefit obligations (as a percent)	5.40%	2.50%	2%

Employee Benefit Plans - Reconc

Employee Benefit Plans - Reconciliation of the Changes in Benefit Obligation, Plan Assets, and Funded Status (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Change in Plan Assets
Fair value of plan assets, beginning of year	$ 112
Fair value of plan assets, end of year	113.5	$ 112
Amounts recognized in the Consolidated Balance Sheets as of December 31
Long-term pension obligation	(55.8)	(51.7)
Long-term postretirement medical and other benefit obligations	(5.6)	(8.2)
United States
Change in Benefit Obligation
Benefit obligation, beginning of year	106.4	141.2
Service cost	0	0
Interest cost	5.5	3.2
Participant contributions	0	0
Actuarial (gain) loss	2.5	(30.1)
Currency translation adjustment	0	0
Pension Settlement	0	0
Benefits paid	(8)	(7.9)
Benefit obligation, end of year	106.4	106.4	$ 141.2
Change in Plan Assets
Fair value of plan assets, beginning of year	82.3	114.6
Actual return on plan assets	7.4	(24.9)
Employer contributions	0.5	0.5
Participant contributions	0	0
Currency translation adjustment	0	0
Pension settlement	0	0
Benefits paid	(8)	(7.9)
Fair value of plan assets, end of year	82.2	82.3	114.6
Funded status	(24.2)	(24.1)
Amounts recognized in the Consolidated Balance Sheets as of December 31
Pension asset	0	0
Short-term pension obligation	(0.5)	(0.5)
Long-term pension obligation	(23.7)	(23.6)
Short-term postretirement medical and other benefit obligations	0	0
Long-term postretirement medical and other benefit obligations	0	0
Net amount recognized	$ (24.2)	$ (24.1)
Weighted-Average Assumptions
Discount rate	5.10%	2.80%
Non-US Pension Plans
Change in Benefit Obligation
Benefit obligation, beginning of year	$ 59	$ 94.5
Service cost	1.2	1.6
Interest cost	3	1.7
Participant contributions	0	0
Actuarial (gain) loss	(0.3)	(27.1)
Currency translation adjustment	2.6	(8)
Pension Settlement	(0.1)	(0.3)
Benefits paid	(3.5)	(3.4)
Benefit obligation, end of year	61.9	59	94.5
Change in Plan Assets
Fair value of plan assets, beginning of year	29.7	50.2
Actual return on plan assets	0	(15)
Employer contributions	3.6	3.4
Participant contributions	0	0
Currency translation adjustment	1.6	(5.2)
Pension settlement	(0.1)	(0.3)
Benefits paid	(3.5)	(3.4)
Fair value of plan assets, end of year	31.3	29.7	50.2
Funded status	(30.6)	(29.3)
Amounts recognized in the Consolidated Balance Sheets as of December 31
Pension asset	2.7	0
Short-term pension obligation	(1.2)	(1.2)
Long-term pension obligation	(32.1)	(28.1)
Short-term postretirement medical and other benefit obligations	0	0
Long-term postretirement medical and other benefit obligations	0	0
Net amount recognized	$ (30.6)	$ (29.3)
Weighted-Average Assumptions
Discount rate	4.20%	4.20%
Rate of compensation increase	3.80%	2.70%
Postretirement Medical and Other
Change in Benefit Obligation
Benefit obligation, beginning of year	$ 9.5	$ 13.7
Service cost	0.1	0.1	0.1
Interest cost	0.4	0.2	0.2
Participant contributions	0.1	0.1
Actuarial (gain) loss	(2.4)	(3.4)
Currency translation adjustment	0	0
Pension Settlement	0	0
Benefits paid	(1.1)	(1.2)
Benefit obligation, end of year	6.6	9.5	13.7
Change in Plan Assets
Fair value of plan assets, beginning of year	0	0
Actual return on plan assets	0	0
Employer contributions	1	1.1
Participant contributions	0.1	0.1
Currency translation adjustment	0	0
Pension settlement	0	0
Benefits paid	(1.1)	(1.2)
Fair value of plan assets, end of year	0	0	$ 0
Funded status	(6.6)	(9.5)
Amounts recognized in the Consolidated Balance Sheets as of December 31
Pension asset	0	0
Short-term pension obligation	0	0
Long-term pension obligation	0	0
Short-term postretirement medical and other benefit obligations	(1)	(1.3)
Long-term postretirement medical and other benefit obligations	(5.6)	(8.2)
Net amount recognized	$ (6.6)	$ (9.5)
Weighted-Average Assumptions
Discount rate	5%	5.40%

Employee Benefit Plans - Amount

Employee Benefit Plans - Amounts Recognized in Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Pension Plan
Defined Benefit Plan Disclosure [Line Items]
Net actuarial gain (loss)	$ (32)	$ (35)
Prior service cost	(0.2)	(0.3)
Total amount recognized	(32.2)	(35.3)
Postretirement Medical and Other
Defined Benefit Plan Disclosure [Line Items]
Net actuarial gain (loss)	8.3	7
Prior service cost	0	0
Total amount recognized	$ 8.3	$ 7

Employee Benefit Plans - Sche_2

Employee Benefit Plans - Schedule of the Weighted-Average Asset Allocation of the Pension Plans (Details)		Dec. 31, 2023	Dec. 31, 2022
United States
Defined Benefit Plan Disclosure [Line Items]
Weighted-average asset allocation (as a percent), Total		100%	100%
Non-US Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Weighted-average asset allocation (as a percent), Total		100%	100%
Equity Securities | United States
Defined Benefit Plan Disclosure [Line Items]
Weighted-average asset allocation (as a percent), Total		53.30%	52.80%
Equity Securities | Non-US Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Weighted-average asset allocation (as a percent), Total		0%	0%
Fixed Income | United States
Defined Benefit Plan Disclosure [Line Items]
Weighted-average asset allocation (as a percent), Total		39.70%	36.90%
Fixed Income | Non-US Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Weighted-average asset allocation (as a percent), Total		39.40%	45.20%
Other | United States
Defined Benefit Plan Disclosure [Line Items]
Weighted-average asset allocation (as a percent), Total		7%	10.30%
Other | Non-US Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Weighted-average asset allocation (as a percent), Total	[1]	60.60%	54.80%
[1] Includes diversified investments that have equity and fixed income holdings.

Employee Benefit Plans - Sche_3

Employee Benefit Plans - Schedule of the Actual Allocations for the Pension Assets and Target Allocations by Asset Class (Details)		Dec. 31, 2023	Dec. 31, 2022
U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Weighted-average asset allocation (as a percent)		100%	100%
Non-U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Weighted-average asset allocation (as a percent)		100%	100%
Equity Securities | U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Target Allocations (as a percent)		50%
Weighted-average asset allocation (as a percent)		53.30%	52.80%
Equity Securities | Non-U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Target Allocations (as a percent)		0%
Weighted-average asset allocation (as a percent)		0%	0%
Debt Securities | U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Target Allocations (as a percent)		40%
Weighted-average asset allocation (as a percent)		39.70%
Debt Securities | Non-U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Target Allocations (as a percent)		48%
Weighted-average asset allocation (as a percent)		39.40%
Other | U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Target Allocations (as a percent)		10%
Weighted-average asset allocation (as a percent)		7%	10.30%
Other | Non-U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Target Allocations (as a percent)		52%
Weighted-average asset allocation (as a percent)	[1]	60.60%	54.80%
[1] Includes diversified investments that have equity and fixed income holdings.

Employee Benefit Plans - Sche_4

Employee Benefit Plans - Schedule of Plan Assets Using the Fair Value Hierarchy (Details) - USD ($) $ in Millions		Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		$ 113.5	$ 112
Net Asset Value ("NAV")
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	[1]	104.4	101.9
Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		1.7	0.9
Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0.7
Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		7.4	8.5
U.S. equity
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		21.7	16.9
U.S. equity | Net Asset Value ("NAV")
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	[1]	21.7	16.9
U.S. equity | Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
U.S. equity | Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
U.S. equity | Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
International equity
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		22.1	27.8
International equity | Net Asset Value ("NAV")
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	[1]	22.1	27.8
International equity | Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
International equity | Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
International equity | Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Corporate bonds and notes
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		16.6	18.5
Corporate bonds and notes | Net Asset Value ("NAV")
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	[1]	16.6	18.5
Corporate bonds and notes | Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Corporate bonds and notes | Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Corporate bonds and notes | Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Government and agency bonds
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		25.5	25.4
Government and agency bonds | Net Asset Value ("NAV")
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	[1]	25.5	25.4
Government and agency bonds | Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Government and agency bonds | Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Government and agency bonds | Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Commingled funds
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		11.1	8.6
Commingled funds | Net Asset Value ("NAV")
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	[1]	11.1	8.6
Commingled funds | Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Commingled funds | Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Commingled funds | Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
International fixed income
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		4.7	1.9
International fixed income | Net Asset Value ("NAV")
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	[1]	4.7	1.9
International fixed income | Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
International fixed income | Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
International fixed income | Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		1	0.9
Cash and cash equivalents | Net Asset Value ("NAV")
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	[1]	0	0
Cash and cash equivalents | Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		1	0.9
Cash and cash equivalents | Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Cash and cash equivalents | Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Money market funds
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0.7	0.7
Money market funds | Net Asset Value ("NAV")
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	[1]	0	0
Money market funds | Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0.7	0
Money market funds | Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0.7
Money market funds | Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Insurance Group Annuity Contracts
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		7.4	8.5	$ 12.6
Insurance Group Annuity Contracts | Net Asset Value ("NAV")
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	[1]	0	0
Insurance Group Annuity Contracts | Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Insurance Group Annuity Contracts | Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Insurance Group Annuity Contracts | Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		7.4	8.5
Other
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		2.7	2.8
Other | Net Asset Value ("NAV")
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	[1]	2.7	2.8
Other | Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Other | Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Other | Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		$ 0	$ 0
[1] Certain assets that are measured at fair value using the NAV per share practical expedient have not been classified in the fair value hierarchy.

Employee Benefit Plans - Reco_2

Employee Benefit Plans - Reconciliation of the Fair Values Measurements of Plan Assets Using Significant Unobservable Inputs (Level 3) from the Beginning of the Year to the End of the Year (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Reconciliation of fair value measurements of plan assets using significant observable inputs
Fair value of plan assets, beginning of year	$ 112
Fair value of plan assets, end of year	113.5	$ 112
Insurance Group Annuity Contracts
Reconciliation of fair value measurements of plan assets using significant observable inputs
Fair value of plan assets, beginning of year	8.5	12.6
Additions	0.5	0
Actual return on assets	(1.2)	(1.9)
Benefit payments	(0.9)	(0.8)
Foreign currency impact	0.5	(1.4)
Fair value of plan assets, end of year	$ 7.4	$ 8.5

Employee Benefit Plans - Sche_5

Employee Benefit Plans - Schedule of Projected Future Benefit Payments from the Plans (Details) $ in Millions	Dec. 31, 2023 USD ($)
U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
2024	$ 8.7
2025	8.8
2026	8.7
2027	8.7
2028	8.7
Thereafter	41.2
Total	84.8
Non-U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
2024	3
2025	3
2026	3.4
2027	3.6
2028	4.2
Thereafter	20.7
Total	37.9
Postretirement Medical and Other
Defined Benefit Plan Disclosure [Line Items]
2024	1
2025	0.9
2026	0.8
2027	0.8
2028	0.7
Thereafter	2.6
Total	$ 6.8

Employee Benefit Plans - Sche_6

Employee Benefit Plans - Schedule of Fair Value of Plan Assets for Which the Accumulated Benefit Obligation is in Excess of the Plan Assets (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
United States
Defined Benefit Plan Disclosure [Line Items]
Projected benefit obligation	$ 106.4	$ 106.4
Accumulated benefit obligation	106.4	106.4
Fair value of plan assets	82.2	82.3
Non-U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Projected benefit obligation	33.8	59
Accumulated benefit obligation	30.6	56.1
Fair value of plan assets	$ 0.5	$ 29.7

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Leases [Line Items]
Operating leases, existence of option to extend	true
Operating leases, existence of option to terminate	true
Operating leases, termination term	1 year
Cash payment for operating leases	$ 29.5	$ 26.8	$ 25.1
Operating lease right-of-use asset obtained in exchange for lease obligations	$ 26
Operating leases, weighted-average remaining lease term	6 years 4 months 24 days	6 years 3 months 18 days
Operating leases, weighted-average discount rate	5.90%	4.90%
Undiscounted lease obligations	$ 12.4
Additional Operating Lease Facility
Leases [Line Items]
Undiscounted lease obligations	$ 4
Maximum
Leases [Line Items]
Operating leases, remaining lease term	20 years
Operating leases, renewal lease term	9 years
Maximum | Additional Operating Lease Facility
Leases [Line Items]
Term of contract	20 years

Leases - Summary of Components

Leases - Summary of Components of Lease Expense (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Leases [Abstract]
Operating lease cost	$ 15.5	$ 14	$ 13.2
Variable lease cost	1.2	1.4	1.5
Total lease cost	$ 16.7	$ 15.4	$ 14.7

Leases - Summary of Supplementa

Leases - Summary of Supplemental Consolidated Balance Sheet Information Related to Leases (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Leases [Abstract]
Operating lease right-of-use assets	$ 59.7	$ 45.2
Other liabilities	$ 13	$ 11.6
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	Other liabilities	Other liabilities
Operating lease liabilities	$ 47.2	$ 34.3
Total operating lease liabilities	$ 60.2	$ 45.9

Leases - Summary of Maturities

Leases - Summary of Maturities of Operating Lease Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Leases [Abstract]
2024	$ 15.4
2025	13.4
2026	10.7
2027	9.8
2028	7.6
Thereafter	15.7
Total lease payments	72.6
Less: imputed interest	(12.4)
Present value of lease liabilities	$ 60.2	$ 45.9

Schedule II_ Valuation and Qual

Schedule II: Valuation and Qualifying Accounts (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Valuation and Qualifying Accounts
Utilization of Reserve	$ 1.4	$ 1.8	$ 1.3
Other, Primarily Impact of Foreign Exchange Rates	(0.1)	(0.3)	0.1
Allowance for Doubtful Accounts
Valuation and Qualifying Accounts
Balance at Beginning of Year	5.3	7.3	8.5
Charge to Costs and Expenses	2.3	0.1	0
Utilization of Reserve	(1.4)	(1.8)	(1.3)
Other, Primarily Impact of Foreign Exchange Rates	(0.1)	(0.3)	0.1
Balance at end of Year	6.1	5.3	7.3
Deferred Tax Valuation Allowance
Valuation and Qualifying Accounts
Balance at Beginning of Year	174.1	170.5	171.4
Charge to Costs and Expenses	1.7	10.6	9.1
Utilization of Reserve	(30.2)	(4.9)	(4.9)
Other, Primarily Impact of Foreign Exchange Rates	(14.8)	(2.1)	(5.1)
Balance at end of Year	$ 130.8	$ 174.1	$ 170.5